BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64-74. [PMID: 16361024 DOI: 10.1016/s1474-4422(05)70284-2] [Cited by in Crossref: 1346] [Cited by in F6Publishing: 1435] [Article Influence: 84.1] [Reference Citation Analysis]
Number Citing Articles
1 Uygar B, Lagerlöf O. Brain O-GlcNAcylation: From Molecular Mechanisms to Clinical Phenotype. Advances in Neurobiology 2023. [DOI: 10.1007/978-3-031-12390-0_9] [Reference Citation Analysis]
2 de Almeida GR, Szczepanik JC, Selhorst I, Cunha MP, Dafre AL. The expanding impact of methylglyoxal on behavior-related disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2023;120:110635. [DOI: 10.1016/j.pnpbp.2022.110635] [Reference Citation Analysis]
3 Hajek A, Kretzler B, Riedel-heller SG, König H. Frequency and correlates of mild cognitive impairment and dementia among the oldest old – Evidence from the representative “Survey on quality of life and subjective well-being of the very old in North Rhine-Westphalia (NRW80+)”. Archives of Gerontology and Geriatrics 2023;104:104804. [DOI: 10.1016/j.archger.2022.104804] [Reference Citation Analysis]
4 Wang X, Chu C, Li H, Lu K, Liu C, Cai Y, Quan S, Zhang S. Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1018027] [Reference Citation Analysis]
5 Singh DD, Shati AA, Alfaifi MY, Elbehairi SEI, Han I, Choi E, Yadav DK. Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development. Cells 2022;11:3767. [DOI: 10.3390/cells11233767] [Reference Citation Analysis]
6 Sood A, Fernandes V, Preeti K, Khot M, Khatri DK, Singh SB. Fingolimod Alleviates Cognitive Deficit in Type 2 Diabetes by Promoting Microglial M2 Polarization via the pSTAT3-jmjd3 Axis. Mol Neurobiol 2022. [DOI: 10.1007/s12035-022-03120-x] [Reference Citation Analysis]
7 Li Z, Wang S, Liu S, Gong X, Wang Y, Wu D, Yang M, Li R, Li H, Li X, Chen S, Jia R, Guo J, Wang J, Liu M, He Y, Wang Y. Synergistic impact of diabetes and cognitive impairment on all-cause and cause-specific mortality in Chinese older adults: A prospective population-based cohort study. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.997260] [Reference Citation Analysis]
8 van Arendonk J, Neitzel J, Steketee RME, van Assema DME, Vrooman HA, Segbers M, Ikram MA, Vernooij MW. Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study. Brain 2022. [DOI: 10.1093/brain/awac354] [Reference Citation Analysis]
9 Gonçalves JS, Seiça RM, Laranjinha J, Lourenço CF. Impairment of neurovascular coupling in the hippocampus due to decreased nitric oxide bioavailability supports early cognitive dysfunction in type 2 diabetic rats. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.11.009] [Reference Citation Analysis]
10 Cachide M, Carvalho L, Rosa IM, Wiltfang J, Henriques AG, da Cruz e Silva OAB. BIN1 rs744373 SNP and APOE alleles specifically associate to common diseases. Front Dement 2022;1. [DOI: 10.3389/frdem.2022.1001113] [Reference Citation Analysis]
11 Uthaiah CA, Devaru NC, Shivakumar NH, R R, Madhunapantula SV. Vitamin D Mitigates Hyperglycemia-Induced Cognition Decline in Danio rerio (Zebrafish) through the Activation of Antioxidant Mechanisms. Antioxidants 2022;11:2114. [DOI: 10.3390/antiox11112114] [Reference Citation Analysis]
12 Blum S, Conen D. Mechanisms and clinical manifestations of cognitive decline in atrial fibrillation patients: potential implications for preventing dementia. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.10.013] [Reference Citation Analysis]
13 Hong S, Kim H. Health related lifestyle changes in middle-aged and older Korean adults and cognitive function: Korean Longitudinal Study of Aging (2006 and 2020). kjhep 2022;39:69-83. [DOI: 10.14367/kjhep.2022.39.3.69] [Reference Citation Analysis]
14 Min SH. Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802). Diabetes Metab J 2022;46:813-4. [DOI: 10.4093/dmj.2022.0259] [Reference Citation Analysis]
15 Čater M, Hölter SM. A Pathophysiological Intersection of Diabetes and Alzheimer's Disease. Int J Mol Sci 2022;23:11562. [PMID: 36232867 DOI: 10.3390/ijms231911562] [Reference Citation Analysis]
16 Zhang Y, Yuan Y, Zhang J, Zhao Y, Zhang Y, Fu J. Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice. Front Aging Neurosci 2022;14:1004557. [DOI: 10.3389/fnagi.2022.1004557] [Reference Citation Analysis]
17 Yu L, Jin J, Xu Y, Zhu X. Aberrant energy metabolism in Alzheimer’s disease. Journal of Translational Internal Medicine 2022;0. [DOI: 10.2478/jtim-2022-0024] [Reference Citation Analysis]
18 Khandelwal M, Manglani K, Upadhyay P, Azad M, Gupta S. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice. Neurobiol Dis 2022;174:105876. [PMID: 36162737 DOI: 10.1016/j.nbd.2022.105876] [Reference Citation Analysis]
19 Claro AE, Palanza C, Mazza M, Rizzi A, Tartaglione L, Marano G, Muti-Schuenemann G, Rigoni M, Muti P, Pontecorvi A, Janiri L, Sani G, Pitocco D. Why do we not reverse the path? Stress can cause depression, reduction of brain-derived neurotrophic factor and increased inflammation. World J Psychiatry 2022; 12(9): 1264-1267 [DOI: 10.5498/wjp.v12.i9.1264] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Liu G, Li Y, Xu Y, Li W. Type 2 diabetes is associated with increased risk of dementia, but not mild cognitive impairment: a cross-sectional study among the elderly in Chinese communities. Front Aging Neurosci 2022;14:1004954. [DOI: 10.3389/fnagi.2022.1004954] [Reference Citation Analysis]
21 Deng M, Wang G, Gao X, Wang Y, Ni Y, Chen Y, Xu J, Jiang W. The nonlinear association between HbA1c and cognitive impairment in patients with alcohol use disorder. J Addict Dis 2022;:1-9. [PMID: 36094304 DOI: 10.1080/10550887.2022.2120791] [Reference Citation Analysis]
22 Long C, Han X, Yang Y, Li T, Zhou Q, Chen Q. Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis. Front Aging Neurosci 2022;14:963933. [DOI: 10.3389/fnagi.2022.963933] [Reference Citation Analysis]
23 Takemori K, Akaho K, Iwase M, Okano M, Kometani T. Effects of Persimmon Fruit Polyphenols on Postprandial Plasma Glucose Elevation in Rats and Humans. J Nutr Sci Vitaminol (Tokyo) 2022;68:331-41. [PMID: 36047105 DOI: 10.3177/jnsv.68.331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Marissal-arvy N, Moisan M. Diabetes and associated cognitive disorders: Role of the Hypothalamic-Pituitary Adrenal axis. Metabolism Open 2022;15:100202. [DOI: 10.1016/j.metop.2022.100202] [Reference Citation Analysis]
25 Huang J, Lin W, Sun Y, Wang Q, He S, Han Z, Lu L, Kang X, Chen Y, Guo H, Cui Z, Sun C, Go K, Wu J, Yao M, Cao M, Xu Y. Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injury. Front Aging Neurosci 2022;14:944195. [DOI: 10.3389/fnagi.2022.944195] [Reference Citation Analysis]
26 Dybjer E, Kumar A, Nägga K, Engström G, Mattsson-carlgren N, Nilsson PM, Melander O, Hansson O. Polygenic risk of type 2 diabetes is associated with Vascular Dementia but not with Alzheimer's Disease: a Prospective Cohort Study.. [DOI: 10.21203/rs.3.rs-1996829/v1] [Reference Citation Analysis]
27 Gairing SJ, Schleicher EM, Labenz C. Diabetes mellitus - risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis? Metab Brain Dis 2022. [PMID: 36001211 DOI: 10.1007/s11011-022-01068-4] [Reference Citation Analysis]
28 Yokokawa T, Sasaki S, Sase K, Yoshii N, Yasuda J, Hayashi T, Fujita S. Association of serum brain-derived neurotrophic factor with hepatic enzymes, AST/ALT ratio, and FIB-4 index in middle-aged and older women. PLoS ONE 2022;17:e0273056. [DOI: 10.1371/journal.pone.0273056] [Reference Citation Analysis]
29 Martín-martín Y, Pérez-garcía A, Torrecilla-parra M, Fernández-de Frutos M, Pardo-marqués V, Casarejos MJ, Busto R, Ramírez CM. New Insights on the Regulation of the Insulin-Degrading Enzyme: Role of microRNAs and RBPs. Cells 2022;11:2538. [DOI: 10.3390/cells11162538] [Reference Citation Analysis]
30 Zhang X, Lei T, Wang D, Cai S, Hang Z, Yang Y, Bi W, Xiao Z, Du H. Stem cells from human exfoliated deciduous teeth relieves Alzheimer's disease symptoms in SAMP8 mice by up-regulating the PPARγ pathway. Biomed Pharmacother 2022;152:113169. [PMID: 35689863 DOI: 10.1016/j.biopha.2022.113169] [Reference Citation Analysis]
31 Verhagen C, Janssen J, Minderhoud CA, van den Berg E, Wanner C, Passera A, Johansen OE, Biessels GJ. Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108303] [Reference Citation Analysis]
32 Yen F, Wei JC, Yip H, Hwu C, Hsu C. Diabetes, Hypertension, and the Risk of Dementia. JAD 2022. [DOI: 10.3233/jad-220207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Garg D, Gupta A, Agarwal A, Mishra B, Srivastava MVP, Basheer A, Vishnu VY. Latest Trends in Outcome Measures in Dementia and Mild Cognitive Impairment Trials. Brain Sciences 2022;12:922. [DOI: 10.3390/brainsci12070922] [Reference Citation Analysis]
34 Zhang L, Li C, Huang R, Teng H, Zhang Y, Zhou M, Liu X, Fan B, Luo H, He A, Zhao A, Lu M, Chopp M, Zhang ZG. Cerebral endothelial cell derived small extracellular vesicles improve cognitive function in aged diabetic rats. Front Aging Neurosci 2022;14:926485. [DOI: 10.3389/fnagi.2022.926485] [Reference Citation Analysis]
35 Kongtawelert P, Kaewmool C, Phitak T, Phimphilai M, Pothacharoen P, Shwe TH. Sesamin protects against neurotoxicity via inhibition of microglial activation under high glucose circumstances through modulating p38 and JNK signaling pathways. Sci Rep 2022;12:11296. [PMID: 35788665 DOI: 10.1038/s41598-022-15411-3] [Reference Citation Analysis]
36 Kilvert A, Fox C. Risk factor modification to reduce the risk of dementia in diabetes. Practical Diabetes 2022;39:3-5. [DOI: 10.1002/pdi.2401] [Reference Citation Analysis]
37 Yu W, Yin H, Sun Y, Shi S, Li J, Wang X. The attenuation effect of potassium 2-(1-hydroxypentyl)-benzoate in a mouse model of diabetes-associated cognitive decline: The protein expression in the brain. CNS Neurosci Ther 2022;28:1108-23. [PMID: 35445545 DOI: 10.1111/cns.13847] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Miya A, Nakamura A, Yokota I, Cho KY, Kameda H, Nomoto H, Takase T, Omori K, Ono M, Nagai S, Taneda S, Miyoshi H, Atsumi T. The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes. Geriatr Gerontol Int 2022. [PMID: 35773969 DOI: 10.1111/ggi.14415] [Reference Citation Analysis]
39 Thota RN, Chatterjee P, Pedrini S, Hone E, Ferguson JJA, Garg ML, Martins RN. Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults. Front Endocrinol 2022;13:915449. [DOI: 10.3389/fendo.2022.915449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Koh DH, Rho YJ, Lee SY, Kim KN, Ju YJ. Association between Blood Glucose Control and Subjective Cognitive Decline in Korean Patients with Diabetes Aged over 50 Years. Int J Environ Res Public Health 2022;19:7267. [PMID: 35742517 DOI: 10.3390/ijerph19127267] [Reference Citation Analysis]
41 Huang J, Xu Z, Chen H, Lin Y, Wei J, Wang S, Yu H, Huang S, Zhang Y, Li C, Zhou X. Shen Qi Wan Ameliorates Learning and Memory Impairment Induced by STZ in AD Rats through PI3K/AKT Pathway. Brain Sci 2022;12:758. [PMID: 35741643 DOI: 10.3390/brainsci12060758] [Reference Citation Analysis]
42 Palix C, Felisatti F, Gonneaud J, Kuhn E, Mézenge F, Landeau B, Chocat A, Quillard A, Egret S, Delarue M, Sayette VDL, Vivien D, Chételat G, Poisnel G. Relationships between diabetes-related vascular risk factors and neurodegeneration biomarkers in healthy aging and Alzheimer's disease. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.06.004] [Reference Citation Analysis]
43 Luo A, Xie Z, Wang Y, Wang X, Li S, Yan J, Zhan G, Zhou Z, Zhao Y, Li S. Type 2 diabetes mellitus-associated cognitive dysfunction: Advances in potential mechanisms and therapies. Neurosci Biobehav Rev 2022;137:104642. [PMID: 35367221 DOI: 10.1016/j.neubiorev.2022.104642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Ehtewish H, Arredouani A, El-Agnaf O. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. Int J Mol Sci 2022;23:6144. [PMID: 35682821 DOI: 10.3390/ijms23116144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
45 Antal B, McMahon LP, Sultan SF, Lithen A, Wexler DJ, Dickerson B, Ratai EM, Mujica-Parodi LR. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses. Elife 2022;11:e73138. [PMID: 35608247 DOI: 10.7554/eLife.73138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Pradhan LK, Sahoo PK, Chauhan S, Das SK. Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease. J Mol Neurosci 2022. [PMID: 35553375 DOI: 10.1007/s12031-022-02009-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Ang SF, Low S, Ng TP, Tan CS, Ang K, Lim Z, Tang WE, Subramaniam T, Sum CF, Lim SC, Kandiah N. Ethnic-Specific Type 2 Diabetes Risk Factor PAX4 R192H Is Associated with Attention-Specific Cognitive Impairment in Chinese with Type 2 Diabetes. JAD 2022. [DOI: 10.3233/jad-220036] [Reference Citation Analysis]
48 Piccialli I, Tedeschi V, Caputo L, D’errico S, Ciccone R, De Feo V, Secondo A, Pannaccione A. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes. Front Pharmacol 2022;13:876614. [DOI: 10.3389/fphar.2022.876614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
49 Matsuzaki K, Nakajima A, Guo Y, Ohizumi Y. A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism. Nutrients 2022;14:1847. [PMID: 35565814 DOI: 10.3390/nu14091847] [Reference Citation Analysis]
50 Wu Q, Dong J, Bai X, Jiang Y, Li J, Fan S, Cheng Y, Jiang G. Propionate ameliorates diabetes-induced neurological dysfunction through regulating the PI3K/Akt/eNOS signaling pathway. Eur J Pharmacol 2022;:174974. [PMID: 35490725 DOI: 10.1016/j.ejphar.2022.174974] [Reference Citation Analysis]
51 Fink A, Doerre A, Demuth I, Doblhammer G. Potential of prevention strategies for the modifiable risk factor type 2 diabetes with relation to the future number of dementia patients in Germany- a multi-state projection through 2040. BMC Neurol 2022;22:157. [PMID: 35468764 DOI: 10.1186/s12883-022-02682-6] [Reference Citation Analysis]
52 Ortiz GG, Huerta M, González-Usigli HA, Torres-Sánchez ED, Delgado-Lara DL, Pacheco-Moisés FP, Mireles-Ramírez MA, Torres-Mendoza BM, Moreno-Cih RI, Velázquez-Brizuela IE. Cognitive disorder and dementia in type 2 diabetes mellitus. World J Diabetes 2022; 13(4): 319-337 [DOI: 10.4239/wjd.v13.i4.319] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
53 Parish S, Mafham M, Offer A, Barton J, Wallendszus K, Stevens W, Buck G, Haynes R, Collins R, Bowman L, Armitage J; ASCEND Study Collaborative Group . Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial. Eur Heart J 2022:ehac179. [PMID: 35393614 DOI: 10.1093/eurheartj/ehac179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Li X, Yin Y, Li W, Li S, Zhang D, Liu Z. Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse. Bioengineered 2022;13:9387-96. [PMID: 35389830 DOI: 10.1080/21655979.2022.2055699] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Imre N, Balogh R, Gosztolya G, Tóth L, Hoffmann I, Várkonyi T, Lengyel C, Pákáski M, Kálmán J. Temporal Speech Parameters Indicate Early Cognitive Decline in Elderly Patients With Type 2 Diabetes Mellitus. Alzheimer Dis Assoc Disord 2022;36:148-55. [PMID: 35293378 DOI: 10.1097/WAD.0000000000000492] [Reference Citation Analysis]
56 Magyari A, Ye M, Margolis DJ, McCulloch CE, Cummings SR, Yaffe K, Langan SM, Abuabara K. Adult atopic eczema and the risk of dementia: A population-based cohort study. J Am Acad Dermatol 2022:S0190-9622(22)00541-2. [PMID: 35367295 DOI: 10.1016/j.jaad.2022.03.049] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Smith L, Shin JI, Butler L, Barnett Y, Oh H, Jacob L, Kostev K, Veronese N, Soysal P, Tully M, López Sánchez GF, Koyanagi A. Physical multimorbidity and depression: A mediation analysis of influential factors among 34,129 adults aged ≥50 years from low- and middle-income countries. Depress Anxiety 2022. [PMID: 35312125 DOI: 10.1002/da.23250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Al Adem K, Shanti A, Srivastava A, Homouz D, Thomas SA, Khair M, Stefanini C, Chan V, Kim T, Lee S. Linking Alzheimer’s Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates. Front Mol Biosci 2022;9:842582. [DOI: 10.3389/fmolb.2022.842582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Song X, Zhu Z, Qian X, Liu X, Chen S, Tang H. Multi-Omics Characterization of Type 2 Diabetes Mellitus-Induced Cognitive Impairment in the db/db Mouse Model. Molecules 2022;27:1904. [PMID: 35335269 DOI: 10.3390/molecules27061904] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Yang Y, Zhao JJ, Yu XF. Expert Consensus on Cognitive Dysfunction in Diabetes. Curr Med Sci 2022. [PMID: 35290601 DOI: 10.1007/s11596-022-2549-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
61 Kim HK, Song J. Hypothyroidism and Diabetes-Related Dementia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia. Int J Mol Sci 2022;23:2982. [PMID: 35328405 DOI: 10.3390/ijms23062982] [Reference Citation Analysis]
62 Meng L, Wang Z, Ji HF, Shen L. Causal association evaluation of diabetes with Alzheimer's disease and genetic analysis of antidiabetic drugs against Alzheimer's disease. Cell Biosci 2022;12:28. [PMID: 35272707 DOI: 10.1186/s13578-022-00768-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Li Z, Zhang W, Gao F, Shen Y, Kang D, Tang Q. Different Complement Activation Pathways Underly Cognitive Impairment and Type 2 Diabetes Mellitus Combined With Cognitive Impairment. Front Aging Neurosci 2022;14:810335. [DOI: 10.3389/fnagi.2022.810335] [Reference Citation Analysis]
64 Subedi S, Sasidharan S, Nag N, Saudagar P, Tripathi T. Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition. Molecules 2022;27:1776. [PMID: 35335141 DOI: 10.3390/molecules27061776] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
65 Spence AB, Liu C, Rubin L, Aouizerat B, Vance DE, Bolivar H, Lahiri CD, Adimora AA, Weber K, Gustafson D, Sosanya O, Turner RS, Kassaye S. Class-Based Antiretroviral Exposure and Cognition Among Women Living with HIV. AIDS Res Hum Retroviruses 2022. [PMID: 35109713 DOI: 10.1089/AID.2021.0097] [Reference Citation Analysis]
66 O'Bryant SE, Petersen M, Hall J, Johnson LA; HABS-HD Study Team. Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice. Alzheimers Dement 2022. [PMID: 35235702 DOI: 10.1002/alz.12647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
67 Nie R, Lu J, Xu R, Yang J, Shen X, Ouyang X, Zhu D, Huang Y, Zhao T, Zhao X, Lu Y, Qian M, Wang J, Shen X. Ipriflavone as a non-steroidal glucocorticoid receptor antagonist ameliorates diabetic cognitive impairment in mice. Aging Cell 2022;21:e13572. [PMID: 35172041 DOI: 10.1111/acel.13572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Kalinichenko LS, Gulbins E, Kornhuber J, Müller CP. Sphingolipid control of cognitive functions in health and disease. Progress in Lipid Research 2022. [DOI: 10.1016/j.plipres.2022.101162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Lacy ME, Moran C, Gilsanz P, Beeri MS, Karter AJ, Whitmer RA. Comparison of cognitive function in older adults with type 1 diabetes, type 2 diabetes, and no diabetes: results from the Study of Longevity in Diabetes (SOLID). BMJ Open Diabetes Res Care 2022;10:e002557. [PMID: 35346969 DOI: 10.1136/bmjdrc-2021-002557] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Ahmad R, Chowdhury K, Kumar S, Irfan M, Reddy GS, Akter F, Jahan D, Haque M. Diabetes Mellitus: A Path to Amnesia, Personality, and Behavior Change. Biology 2022;11:382. [DOI: 10.3390/biology11030382] [Reference Citation Analysis]
71 Falsetti L, Viticchi G, Zaccone V, Guerrieri E, Moroncini G, Luzzi S, Silvestrini M. Shared Molecular Mechanisms among Alzheimer’s Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review. Biomedicines 2022;10:439. [DOI: 10.3390/biomedicines10020439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Niyasti P, Saberi A, Hatamyain H, Ajamian F, Shirkouhi SG, Mirzanejad L, Andalib S. Association of Insulin Receptor Substrate-1 Gene Polymorphism (rs1801278) with Alzheimer’s Disease. ADR 2022. [DOI: 10.3233/adr-210060] [Reference Citation Analysis]
73 Varghese SM, Joy N, John AM, George G, Chandy GM, Benjamin AI. Sweet Memories or Not? A Comparative Study on Cognitive Impairment in Diabetes Mellitus. Front Public Health 2022;10:822062. [DOI: 10.3389/fpubh.2022.822062] [Reference Citation Analysis]
74 Zhang G, Meng L, Wang Z, Peng Q, Chen G, Xiong J, Zhang Z. Islet amyloid polypeptide cross-seeds tau and drives the neurofibrillary pathology in Alzheimer’s disease. Mol Neurodegeneration 2022;17. [DOI: 10.1186/s13024-022-00518-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Wan J, Zhou S, Mea HJ, Guo Y, Ku H, Urbina BM. Emerging Roles of Microfluidics in Brain Research: From Cerebral Fluids Manipulation to Brain-on-a-Chip and Neuroelectronic Devices Engineering. Chem Rev 2022. [PMID: 35080375 DOI: 10.1021/acs.chemrev.1c00480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Zhang R, Liao W, Wu K, Hua L, Wu M, Li C, Cai F. Matrine alleviates spatial learning and memory impairment in diabetic mice by inhibiting endoplasmic reticulum stress and through modulation of PK2/PKRs pathway. Neurochem Int 2022;:105289. [PMID: 35074478 DOI: 10.1016/j.neuint.2022.105289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Lee S, Oh JW, Son NH, Chung W. Association between Handgrip Strength and Cognitive Function in Older Adults: Korean Longitudinal Study of Aging (2006-2018). Int J Environ Res Public Health 2022;19:1048. [PMID: 35162070 DOI: 10.3390/ijerph19031048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
78 Chen Y, Lu B, Shu Y, Sun Y. Spatiotemporal Dynamics of Cerebral Vascular Permeability in Type 2 Diabetes-Related Cerebral Microangiopathy. Front Endocrinol 2022;12:805637. [DOI: 10.3389/fendo.2021.805637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 O'Toole SM, Walker RJ, Garacci E, Dawson AZ, Campbell JA, Egede LE. Explanatory role of sociodemographic, clinical, behavioral, and social factors on cognitive decline in older adults with diabetes. BMC Geriatr 2022;22:39. [PMID: 35012474 DOI: 10.1186/s12877-021-02740-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Confettura AD, Cuboni E, Ammar MR, Jia S, Gomes GM, Yuanxiang P, Raman R, Li T, Grochowska KM, Ahrends R, Karpova A, Dityatev A, Kreutz MR. Neddylation-dependent protein degradation is a nexus between synaptic insulin resistance, neuroinflammation and Alzheimer's disease. Transl Neurodegener 2022;11:2. [PMID: 34986876 DOI: 10.1186/s40035-021-00277-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
81 Lei H, Hu R, Luo G, Yang T, Shen H, Deng H, Chen C, Zhao H, Liu J. Altered Structural and Functional MRI Connectivity in Type 2 Diabetes Mellitus Related Cognitive Impairment: A Review. Front Hum Neurosci 2022;15:755017. [DOI: 10.3389/fnhum.2021.755017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
82 Wu K, Liu H, Zheng J, Zou L, Gu S, Zhou R, Yuan Z, Huang Z, Wu X. Diabetes Treatment Is Associated With Better Cognitive Function: The Age Disparity. Front Aging Neurosci 2022;13:753129. [DOI: 10.3389/fnagi.2021.753129] [Reference Citation Analysis]
83 穆 珍. Research Progress of Non-Drug Intervention in Patients with Type 2 Diabetes Mellitus and Mild Cognitive Impairment. ACM 2022;12:10472-10479. [DOI: 10.12677/acm.2022.12111509] [Reference Citation Analysis]
84 Maekawa T, Sasase T, Shinohara M, Kume S, Ohta T. Brain abnormalities in spontaneously diabetic Torii-Leprfa (SDT fatty) rats. THE PROCEEDINGS OF THE 4TH EPI INTERNATIONAL CONFERENCE ON SCIENCE AND ENGINEERING (EICSE) 2020 2022. [DOI: 10.1063/5.0098989] [Reference Citation Analysis]
85 El- Safty H, Ismail A, Mohsen R, El-sahar AE, Saad MA. Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway. Brain Research Bulletin 2022. [DOI: 10.1016/j.brainresbull.2022.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Ouerdane Y, El-nahas ZS, Ouerdane F, Hamam KM, Ebada MA. Gut–Brain Axis in Alzheimer’s Disease: Interplay Between Cholecystokinin, Dysbiosis, and Brain-Derived Neurotrophic Factor. Current Thoughts on Dementia 2022. [DOI: 10.1007/978-981-16-7606-2_12] [Reference Citation Analysis]
87 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S46-59. [PMID: 34964869 DOI: 10.2337/dc22-S004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 21.0] [Reference Citation Analysis]
88 Kirvalidze M, Hodkinson A, Storman D, Fairchild TJ, Bała M, Beridze G, Zuriaga A, Brudasc NI, Brini S. The role of glucose on cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: a systematic review of observational studies. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104551] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 He R, Zheng R, Li J, Cao Q, Hou T, Zhao Z, Xu M, Chen Y, Lu J, Wang T, Xu Y, Bi Y, Wang W, Li M, Liu Y, Ning G. Individual and Combined Associations of Glucose Metabolic Components With Cognitive Function Modified by Obesity. Front Endocrinol (Lausanne) 2021;12:769120. [PMID: 34966358 DOI: 10.3389/fendo.2021.769120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lee A, Mason ML, Lin T, Kumar SB, Kowdley D, Leung JH, Muhanna D, Sun Y, Ortega-Anaya J, Yu L, Fitzgerald J, DeVries AC, Nelson RJ, Weil ZM, Jiménez-Flores R, Parquette JR, Ziouzenkova O. Amino Acid Nanofibers Improve Glycemia and Confer Cognitive Therapeutic Efficacy to Bound Insulin. Pharmaceutics 2021;14:81. [PMID: 35056977 DOI: 10.3390/pharmaceutics14010081] [Reference Citation Analysis]
91 Chung JY, Kim OY, Song J. Role of ketone bodies in diabetes-induced dementia: sirtuins, insulin resistance, synaptic plasticity, mitochondrial dysfunction, and neurotransmitter. Nutrition Reviews 2021. [DOI: 10.1093/nutrit/nuab118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Peters R, Breitner J, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Weber C, Anderson C, Anstey KJ, Dodge HH. Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors. Alzheimers Dement (N Y) 2021;7:e12202. [PMID: 34934803 DOI: 10.1002/trc2.12202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Rundek T, Tolea M, Ariko T, Fagerli EA, Camargo CJ. Vascular Cognitive Impairment (VCI). Neurotherapeutics. [DOI: 10.1007/s13311-021-01170-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
94 Sluiman AJ, McLachlan S, Forster RB, Strachan MWJ, Deary IJ, Price JF. Higher baseline inflammatory marker levels predict greater cognitive decline in older people with type 2 diabetes: year 10 follow-up of the Edinburgh Type 2 Diabetes Study. Diabetologia 2021. [PMID: 34932135 DOI: 10.1007/s00125-021-05634-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Afzal M, Al-Abbasi FA, Kazmi I, Imam SS, Alshehri S, Ghoneim MM, Almalki WH, Nadeem MS, Sayyed N. Fustin Inhibits Oxidative Free Radicals and Inflammatory Cytokines in Cerebral Cortex and Hippocampus and Protects Cognitive Impairment in Streptozotocin-Induced Diabetic Rats. ACS Chem Neurosci 2021;12:4587-97. [PMID: 34860003 DOI: 10.1021/acschemneuro.1c00712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Kamdi SP, Badwaik HR, Raval A, Ajazuddin, Nakhate KT. Ameliorative potential of phloridzin in type 2 diabetes-induced memory deficits in rats. Eur J Pharmacol 2021;913:174645. [PMID: 34800467 DOI: 10.1016/j.ejphar.2021.174645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
97 Lin L, Wu Y, Chen Z, Huang L, Wang L, Liu L. Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction. Front Aging Neurosci 2021;13:775244. [PMID: 34899278 DOI: 10.3389/fnagi.2021.775244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Runk A, Jia Y, Liu A, Chang CH, Ganguli M, Snitz BE. Associations between Visual Acuity and Cognitive Decline in Older Adulthood: A 9-Year Longitudinal Study. J Int Neuropsychol Soc. [DOI: 10.1017/s1355617721001363] [Reference Citation Analysis]
99 Tamaki Y, Hiratsuka Y, Kumakawa T. Evaluation of Risk Factors for Dementia Incidence Based on Previous Questionnaire Results of Specific Health Checkups in Japan. JAL 2021;1:48-59. [DOI: 10.3390/jal1010006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Kaewpoowat Q, Rerkasem A, Rerkasem K, Robertson KR, Aita SL, Roth RM, Yasri S, Choovuthayakorn J, Ausayakhun S, Supparatpinyo K, Robbins NM. Cardio-ankle vascular index of increased arterial wall stiffness is associated with neurocognitive impairment in well-controlled HIV. HIV Med 2021. [PMID: 34859556 DOI: 10.1111/hiv.13213] [Reference Citation Analysis]
101 Qin G, Dong Y, Liu Z, Gong Z, Gao C, Zheng M, Tian M, He Y, Zhong L, Wang P. Shen-Zhi-Ling oral liquid ameliorates cerebral glucose metabolism disorder in early AD via insulin signal transduction pathway in vivo and in vitro. Chin Med 2021;16:128. [PMID: 34857022 DOI: 10.1186/s13020-021-00540-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
102 Gauci S, Young LM, White DJ, Reddan JM, Lassemillante AC, Meyer D, Pipingas A, Scholey A. Diet May Moderate the Relationship Between Arterial Stiffness and Cognitive Performance in Older Adults. J Alzheimers Dis 2021. [PMID: 34864661 DOI: 10.3233/JAD-210567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
103 Hermanns N, Kulzer B. Psychosoziale Aspekte und Diabetes. Public Health Forum 2021;29:346-348. [DOI: 10.1515/pubhef-2021-0093] [Reference Citation Analysis]
104 Pisa E, Martire A, Chiodi V, Traversa A, Caputo V, Hauser J, Macrì S. Exposure to 3'Sialyllactose-Poor Milk during Lactation Impairs Cognitive Capabilities in Adulthood. Nutrients 2021;13:4191. [PMID: 34959743 DOI: 10.3390/nu13124191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
105 Sadrolashrafi K, Craft S, Decourt B, Adem A, Wilson JR, Miller J, Sabbagh MN. Is diabetes associated with increased pathological burden in Alzheimer's disease? Alzheimers Dement (Amst) 2021;13:e12248. [PMID: 34796262 DOI: 10.1002/dad2.12248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
106 Shinjyo N, Kita K. Infection and Immunometabolism in the Central Nervous System: A Possible Mechanistic Link Between Metabolic Imbalance and Dementia. Front Cell Neurosci 2021;15:765217. [PMID: 34795562 DOI: 10.3389/fncel.2021.765217] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
107 Pignalosa FC, Desiderio A, Mirra P, Nigro C, Perruolo G, Ulianich L, Formisano P, Beguinot F, Miele C, Napoli R, Fiory F. Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction. Int J Mol Sci 2021;22:12366. [PMID: 34830246 DOI: 10.3390/ijms222212366] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
108 Takeishi J, Tatewaki Y, Nakase T, Takano Y, Tomita N, Yamamoto S, Mutoh T, Taki Y. Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet. Int J Mol Sci 2021;22:12310. [PMID: 34830192 DOI: 10.3390/ijms222212310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
109 Noguchi-Shinohara M, Yuki-Nozaki S, Abe C, Mori A, Horimoto M, Yokogawa M, Ishida N, Suga Y, Ishizaki J, Ishimiya M, Nakamura H, Komai K, Nakamura H, Shibata M, Ohara T, Hata J, Ninomiya T, Yamada M; Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD) study group. Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD Study. J Alzheimers Dis 2021. [PMID: 34806607 DOI: 10.3233/JAD-215153] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
110 Samoilova IG, Matveeva MV, Kudlay DA, Tonkikh OS, Tolmachev IV. Neural networks in the predictive diagnosis of cognitive impairment in type 1 and type 2 diabetes mellitus. Terapevticheskii arkhiv 2021;93:1349-58. [DOI: 10.26442/00403660.2021.11.201253] [Reference Citation Analysis]
111 Lauer AA, Griebsch LV, Pilz SM, Janitschke D, Theiss EL, Reichrath J, Herr C, Beisswenger C, Bals R, Valencak TG, Portius D, Grimm HS, Hartmann T, Grimm MOW. Impact of Vitamin D3 Deficiency on Phosphatidylcholine-/Ethanolamine, Plasmalogen-, Lyso-Phosphatidylcholine-/Ethanolamine, Carnitine- and Triacyl Glyceride-Homeostasis in Neuroblastoma Cells and Murine Brain. Biomolecules 2021;11:1699. [PMID: 34827697 DOI: 10.3390/biom11111699] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Gurdon B, Kaczorowski C. Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models. Neurobiol Dis 2021;161:105558. [PMID: 34767943 DOI: 10.1016/j.nbd.2021.105558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Yoo H, Kim H, Koh I, Lee K, Ok J. Effect of Metabolic Syndrome on the Incidence of Dementia Based on National Insurance Data in Korea. Metab Syndr Relat Disord 2021. [PMID: 34756135 DOI: 10.1089/met.2021.0046] [Reference Citation Analysis]
114 He Z, You G, Liu Q, Li N. Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound. Int J Mol Sci 2021;22:11931. [PMID: 34769364 DOI: 10.3390/ijms222111931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
115 Yu J, Liao X, Zhong Y, Wu Y, Lai X, Jiao H, Yan M, Zhang Y, Ma C, Wang S. The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis. Front Endocrinol (Lausanne) 2021;12:770145. [PMID: 34690937 DOI: 10.3389/fendo.2021.770145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
116 Liu XY, Zhang N, Zhang SX, Xu P. Potential new therapeutic target for Alzheimer's disease: Glucagon-like peptide-1. Eur J Neurosci 2021;54:7749-69. [PMID: 34676939 DOI: 10.1111/ejn.15502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
117 Midorikawa M, Suzuki H, Suzuki Y, Yamauchi K, Sato H, Nemoto K, Sugano Y, Iwasaki H, Sekiya M, Yatoh S, Yahagi N, Hada Y, Arai T, Shimano H. Relationships between Cognitive Function and Odor Identification, Balance Capability, and Muscle Strength in Middle-Aged Persons with and without Type 2 Diabetes. J Diabetes Res 2021;2021:9961612. [PMID: 34660814 DOI: 10.1155/2021/9961612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
118 Wu Q, Dong J, Cheng Y, Jiang G. Propionate ameliorates diabetes-induced neurological dysfunction through regulating the PI3K/Akt/eNOS signaling pathway.. [DOI: 10.1101/2021.10.15.464493] [Reference Citation Analysis]
119 Srikanth V. Type 2 Diabetes, Glycemia, and Brain Health: The Complexity of Causality. Diabetes 2021;70:2187-9. [PMID: 34593540 DOI: 10.2337/dbi21-0018] [Reference Citation Analysis]
120 Yu H, Liu Y, He T, Zhang Y, He J, Li M, Jiang B, Gao Y, Chen C, Ke D, Liu J, He B, Yang X, Wang JZ. Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients. Aging Cell 2021;20:e13469. [PMID: 34528736 DOI: 10.1111/acel.13469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
121 Jiang X, Wang Z, Hu N, Yang Y, Xiong R, Fu Z. Cognition effectiveness of continuous positive airway pressure treatment in obstructive sleep apnea syndrome patients with cognitive impairment: a meta-analysis. Exp Brain Res 2021;239:3537-52. [PMID: 34546386 DOI: 10.1007/s00221-021-06225-2] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Avila JC, Mejia-Arangom S, Jupiter D, Downer B, Wong R. The Effect of Diabetes on the Cognitive Trajectory of Older Adults in Mexico and the United States. J Gerontol B Psychol Sci Soc Sci 2021;76:e153-64. [PMID: 32678911 DOI: 10.1093/geronb/gbaa094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
123 Šimonienė D, Veličkienė D. Relation between Exogenous Insulin and Cognitive Function in Type 2 Diabetes Mellitus. Medicina (Kaunas) 2021;57:943. [PMID: 34577866 DOI: 10.3390/medicina57090943] [Reference Citation Analysis]
124 Koloteva-Levine N, Aubrey LD, Marchante R, Purton TJ, Hiscock JR, Tuite MF, Xue WF. Amyloid particles facilitate surface-catalyzed cross-seeding by acting as promiscuous nanoparticles. Proc Natl Acad Sci U S A 2021;118:e2104148118. [PMID: 34462352 DOI: 10.1073/pnas.2104148118] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
125 Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment. Pharmaceuticals (Basel) 2021;14:890. [PMID: 34577590 DOI: 10.3390/ph14090890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
126 Bouyahya A, El Omari N, Elmenyiy N, Guaouguaou F, Balahbib A, Belmehdi O, Salhi N, Imtara H, Mrabti HN, El-shazly M, Bakri Y. Moroccan antidiabetic medicinal plants: Ethnobotanical studies, phytochemical bioactive compounds, preclinical investigations, toxicological validations and clinical evidences; challenges, guidance and perspectives for future management of diabetes worldwide. Trends in Food Science & Technology 2021;115:147-254. [DOI: 10.1016/j.tifs.2021.03.032] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
127 Esin RG, Khairullin IK, Esin OR. [Diabetic encephalopathy: current insights and potential therapeutic strategies]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:49-54. [PMID: 34460157 DOI: 10.17116/jnevro202112107149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Huang L, Zhang Q, Tang T, Yang M, Chen C, Tao J, Liang S. Abnormalities of Brain White Matter in Type 2 Diabetes Mellitus: A Meta-Analysis of Diffusion Tensor Imaging. Front Aging Neurosci 2021;13:693890. [PMID: 34421572 DOI: 10.3389/fnagi.2021.693890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D. The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress? Cell Stress Chaperones 2021. [PMID: 34386944 DOI: 10.1007/s12192-021-01231-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
130 Liu CH, Sung PS, Li YR, Huang WK, Lee TW, Huang CC, Lee TH, Chen TH, Wei YC. Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study. PLoS Med 2021;18:e1003707. [PMID: 34280191 DOI: 10.1371/journal.pmed.1003707] [Reference Citation Analysis]
131 Lai F, Mercaldo N, Wang CM, Hersch GG, Rosas HD. Association between Inflammatory Conditions and Alzheimer's Disease Age of Onset in Down Syndrome. J Clin Med 2021;10:3116. [PMID: 34300282 DOI: 10.3390/jcm10143116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
132 Jacków-Nowicka J, Podgórski P, Bladowska J, Szcześniak D, Rymaszewska J, Zatońska K, Połtyn-Zaradna K, Szuba A, Sa Siadek M, Zimny A. The Impact of Common Epidemiological Factors on Gray and White Matter Volumes in Magnetic Resonance Imaging-Is Prevention of Brain Degeneration Possible? Front Neurol 2021;12:633619. [PMID: 34326804 DOI: 10.3389/fneur.2021.633619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Kuşoğlu L, Oktay C, Yiğit Ö. Acil Servise Başvuran 50 Yaş ve Üzeri Hastalarda Bilişsel Fonksiyon Bozukluğu. Akdeniz Medical Journal 2021;7:258-267. [DOI: 10.53394/akd.958952] [Reference Citation Analysis]
134 Sugimoto T, Araki A, Fujita H, Honda K, Inagaki N, Ishida T, Kato J, Kishi M, Kobayashi K, Kouyama K, Noma H, Ohishi M, Satoh-Asahara N, Shimada H, Sugimoto K, Suzuki S, Takeya Y, Tamura Y, Tokuda H, Umegaki H, Watada H, Yamada Y, Sakurai T. The Multi-Domain Intervention Trial in Older Adults With Diabetes Mellitus for Prevention of Dementia in Japan: Study Protocol for a Multi-Center, Randomized, 18-Month Controlled Trial. Front Aging Neurosci 2021;13:680341. [PMID: 34322009 DOI: 10.3389/fnagi.2021.680341] [Reference Citation Analysis]
135 Querfurth H, Lee HK. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener 2021;16:44. [PMID: 34215308 DOI: 10.1186/s13024-021-00428-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 29.0] [Reference Citation Analysis]
136 Davarpanah M, Shokri-Mashhadi N, Ziaei R, Saneei P. A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile. Sci Rep 2021;11:13773. [PMID: 34215825 DOI: 10.1038/s41598-021-93271-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
137 Lesiewska N, Bieliński M. Cognitive Functions in Pregnant Women. Donald School Journal of Ultrasound in Obstetrics and Gynecology 2021;15:203-214. [DOI: 10.5005/jp-journals-10009-1690] [Reference Citation Analysis]
138 Chen Y, Zhou Z, Liang Y, Tan X, Li Y, Qin C, Feng Y, Ma X, Mo Z, Xia J, Zhang H, Qiu S, Shen D. Classification of type 2 diabetes mellitus with or without cognitive impairment from healthy controls using high-order functional connectivity. Hum Brain Mapp 2021;42:4671-84. [PMID: 34213081 DOI: 10.1002/hbm.25575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
139 Chang PY, Wang II, Chiang CE, Chen CH, Yeh WY, Henderson VW, Tsai YW, Cheng HM. Vascular complications of diabetes: natural history and corresponding risks of dementia in a national cohort of adults with diabetes. Acta Diabetol 2021;58:859-67. [PMID: 33624125 DOI: 10.1007/s00592-021-01685-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
140 Muzambi R, Bhaskaran K, Smeeth L, Brayne C, Chaturvedi N, Warren-Gash C. Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study. Lancet Healthy Longev 2021;2:e426-35. [PMID: 34240064 DOI: 10.1016/S2666-7568(21)00118-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
141 Chen R, Zeng Y, Xiao W, Zhang L, Shu Y. LC-MS-Based Untargeted Metabolomics Reveals Early Biomarkers in STZ-Induced Diabetic Rats With Cognitive Impairment. Front Endocrinol (Lausanne) 2021;12:665309. [PMID: 34276557 DOI: 10.3389/fendo.2021.665309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
142 Siru R, Burkhardt MS, Davis WA, Hiew J, Manning L, Ritter JC, Norman PE, Makepeace A, Fegan PG, Bruce DG, Davis TME, Hamilton EJ. Cognitive Impairment in People with Diabetes-Related Foot Ulceration. J Clin Med 2021;10:2808. [PMID: 34202360 DOI: 10.3390/jcm10132808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
143 Joshi M, Shah DP, Krishnakumar A. Extreme Glycemic Fluctuations Debilitate NRG1, ErbB Receptors and Olig1 Function: Association with Regeneration, Cognition and Mood Alterations During Diabetes. Mol Neurobiol 2021. [PMID: 34165684 DOI: 10.1007/s12035-021-02455-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Dou Y, Tan Y, Yu T, Ma X, Zhou Y, Zhao Y, Zhao Y, Liu X. MiR-132 down-regulates high glucose-induced β-dystroglycan degradation through Matrix Metalloproteinases-9 up-regulation in primary neurons. J Cell Mol Med 2021;25:7783-95. [PMID: 34160889 DOI: 10.1111/jcmm.16669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
145 Hsu MC, Lee SC, Ouyang WC. Use of Charlson Comorbidity Index and Nomogram to Predict Mortality in Elderly Patients with Late-Life Schizophrenia. Healthcare (Basel) 2021;9:783. [PMID: 34206232 DOI: 10.3390/healthcare9070783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Fujihara K, Matsubayashi Y, Harada Yamada M, Kitazawa M, Yamamoto M, Kaneko M, Kodama S, Yahiro T, Tsutsui A, Kato K, Sone H. Combination of diabetes mellitus and lack of habitual physical activity is a risk factor for functional disability in Japanese. BMJ Open Diabetes Res Care 2020;8:e000901. [PMID: 32049629 DOI: 10.1136/bmjdrc-2019-000901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
147 Saunders AM, Burns DK, Gottschalk WK. Reassessment of Pioglitazone for Alzheimer's Disease. Front Neurosci 2021;15:666958. [PMID: 34220427 DOI: 10.3389/fnins.2021.666958] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
148 Klimova B, Novotny M, Schlegel P, Valis M. The Effect of Mediterranean Diet on Cognitive Functions in the Elderly Population. Nutrients 2021;13:2067. [PMID: 34208741 DOI: 10.3390/nu13062067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
149 Hirao K, Yamashita F, Sakurai S, Tsugawa A, Haime R, Fukasawa R, Sato T, Kanetaka H, Umahara T, Sakurai H, Hanyu H, Shimizu S. Association of regional white matter hyperintensity volumes with cognitive dysfunction and vascular risk factors in patients with amnestic mild cognitive impairment. Geriatr Gerontol Int 2021;21:644-50. [PMID: 34105230 DOI: 10.1111/ggi.14211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
150 Ye S, Xie DJ, Zhou P, Gao HW, Zhang MT, Chen DB, Qin YP, Lei X, Li XQ, Liu J, Cheng YX, Yao YC, Cai B, Shen GM. Huang-Pu-Tong-Qiao Formula Ameliorates the Hippocampus Apoptosis in Diabetic Cognitive Dysfunction Mice by Activating CREB/BDNF/TrkB Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:5514175. [PMID: 34211563 DOI: 10.1155/2021/5514175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Secnik J, Xu H, Schwertner E, Hammar N, Alvarsson M, Winblad B, Eriksdotter M, Garcia-Ptacek S, Religa D. Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years. J Alzheimers Dis 2020;76:1581-94. [PMID: 32741836 DOI: 10.3233/JAD-200618] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
152 Antal B, Mcmahon LP, Sultan SF, Lithen A, Wexler DJ, Dickerson B, Ratai E, Mujica-parodi LR. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: complementary findings from UK Biobank and meta-analyses.. [DOI: 10.1101/2021.05.23.21257682] [Reference Citation Analysis]
153 Chang CY, Lin FJ, Hong JL, Wu CH. Adherence to Statins Use and Risk of Dementia among Patients with Diabetes and Comorbid Hyperlipidemia. Inquiry 2021;58:469580211019201. [PMID: 34036836 DOI: 10.1177/00469580211019201] [Reference Citation Analysis]
154 Paterson EN, Maxwell AP, Kee F, Cruise S, Young IS, McGuinness B, McKay GJ. Association of renal impairment with cognitive dysfunction in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA). Nephrol Dial Transplant 2021;36:1492-9. [PMID: 34038557 DOI: 10.1093/ndt/gfab182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
155 Tournissac M, Vu TM, Vrabic N, Hozer C, Tremblay C, Mélançon K, Planel E, Pifferi F, Calon F. Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model. Alzheimers Res Ther 2021;13:103. [PMID: 34020681 DOI: 10.1186/s13195-021-00842-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
156 Burillo J, Marqués P, Jiménez B, González-Blanco C, Benito M, Guillén C. Insulin Resistance and Diabetes Mellitus in Alzheimer's Disease. Cells 2021;10:1236. [PMID: 34069890 DOI: 10.3390/cells10051236] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
157 Lim D, Jeong JH, Song J. Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature. CNS Neurosci Ther 2021;27:883-94. [PMID: 33945675 DOI: 10.1111/cns.13653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
158 Zhang X, Hou Y, Li J, Wang J. The Role of Astaxanthin on Chronic Diseases. Crystals 2021;11:505. [DOI: 10.3390/cryst11050505] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
159 Moin ASM, Kahal H, Al-Qaissi A, Kumar N, Sathyapalan T, Atkin SL, Butler AE. Amyloid-related protein changes associated with dementia differ according to severity of hypoglycemia. BMJ Open Diabetes Res Care 2021;9:e002211. [PMID: 33931404 DOI: 10.1136/bmjdrc-2021-002211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
160 Tanokashira D, Wang W, Maruyama M, Kuroiwa C, White MF, Taguchi A. Irs2 deficiency alters hippocampus-associated behaviors during young adulthood. Biochem Biophys Res Commun 2021;559:148-54. [PMID: 33940386 DOI: 10.1016/j.bbrc.2021.04.101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
161 Choi J, Booth G, Jung HY, Lapointe-Shaw L, Tang T, Kwan JL, Rawal S, Weinerman A, Verma A, Razak F. Association of diabetes with frequency and cost of hospital admissions: a retrospective cohort study. CMAJ Open 2021;9:E406-12. [PMID: 33863799 DOI: 10.9778/cmajo.20190213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
162 Tanaka S, Yamashita M, Saito H, Kamiya K, Maeda D, Konishi M, Matsue Y. Multidomain Frailty in Heart Failure: Current Status and Future Perspectives. Curr Heart Fail Rep 2021;18:107-20. [PMID: 33835397 DOI: 10.1007/s11897-021-00513-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
163 Wei R, Zhuge X, Yue P, Liu M, Zhu L, Liu J, Xia C. Effect of hepatic sympathetic nerve removal on energy metabolism in an animal model of cognitive impairment and its relationship to Glut2 expression. Open Life Sci 2020;15:311-7. [PMID: 33817219 DOI: 10.1515/biol-2020-0033] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
164 Ware EB, Morataya C, Fu M, Bakulski KM. Type 2 Diabetes and Cognitive Status in the Health and Retirement Study: A Mendelian Randomization Approach. Front Genet 2021;12:634767. [PMID: 33868373 DOI: 10.3389/fgene.2021.634767] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
165 Zhang H, Huang R, Tian S, An K, Zhu W, Shi J, Cao W, Wang S. The CC Genotype of Insulin-Induced Gene 2 rs7566605 Is a Protective Factor of Hypercholesteremia Susceptible to Mild Cognitive Impairment, Especially to the Executive Function of Patients with Type 2 Diabetes Mellitus. Biomed Res Int 2020;2020:4935831. [PMID: 32596317 DOI: 10.1155/2020/4935831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 O'Neill RA, Maxwell AP, Paterson EN, Kee F, Young I, Hogg RE, Cruise S, Murphy S, McGuinness B, McKay GJ. Retinal microvascular parameters are not significantly associated with mild cognitive impairment in the Northern Ireland Cohort for the Longitudinal Study of Ageing. BMC Neurol 2021;21:112. [PMID: 33706706 DOI: 10.1186/s12883-021-02137-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Medrano M, Castro-Tejada G, Lantigua R, Silvestre G, Diaz S, Mota P, Diaz-Garelli F. Vascular mild cognitive impairment and its relationship to hemoglobin A1c levels and apolipoprotein E genotypes in the Dominican Republic. Dement Neuropsychol 2021;15:69-78. [PMID: 33907599 DOI: 10.1590/1980-57642021dn15-010007] [Reference Citation Analysis]
168 Doucet J, Verny C, Hilbert C, Rekik A, Bordier L, Bauduceau B. Les complications gériatriques ne doivent pas être négligées chez les patients diabétiques âgés. Les apports du suivi de l’étude GERODIAB. Médecine des Maladies Métaboliques 2021;15:224-230. [DOI: 10.1016/j.mmm.2020.12.009] [Reference Citation Analysis]
169 Cogo A, Mangin G, Maïer B, Callebert J, Mazighi M, Chabriat H, Launay JM, Huberfeld G, Kubis N. Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline. Mol Neurodegener 2021;16:7. [PMID: 33588894 DOI: 10.1186/s13024-020-00421-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
170 Elesawy BH, Raafat BM, Muqbali AA, Abbas AM, Sakr HF. The Impact of Intermittent Fasting on Brain-Derived Neurotrophic Factor, Neurotrophin 3, and Rat Behavior in a Rat Model of Type 2 Diabetes Mellitus. Brain Sci 2021;11:242. [PMID: 33671898 DOI: 10.3390/brainsci11020242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
171 Giudici KV. Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020. J Prev Alzheimers Dis 2021;8:118-22. [PMID: 33569556 DOI: 10.14283/jpad.2021.6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
172 Santiago JA, Potashkin JA. The Impact of Disease Comorbidities in Alzheimer's Disease. Front Aging Neurosci 2021;13:631770. [PMID: 33643025 DOI: 10.3389/fnagi.2021.631770] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 36.0] [Reference Citation Analysis]
173 Qi F, Zhang D, Gao J, Tang M, Wang M, Su Y, Lei Y, Shao Z, Zhang X. Functional Disconnection of the Angular Gyrus Related to Cognitive Impairment in Patients With Type 2 Diabetes Mellitus. Front Hum Neurosci 2021;15:621080. [PMID: 33613213 DOI: 10.3389/fnhum.2021.621080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
174 Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol 2021;17:195-206. [PMID: 33469209 DOI: 10.1038/s41574-020-00451-4] [Cited by in Crossref: 78] [Cited by in F6Publishing: 85] [Article Influence: 78.0] [Reference Citation Analysis]
175 Wang JT, Yu ZY, Tao YH, Liu YC, Wang YM, Guo QL, Xue JZ, Wen XH, Zhang Q, Xu XD, He CF, Xue WJ, Guo JC, Zhou HG. A novel palmitic acid hydroxy stearic acid (5-PAHSA) plays a neuroprotective role by inhibiting phosphorylation of the m-TOR-ULK1 pathway and regulating autophagy. CNS Neurosci Ther 2021;27:484-96. [PMID: 33459523 DOI: 10.1111/cns.13573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
176 Li C, Jin R, Liu K, Li Y, Zuo Z, Tong H, Zhang J, Zhang J, Guo Y, Lai Y, Sun J, Wang J, Xiong K, Chen X. White Matter Atrophy in Type 2 Diabetes Mellitus Patients With Mild Cognitive Impairment. Front Neurosci 2020;14:602501. [PMID: 33536867 DOI: 10.3389/fnins.2020.602501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 Chang Y, Kim CK, Kim MK, Seo WK, Oh K. Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients. Sci Rep 2021;11:1229. [PMID: 33441784 DOI: 10.1038/s41598-020-80315-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
178 Chen J, Mooldijk SS, Licher S, Waqas K, Ikram MK, Uitterlinden AG, Zillikens MC, Ikram MA. Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia. JAMA Netw Open 2021;4:e2033012. [PMID: 33416887 DOI: 10.1001/jamanetworkopen.2020.33012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
179 Rajeev A, Ali M, Tuinebreijer W, Zourob E, Anto J. Preexisting dementia is associated with higher mortality rate in patients with femoral neck fracture. Aging Med (Milton) 2021;4:12-8. [PMID: 33738375 DOI: 10.1002/agm2.12142] [Reference Citation Analysis]
180 Matsuzaki K, Ohizumi Y. Beneficial Effects of Citrus-Derived Polymethoxylated Flavones for Central Nervous System Disorders. Nutrients 2021;13:E145. [PMID: 33406641 DOI: 10.3390/nu13010145] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
181 Medinas DB, Hazari Y, Hetz C. Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders. Prog Mol Subcell Biol 2021;59:239-78. [PMID: 34050870 DOI: 10.1007/978-3-030-67696-4_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Ilinca S, Suzuki E. Gender and socioeconomic differences in modifiable risk factors for Alzheimer’s disease and other types of dementia throughout the life course. Sex and Gender Differences in Alzheimer's Disease 2021. [DOI: 10.1016/b978-0-12-819344-0.00004-1] [Reference Citation Analysis]
183 Luna J, Peláez E, Loayza FR, Alvarado R, Pastor MA. Pattern Recognition of White Matter Lesions Associated With Diabetes Mellitus Type 2. IFAC-PapersOnLine 2021;54:370-375. [DOI: 10.1016/j.ifacol.2021.10.284] [Reference Citation Analysis]
184 Elliott JM. The Role of Glycaemic Control in Cognitive Functioning. Chemically Modified Minds 2021. [DOI: 10.1007/978-981-15-6771-1_6] [Reference Citation Analysis]
185 Chee TT. Psychiatric Diseases in Relation to Physical Illness. Encyclopedia of Gerontology and Population Aging 2021. [DOI: 10.1007/978-3-030-22009-9_423] [Reference Citation Analysis]
186 Wanvoegbe FA, Gnonlonfoun DD, Agbodande KA, Fandi AA, Gnanguenon MB, Azon-kouanou A, Adjien C, Amoussou-guenou D, Zannou DM, Houinato D. Dementia and Diabetes Mellitus in Porto-Novo: Frequency and Determining Factors. OJIM 2021;11:246-257. [DOI: 10.4236/ojim.2021.114021] [Reference Citation Analysis]
187 Kelley RE. Traumatic and Degenerative Hypothalamic Diseases. The Human Hypothalamus 2021. [DOI: 10.1007/978-3-030-62187-2_21] [Reference Citation Analysis]
188 Purusothaman D, Chalichem NSS, Bethapudi B, Murugan S, Mundkinajeddu D. Bacopa monnieri for cognitive health—a review of molecular mechanisms of action. Nutraceuticals in Brain Health and Beyond 2021. [DOI: 10.1016/b978-0-12-820593-8.00003-3] [Reference Citation Analysis]
189 Spagnuolo MS, Iossa S, Cigliano L. Sweet but Bitter: Focus on Fructose Impact on Brain Function in Rodent Models. Nutrients 2020;13:E1. [PMID: 33374894 DOI: 10.3390/nu13010001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
190 Olshevskiy NA, Glushenko SM, Gumenyuk LN, Gerbali OY, Sarchuk EV, Sorokina LE. Prospects Of Using Resveratrol For Cognitive Impairment Correction In Patients With Type II Diabetes Mellitus. Russ Open Med J 2020;9. [DOI: 10.15275/rusomj.2020.0411] [Reference Citation Analysis]
191 Chen F, Yoshida H. Lifestyle habits and the risk factors of dementia: Evidence from Japan. Geriatr Gerontol Int 2021;21:203-8. [PMID: 33325103 DOI: 10.1111/ggi.14116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
192 Hayashi SI, Rakugi H, Morishita R. Insight into the Role of Angiopoietins in Ageing-Associated Diseases. Cells 2020;9:E2636. [PMID: 33302426 DOI: 10.3390/cells9122636] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
193 Naguib R, Soliman ES, Neimatallah FM, Alkhudhairy NS, Alghamdi AM, Almosa RS, Aldashash KA, Alkhalifah BY, Elmorshedy H. Cognitive impairment among patients with diabetes in Saudi Arabia: a cross-sectional study. Middle East Curr Psychiatry 2020;27:49. [DOI: 10.1186/s43045-020-00058-5] [Reference Citation Analysis]
194 Osama A, Khalil TH, Negm M, Abdel-razek R, Abouelhamd H. Association between microstructural white matter abnormalities and cognitive functioning in patients with type 2 diabetes mellitus: a diffusion tensor imaging study. Egypt J Neurol Psychiatry Neurosurg 2020;56:118. [DOI: 10.1186/s41983-020-00232-w] [Reference Citation Analysis]
195 Carmichael OT, Neiberg RH, Dutton GR, Hayden KM, Horton E, Pi-Sunyer FX, Johnson KC, Rapp SR, Spira AP, Espeland MA. Long-term Change in Physiological Markers and Cognitive Performance in Type 2 Diabetes: The Look AHEAD Study. J Clin Endocrinol Metab 2020;105:dgaa591. [PMID: 32845968 DOI: 10.1210/clinem/dgaa591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
196 Baldwin PA, Sanatkar S, Clarke J, Fletcher S, Gunn J, Wilhelm K, Campbell L, Zwar N, Harris M, Lapsley H, Hadzi-Pavlovic D, Christensen H, Proudfoot J. A Web-Based Mental Health Intervention to Improve Social and Occupational Functioning in Adults With Type 2 Diabetes (The Springboard Trial): 12-Month Outcomes of a Randomized Controlled Trial. J Med Internet Res 2020;22:e16729. [PMID: 33258790 DOI: 10.2196/16729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
197 Jiang YY, Shui JC, Zhang BX, Chin JW, Yue RS. The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus. Front Pharmacol 2020;11:585487. [PMID: 33381036 DOI: 10.3389/fphar.2020.585487] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
198 Barzilay JI, Younes N, Pop-Busui R, Florez H, Seaquist E, Falck-Ytter C, Luchsinger JA; GRADE Research Group. The cross-sectional association of renal dysfunction with tests of cognition in middle-aged adults with early type 2 diabetes: The GRADE Study. J Diabetes Complications 2021;35:107805. [PMID: 33288412 DOI: 10.1016/j.jdiacomp.2020.107805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
199 Brognara L, Volta I, Cassano VM, Navarro-flores E, Cauli O. The Association between Cognitive Impairment and Diabetic Foot Care: Role of Neuropathy and Glycated Hemoglobin. Pathophysiology 2020;27:14-27. [DOI: 10.3390/pathophysiology27010003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
200 Mohammadnejad A, Nygaard M, Li S, Zhang D, Xu C, Li W, Lund J, Christiansen L, Baumbach J, Christensen K, Hjelmborg JVB, Tan Q. Generalized correlation coefficient for genome-wide association analysis of cognitive ability in twins. Aging (Albany NY) 2020;12:22457-94. [PMID: 33232274 DOI: 10.18632/aging.104198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
201 Tamaki Y, Hiratsuka Y, Kumakawa T. Risk Factors for Dementia Incidence Based on Previous Results of the Specific Health Checkups in Japan. Healthcare 2020;8:491. [DOI: 10.3390/healthcare8040491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
202 Foret JT, Dekhtyar M, Birdsill AC, Tanaka H, Haley AP. Metabolic syndrome components moderate the association between executive function and functional connectivity in the default mode network. Brain Imaging Behav 2021;15:2139-48. [PMID: 33179757 DOI: 10.1007/s11682-020-00409-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
203 Mehra A, Sangwan G, Grover S, Kathirvel S, Avasthi A. Prevalence of Psychiatric Morbidity and Cognitive Impairment among Patients Attending the Rural Noncommunicable Disease Clinic. J Neurosci Rural Pract 2020;11:585-92. [PMID: 33144795 DOI: 10.1055/s-0040-1715540] [Reference Citation Analysis]
204 Ding Y, Liu H, Cen M, Tao Y, Lai C, Tang Z. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice. Neurochem Res 2021;46:265-75. [PMID: 33140268 DOI: 10.1007/s11064-020-03160-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
205 Samoilova YG, Rotkank MA, Kudlay DA, Zhukova NG, Matveeva MV, Tolmachev IV. A Prognostic Model of the Development of Cognitive Impairments in Patients with Type 1 Diabetes Mellitus. Neurosci Behav Physi 2020;50:1136-9. [DOI: 10.1007/s11055-020-01015-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Bai F, Li T, Li B, Li X, Zhu L. Serum Human Epididymis Protein 4 Level is Associated with Cognitive Function in Patients with Diabetes Mellitus. Diabetes Metab Syndr Obes 2020;13:3919-24. [PMID: 33122928 DOI: 10.2147/DMSO.S274413] [Reference Citation Analysis]
207 Lissner LJ, Rodrigues L, Wartchow KM, Borba E, Bobermin LD, Fontella FU, Hansen F, Quincozes-Santos A, Souza DOG, Gonçalves CA. Short-Term Alterations in Behavior and Astroglial Function After Intracerebroventricular Infusion of Methylglyoxal in Rats. Neurochem Res 2021;46:183-96. [PMID: 33095439 DOI: 10.1007/s11064-020-03154-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
208 Kim DY, Kang MK, Lee EJ, Kim YH, Oh H, Kim SI, Oh SY, Na W, Kang YH. Eucalyptol Inhibits Amyloid-β-Induced Barrier Dysfunction in Glucose-Exposed Retinal Pigment Epithelial Cells and Diabetic Eyes. Antioxidants (Basel) 2020;9:E1000. [PMID: 33076507 DOI: 10.3390/antiox9101000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
209 Danat IM, Clifford A, Partridge M, Zhou W, Bakre AT, Chen A, McFeeters D, Smith T, Wan Y, Copeland J, Anstey KJ, Chen R. Impacts of Overweight and Obesity in Older Age on the Risk of Dementia: A Systematic Literature Review and a Meta-Analysis. J Alzheimers Dis 2019;70:S87-99. [PMID: 30689574 DOI: 10.3233/JAD-180763] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
210 Bhatti JS, Thamarai K, Kandimalla R, Manczak M, Yin X, Kumar S, Vijayan M, Reddy PH. Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice. Mol Neurobiol 2021;58:795-808. [PMID: 33025510 DOI: 10.1007/s12035-020-02142-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
211 Cao W, Tian S, Zhang H, Zhu W, An K, Shi J, Yuan Y, Wang S. Association of Low-Density Lipoprotein Receptor-Related Protein 1 and Its rs1799986 Polymorphism With Mild Cognitive Impairment in Chinese Patients With Type 2 Diabetes. Front Neurosci 2020;14:743. [PMID: 33013281 DOI: 10.3389/fnins.2020.00743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
212 Secnik J, Schwertner E, Alvarsson M, Hammar N, Fastbom J, Winblad B, Garcia-Ptacek S, Religa D, Eriksdotter M. Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry. BMJ Open Diabetes Res Care 2020;8:e000833. [PMID: 31958305 DOI: 10.1136/bmjdrc-2019-000833] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
213 Fuller OK, Whitham M, Mathivanan S, Febbraio MA. The Protective Effect of Exercise in Neurodegenerative Diseases: The Potential Role of Extracellular Vesicles. Cells 2020;9:E2182. [PMID: 32998245 DOI: 10.3390/cells9102182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
214 Shippy DC, Ulland TK. Microglial Immunometabolism in Alzheimer's Disease. Front Cell Neurosci 2020;14:563446. [PMID: 33192310 DOI: 10.3389/fncel.2020.563446] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
215 Yan T, Zhang Z, Li D. NGF receptors and PI3K/AKT pathway involved in glucose fluctuation-induced damage to neurons and α-lipoic acid treatment. BMC Neurosci 2020;21:38. [PMID: 32943002 DOI: 10.1186/s12868-020-00588-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
216 Zakharov VV, Novikova MS, Vakhnina NV. [Prevention of dementia in patients with mild cognitive impairment]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:167-74. [PMID: 32929941 DOI: 10.17116/jnevro2020120081167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
217 Salinero AE, Robison LS, Gannon OJ, Riccio D, Mansour F, Abi-Ghanem C, Zuloaga KL. Sex-specific effects of high-fat diet on cognitive impairment in a mouse model of VCID. FASEB J 2020;34:15108-22. [PMID: 32939871 DOI: 10.1096/fj.202000085R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
218 Dallora AL, Minku L, Mendes E, Rennemark M, Anderberg P, Sanmartin Berglund J. Multifactorial 10-Year Prior Diagnosis Prediction Model of Dementia. Int J Environ Res Public Health 2020;17:E6674. [PMID: 32937765 DOI: 10.3390/ijerph17186674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
219 Gallardo R, Iadanza MG, Xu Y, Heath GR, Foster R, Radford SE, Ranson NA. Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly. Nat Struct Mol Biol 2020;27:1048-56. [PMID: 32929282 DOI: 10.1038/s41594-020-0496-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 22.5] [Reference Citation Analysis]
220 Li Y, Liang Y, Tan X, Chen Y, Yang J, Zeng H, Qin C, Feng Y, Ma X, Qiu S. Altered Functional Hubs and Connectivity in Type 2 Diabetes Mellitus Without Mild Cognitive Impairment. Front Neurol 2020;11:1016. [PMID: 33071928 DOI: 10.3389/fneur.2020.01016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
221 de Leeuw FA, Karamujić-Čomić H, Tijms BM, Peeters CFW, Kester MI, Scheltens P, Ahmad S, Vojinovic D, Adams HHH, Hankemeier T, Bos D, van der Lugt A, Vernooij MW, Ikram MA, Amin N, Barkhof F, Teunissen CE, van Duijn CM, van der Flier WM. Circulating metabolites are associated with brain atrophy and white matter hyperintensities. Alzheimers Dement 2021;17:205-14. [PMID: 32886448 DOI: 10.1002/alz.12180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
222 Li RZ, Ding XW, Geetha T, Al-Nakkash L, Broderick TL, Babu JR. Beneficial Effect of Genistein on Diabetes-Induced Brain Damage in the ob/ob Mouse Model. Drug Des Devel Ther 2020;14:3325-36. [PMID: 32884237 DOI: 10.2147/DDDT.S249608] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
223 Elmazoglu Z, Rangel-López E, Medina-Campos ON, Pedraza-Chaverri J, Túnez I, Aschner M, Santamaría A, Karasu Ç. Cannabinoid-profiled agents improve cell survival via reduction of oxidative stress and inflammation, and Nrf2 activation in a toxic model combining hyperglycemia+Aβ1-42 peptide in rat hippocampal neurons. Neurochem Int 2020;140:104817. [PMID: 32781098 DOI: 10.1016/j.neuint.2020.104817] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
224 Wang G, Zhang X, Lu X, Liu J, Zhang Z, Wei Z, Wu Z, Wang J. Fish oil supplementation attenuates cognitive impairment by inhibiting neuroinflammation in STZ-induced diabetic rats. Aging (Albany NY) 2020;12:15281-9. [PMID: 32756005 DOI: 10.18632/aging.103426] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
225 Matveeva MV, Samoilova YG, Zhukova NG, Tolmachov IV, Brazovskiy KS, Leiman OP, Fimushkina NY, Rotkank MA. Neuroimaging methods for assessing the brain in diabetes mellitus (literature review). Bûll sib med 2020;19:189-194. [DOI: 10.20538/1682-0363-2020-2-189-194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
226 Ruiz D, Padmanabhan V, Sargis RM. Stress, Sex, and Sugar: Glucocorticoids and Sex-Steroid Crosstalk in the Sex-Specific Misprogramming of Metabolism. J Endocr Soc 2020;4:bvaa087. [PMID: 32734132 DOI: 10.1210/jendso/bvaa087] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
227 Batista AF, Bodart-Santos V, De Felice FG, Ferreira ST. Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases. CNS Drugs 2019;33:209-23. [PMID: 30511349 DOI: 10.1007/s40263-018-0593-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 19.0] [Reference Citation Analysis]
228 Jensen CS, Musaeus CS, Frikke-Schmidt R, Andersen BB, Beyer N, Gottrup H, Høgh P, Vestergaard K, Wermuth L, Frederiksen KS, Waldemar G, Hasselbalch S, Simonsen AH. Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer's Disease. Front Neurosci 2020;14:532. [PMID: 32536853 DOI: 10.3389/fnins.2020.00532] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
229 Ahmed HA, Ishrat T. The Brain AT2R-a Potential Target for Therapy in Alzheimer's Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics. Mol Neurobiol 2020;57:3458-84. [PMID: 32533467 DOI: 10.1007/s12035-020-01964-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
230 Hu W, Li Y, Zhao Y, Dong Y, Cui Y, Sun S, Gong G, Zhang H, Chai Q, Wang J, Liu Z. Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype. Front Aging Neurosci 2020;12:154. [PMID: 32581766 DOI: 10.3389/fnagi.2020.00154] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
231 Carmichael O, Stuchlik P, Pillai S, Biessels GJ, Dhullipudi R, Madden-Rusnak A, Martin S, Hsia DS, Fonseca V, Bazzano L. High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study. J Clin Endocrinol Metab 2019;104:4492-500. [PMID: 31058974 DOI: 10.1210/jc.2018-02750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
232 Powell WR, Buckingham WR, Larson JL, Vilen L, Yu M, Salamat MS, Bendlin BB, Rissman RA, Kind AJH. Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology. JAMA Netw Open 2020;3:e207559. [PMID: 32525547 DOI: 10.1001/jamanetworkopen.2020.7559] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
233 Chau ACM, Cheung EYW, Chan KH, Chow WS, Shea YF, Chiu PKC, Mak HKF. Impaired cerebral blood flow in type 2 diabetes mellitus - A comparative study with subjective cognitive decline, vascular dementia and Alzheimer's disease subjects. Neuroimage Clin 2020;27:102302. [PMID: 32521474 DOI: 10.1016/j.nicl.2020.102302] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
234 Tournissac M, Vu T, Vrabic N, Hozer C, Tremblay C, Mélançon K, Planel E, Pifferi F, Calon F. Repurposing beta3-adrenergic receptor agonists for Alzheimer’s disease: Beneficial effects on recognition memory and amyloid pathology in a mouse model.. [DOI: 10.1101/2020.05.25.114454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Green H, Tsitsi P, Markaki I, Aarsland D, Svenningsson P. Novel Treatment Opportunities Against Cognitive Impairment in Parkinson's Disease with an Emphasis on Diabetes-Related Pathways. CNS Drugs. 2019;33:143-160. [PMID: 30687888 DOI: 10.1007/s40263-018-0601-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
236 Elahi M, Motoi Y, Shimonaka S, Ishida Y, Hioki H, Takanashi M, Ishiguro K, Imai Y, Hattori N. High-fat diet-induced activation of SGK1 promotes Alzheimer’s disease-associated tau pathology.. [DOI: 10.1101/2020.05.14.095471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
237 Tini G, Scagliola R, Monacelli F, La Malfa G, Porto I, Brunelli C, Rosa GM. Alzheimer's Disease and Cardiovascular Disease: A Particular Association. Cardiol Res Pract 2020;2020:2617970. [PMID: 32454996 DOI: 10.1155/2020/2617970] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
238 Ostroumova OD, Surkova EV, Goloborodova IV, Starodubova AV, Kochetkov AI, Kiknadze TD, Galstyan GR. Hypoglycemia and the risk of cognitive impairment and dementia in elderly and senile patients with type 2 diabetes. Diabetes mellitus 2020;23:72-87. [DOI: 10.14341/dm10202] [Reference Citation Analysis]
239 Bi T, Zhan L, Zhou W, Sui H. Effect of the ZiBuPiYin Recipe on Diabetes-Associated Cognitive Decline in Zucker Diabetic Fatty Rats After Chronic Psychological Stress. Front Psychiatry 2020;11:272. [PMID: 32372981 DOI: 10.3389/fpsyt.2020.00272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
240 Feng W, Liu Y, Ding Y, Mao G, Zhao T, Chen K, Qiu X, Xu T, Zhao X, Wu X, Yang L. Typical neurobehavioral methods and transcriptome analysis reveal the neurotoxicity and mechanisms of di(2-ethylhexyl) phthalate on pubertal male ICR mice with type 2 diabetes mellitus. Arch Toxicol 2020;94:1279-302. [DOI: 10.1007/s00204-020-02683-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
241 Daniele G, Campi B, Saba A, Codini S, Ciccarone A, Giusti L, Del Prato S, Esterline RL, Ferrannini E. Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery. Front Endocrinol (Lausanne) 2020;11:216. [PMID: 32362872 DOI: 10.3389/fendo.2020.00216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
242 Zhang S, Xue R, Geng Y, Wang H, Li W. Fisetin Prevents HT22 Cells From High Glucose-Induced Neurotoxicity via PI3K/Akt/CREB Signaling Pathway. Front Neurosci 2020;14:241. [PMID: 32265642 DOI: 10.3389/fnins.2020.00241] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
243 Yorke E, Boima V, Dey ID, Ganu V, Nkornu N, Acquaye KS, Mate-Kole CC. Comparison of neurocognitive changes among newly diagnosed tuberculosis patients with and without dysglycaemia. BMC Psychiatry 2020;20:143. [PMID: 32245444 DOI: 10.1186/s12888-020-02570-8] [Reference Citation Analysis]
244 Hong CT, Chen KY, Wang W, Chiu JY, Wu D, Chao TY, Hu CJ, Chau KD, Bamodu OA. Insulin Resistance Promotes Parkinson's Disease through Aberrant Expression of α-Synuclein, Mitochondrial Dysfunction, and Deregulation of the Polo-Like Kinase 2 Signaling. Cells 2020;9:E740. [PMID: 32192190 DOI: 10.3390/cells9030740] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 20.5] [Reference Citation Analysis]
245 Ou YN, Shen XN, Hu HY, Hu H, Wang ZT, Xu W, Dong Q, Tan L, Yu JT. Fasting blood glucose and cerebrospinal fluid Alzheimer's biomarkers in non-diabetic cognitively normal elders: the CABLE study. Aging (Albany NY) 2020;12:4945-52. [PMID: 32181754 DOI: 10.18632/aging.102921] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
246 Liu Z, Zaid M, Hisamatsu T, Tanaka S, Fujiyoshi A, Miyagawa N, Ito T, Kadota A, Tooyama I, Miura K, Ueshima H. Elevated Fasting Blood Glucose Levels Are Associated With Lower Cognitive Function, With a Threshold in Non-Diabetic Individuals: A Population-Based Study. J Epidemiol 2020;30:121-7. [PMID: 31130559 DOI: 10.2188/jea.JE20180193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Ohara T, Furuta Y, Hirabayashi N, Hata J, Hirakawa Y, Honda T, Yoshida D, Shibata M, Kitazono T, Ninomiya T. Elevated serum glycated albumin and glycated albumin : hemoglobin A1c ratio were associated with hippocampal atrophy in a general elderly population of Japanese: The Hisayama Study. J Diabetes Investig 2020;11:971-9. [PMID: 31999889 DOI: 10.1111/jdi.13220] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
248 Chaturvedi P, Singh AK, Tiwari V, Thacker AK. Diabetes mellitus type 2 impedes functional recovery, neuroplasticity and quality of life after stroke. J Family Med Prim Care 2020;9:1035-41. [PMID: 32318463 DOI: 10.4103/jfmpc.jfmpc_884_19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
249 Whiteley WN, Anand S, Bangdiwala SI, Bosch J, Canavan M, Chertkow H, Gerstein HC, Gorelick P, O'Donnell M, Paré G, Pigeyre M, Seshadri S, Sharma M, Smith EE, Williamson J, Cukierman-Yaffe T, Hart RG, Yusuf S. Are large simple trials for dementia prevention possible? Age Ageing 2020;49:154-60. [PMID: 31830268 DOI: 10.1093/ageing/afz152] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
250 Koren-Iton A, Salomon-Zimri S, Smolar A, Shavit-Stein E, Dori A, Chapman J, Michaelson DM. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology. Int J Mol Sci 2020;21:E1289. [PMID: 32075060 DOI: 10.3390/ijms21041289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
251 Mollon J, Curran JE, Mathias SR, Knowles EEM, Carlisle P, Fox PT, Olvera RL, Göring HHH, Rodrigue A, Almasy L, Duggirala R, Blangero J, Glahn DC. Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology. Diabetologia 2020;63:977-86. [PMID: 32016567 DOI: 10.1007/s00125-020-05101-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
252 Fortune NC, Harville EW, Guralnik JM, Gustat J, Chen W, Qi L, Bazzano LA. Dietary intake and cognitive function: evidence from the Bogalusa Heart Study. Am J Clin Nutr 2019;109:1656-63. [PMID: 31136655 DOI: 10.1093/ajcn/nqz026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
253 Williams T, Borchelt DR, Chakrabarty P. Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease. Mol Neurodegener 2020;15:8. [PMID: 32005122 DOI: 10.1186/s13024-020-0358-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 27.5] [Reference Citation Analysis]
254 Sankar SB, Infante-Garcia C, Weinstock LD, Ramos-Rodriguez JJ, Hierro-Bujalance C, Fernandez-Ponce C, Wood LB, Garcia-Alloza M. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model. J Neuroinflammation 2020;17:38. [PMID: 31992349 DOI: 10.1186/s12974-020-1707-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
255 Ayabe T, Fukuda T, Ano Y. Improving Effects of Hop-Derived Bitter Acids in Beer on Cognitive Functions: A New Strategy for Vagus Nerve Stimulation. Biomolecules 2020;10:E131. [PMID: 31940997 DOI: 10.3390/biom10010131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
256 Chen R, Shu Y, Zeng Y. Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology. Front Aging Neurosci 2019;11:356. [PMID: 31969813 DOI: 10.3389/fnagi.2019.00356] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
257 Delgado J, Bowman K, Clare L. Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007. BMJ Open 2020;10:e029172. [PMID: 31900263 DOI: 10.1136/bmjopen-2019-029172] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
258 Taylor CA, Bouldin ED, Greenlund KJ, McGuire LC. Comorbid Chronic Conditions Among Older Adults with Subjective Cognitive Decline, United States, 2015-2017. Innov Aging 2020;4:igz045. [PMID: 31915725 DOI: 10.1093/geroni/igz045] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
259 Chee TT. Psychiatric Diseases in Relation to Physical Illness. Encyclopedia of Gerontology and Population Aging 2020. [DOI: 10.1007/978-3-319-69892-2_423-1] [Reference Citation Analysis]
260 Mossello E, Marchionni N. Vascular Risk Factors and Cognitive Function. Brain and Heart Dynamics 2020. [DOI: 10.1007/978-3-030-28008-6_62] [Reference Citation Analysis]
261 Rigato M, Fadini GP, Avogaro A. Diabetes and the Cardiovascular System. Endocrinology 2020. [DOI: 10.1007/978-3-030-36694-0_6] [Reference Citation Analysis]
262 Mossello E, Marchionni N. Vascular Risk Factors and Cognitive Function. Brain and Heart Dynamics 2020. [DOI: 10.1007/978-3-319-90305-7_62-1] [Reference Citation Analysis]
263 Ortiz K, Garcia MA, Briceño E, Diminich ED, Arévalo SP, Vega IE, Tarraf W. Glycosylated hemoglobin level, race/ethnicity, and cognition in midlife and early old age. Res Hum Dev 2020;17:20-40. [PMID: 34093090 DOI: 10.1080/15427609.2020.1743810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
264 Koizumi S, Inoue N, Sugihara F, Igase M. Effects of Collagen Hydrolysates on Human Brain Structure and Cognitive Function: A Pilot Clinical Study. Nutrients 2019;12:E50. [PMID: 31878021 DOI: 10.3390/nu12010050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
265 Shirai Y, Kuriki K, Otsuka R, Kato Y, Nishita Y, Tange C, Tomida M, Imai T, Ando F, Shimokata H. <Editors' Choice> Association between green tea intake and risk of cognitive decline, considering glycated hemoglobin level, in older Japanese adults: the NILS-LSA study. Nagoya J Med Sci 2019;81:655-66. [PMID: 31849383 DOI: 10.18999/nagjms.81.4.655] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Cui L, Chen W, Yu X, Ju C. The relationship between cognitive function and having diabetes in patients treated with hemodialysis. Int J Nurs Sci 2020;7:60-5. [PMID: 32099861 DOI: 10.1016/j.ijnss.2019.12.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
267 Nakamura T, Lipton SA. Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases. Antioxid Redox Signal 2020;32:817-33. [PMID: 31657228 DOI: 10.1089/ars.2019.7916] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
268 Szczepanik JC, de Almeida GRL, Cunha MP, Dafre AL. Repeated Methylglyoxal Treatment Depletes Dopamine in the Prefrontal Cortex, and Causes Memory Impairment and Depressive-Like Behavior in Mice. Neurochem Res 2020;45:354-70. [PMID: 31786717 DOI: 10.1007/s11064-019-02921-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
269 Santiago JA, Bottero V, Potashkin JA. Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer's Disease. Front Neurosci 2019;13:1273. [PMID: 31849586 DOI: 10.3389/fnins.2019.01273] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
270 Fernandez-Mendoza J, He F, Calhoun SL, Vgontzas AN, Liao D, Bixler EO. Objective short sleep duration increases the risk of all-cause mortality associated with possible vascular cognitive impairment. Sleep Health 2020;6:71-8. [PMID: 31759934 DOI: 10.1016/j.sleh.2019.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
271 Bandosz P, Ahmadi-Abhari S, Guzman-Castillo M, Pearson-Stuttard J, Collins B, Whittaker H, Shipley MJ, Capewell S, Brunner EJ, O'Flaherty M. Potential impact of diabetes prevention on mortality and future burden of dementia and disability: a modelling study. Diabetologia 2020;63:104-15. [PMID: 31732789 DOI: 10.1007/s00125-019-05015-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
272 Rahman A, Jackson H, Hristov H, Isaacson RS, Saif N, Shetty T, Etingin O, Henchcliffe C, Brinton RD, Mosconi L. Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks. Front Aging Neurosci 2019;11:315. [PMID: 31803046 DOI: 10.3389/fnagi.2019.00315] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 15.7] [Reference Citation Analysis]
273 Yu JH, Han K, Park S, Cho H, Lee DY, Kim JW, Seo JA, Kim SG, Baik SH, Park YG, Choi KM, Kim SM, Kim NH. Incidence and Risk Factors for Dementia in Type 2 Diabetes Mellitus: A Nationwide Population-Based Study in Korea. Diabetes Metab J 2020;44:113-24. [PMID: 31769236 DOI: 10.4093/dmj.2018.0216] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
274 Nici J, Hom J. Neuropsychological function in type 2 diabetes mellitus. Applied Neuropsychology: Adult 2019;26:513-521. [DOI: 10.1080/23279095.2018.1455683] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
275 Lee ATC, Richards M, Chan WC, Chiu HFK, Lee RSY, Lam LCW. Higher dementia incidence in older adults with type 2 diabetes and large reduction in HbA1c. Age Ageing 2019;48:838-44. [PMID: 31574142 DOI: 10.1093/ageing/afz108] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
276 Fernández-de Frutos M, Galán-Chilet I, Goedeke L, Kim B, Pardo-Marqués V, Pérez-García A, Herrero JI, Fernández-Hernando C, Kim J, Ramírez CM. MicroRNA 7 Impairs Insulin Signaling and Regulates Aβ Levels through Posttranscriptional Regulation of the Insulin Receptor Substrate 2, Insulin Receptor, Insulin-Degrading Enzyme, and Liver X Receptor Pathway. Mol Cell Biol 2019;39:e00170-19. [PMID: 31501273 DOI: 10.1128/MCB.00170-19] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 10.7] [Reference Citation Analysis]
277 Kim YG, Park DG, Moon SY, Jeon JY, Kim HJ, Kim DJ, Lee KW, Han SJ. Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study. Diabetes Metab J 2020;44:125-33. [PMID: 31701690 DOI: 10.4093/dmj.2018.0260] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
278 Janoutová J, Kovalová M, Ambroz P, Machaczka O, Zatloukalová A, Němček K, Mrázková E, Košta O, Janout V. Alzheimer's disease, appeal to public health. Psychiatr pro Praxi 2019;20:139-141. [DOI: 10.36290/psy.2019.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Singh M, Raj D, Raina SK, Gandhi MK, Chander V. Using Multistate Observational Studies to Determine Role of Hypertension and Diabetes as Risk Factors for Dementia. J Neurosci Rural Pract 2016;7:S3-6. [PMID: 28163495 DOI: 10.4103/0976-3147.196462] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
280 Ricci G. Social Aspects of Dementia Prevention from a Worldwide to National Perspective: A Review on the International Situation and the Example of Italy. Behav Neurol 2019;2019:8720904. [PMID: 31583024 DOI: 10.1155/2019/8720904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
281 Jolivalt CG, Marquez A, Quach D, Navarro Diaz MC, Anaya C, Kifle B, Muttalib N, Sanchez G, Guernsey L, Hefferan M, Smith DR, Fernyhough P, Johe K, Calcutt NA. Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189. Diabetes 2019;68:2143-54. [PMID: 31492662 DOI: 10.2337/db19-0271] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
282 Hata J, Ohara T, Katakura Y, Shimizu K, Yamashita S, Yoshida D, Honda T, Hirakawa Y, Shibata M, Sakata S, Kitazono T, Kuhara S, Ninomiya T. Association Between Serum β-Alanine and Risk of Dementia. Am J Epidemiol 2019;188:1637-45. [PMID: 31127276 DOI: 10.1093/aje/kwz116] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
283 Buchmann N, Fink A, Tegeler C, Demuth I, Doblhammer G, Steinhagen-Thiessen E. Different treatment forms of type II diabetes and the risk of dementia in German health claims data. Acta Diabetol 2019;56:995-1003. [PMID: 31119454 DOI: 10.1007/s00592-019-01332-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
284 Sviridov D, Miller YI. Biology of Lipid Rafts: Introduction to the Thematic Review Series. J Lipid Res 2020;61:598-600. [PMID: 31462515 DOI: 10.1194/jlr.IN119000330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
285 Jacob L, Haro JM, Koyanagi A. Physical multimorbidity and subjective cognitive complaints among adults in the United Kingdom: a cross-sectional community-based study. Sci Rep 2019;9:12417. [PMID: 31455875 DOI: 10.1038/s41598-019-48894-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
286 Biessels GJ, Whitmer RA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia. 2020;63:3-9. [PMID: 31420699 DOI: 10.1007/s00125-019-04977-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 20.7] [Reference Citation Analysis]
287 Piri R, Naghavi-behzad M, Gerke O, Høilund-carlsen PF, Vafaee MS. Investigations of possible links between Alzheimer’s disease and type 2 diabetes mellitus by positron emission tomography: a systematic review. Clin Transl Imaging 2019;7:327-36. [DOI: 10.1007/s40336-019-00339-y] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
288 Cerza F, Renzi M, Gariazzo C, Davoli M, Michelozzi P, Forastiere F, Cesaroni G. Long-term exposure to air pollution and hospitalization for dementia in the Rome longitudinal study. Environ Health 2019;18:72. [PMID: 31399053 DOI: 10.1186/s12940-019-0511-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
289 Shimizu C, Wakita Y, Kihara M, Kobayashi N, Tsuchiya Y, Nabeshima T. Association of Lifelong Intake of Barley Diet with Healthy Aging: Changes in Physical and Cognitive Functions and Intestinal Microbiome in Senescence-Accelerated Mouse-Prone 8 (SAMP8). Nutrients 2019;11:E1770. [PMID: 31374892 DOI: 10.3390/nu11081770] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
290 Mendes R, Martins S, Fernandes L. Adherence to Medication, Physical Activity and Diet in Older Adults With Diabetes: Its Association With Cognition, Anxiety and Depression. J Clin Med Res 2019;11:583-92. [PMID: 31413770 DOI: 10.14740/jocmr3894] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
291 Oghagbon EK, Giménez-Llort L. Short height and poor education increase the risk of dementia in Nigerian type 2 diabetic women. Alzheimers Dement (Amst) 2019;11:493-9. [PMID: 31334329 DOI: 10.1016/j.dadm.2019.05.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
292 Lee DH, Porta M, Lind L, Lind PM, Jacobs DR Jr. Neurotoxic chemicals in adipose tissue: A role in puzzling findings on obesity and dementia. Neurology 2018;90:176-82. [PMID: 29358509 DOI: 10.1212/WNL.0000000000004851] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
293 Zhuo Y, Fang F, Lu L, Li T, Lian J, Xiong Y, Kong D, Li K. White matter impairment in type 2 diabetes mellitus with and without microvascular disease. Neuroimage Clin 2019;24:101945. [PMID: 31374399 DOI: 10.1016/j.nicl.2019.101945] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
294 Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14:591-604. [PMID: 30022099 DOI: 10.1038/s41574-018-0048-7] [Cited by in Crossref: 385] [Cited by in F6Publishing: 418] [Article Influence: 128.3] [Reference Citation Analysis]
295 Liu H, Liu J, Liu H, Peng L, Feng Z, Rong P, Shen H, Hu D, Zeng LL, Wang W. Pathological Between-Network Positive Connectivity in Early Type 2 Diabetes Patients Without Cerebral Small Vessel Diseases. Front Neurosci 2019;13:731. [PMID: 31379485 DOI: 10.3389/fnins.2019.00731] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
296 Moran C, Callisaya ML, Srikanth V, Arvanitakis Z. Diabetes Therapies for Dementia. Curr Neurol Neurosci Rep 2019;19:58. [PMID: 31300920 DOI: 10.1007/s11910-019-0973-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
297 Medrano-Jiménez E, Jiménez-Ferrer Carrillo I, Pedraza-Escalona M, Ramírez-Serrano CE, Álvarez-Arellano L, Cortés-Mendoza J, Herrera-Ruiz M, Jiménez-Ferrer E, Zamilpa A, Tortoriello J, Pedraza-Alva G, Pérez-Martínez L. Malva parviflora extract ameliorates the deleterious effects of a high fat diet on the cognitive deficit in a mouse model of Alzheimer's disease by restoring microglial function via a PPAR-γ-dependent mechanism. J Neuroinflammation 2019;16:143. [PMID: 31291963 DOI: 10.1186/s12974-019-1515-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 9.7] [Reference Citation Analysis]
298 Ly H, Despa F. Diabetes-related Amylin Dyshomeostasis: a Contributing Factor to Cerebrovascular Pathology and Dementia. J Lipid Atheroscler 2019;8:144-51. [PMID: 32821704 DOI: 10.12997/jla.2019.8.2.144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
299 Szabolcs S, András A, Ferenc O, Dániel B. Occurrence of internal diseases in the premotor phase of Parkinson’s disease by analyzing a large database covering a whole population. Bulletin of Medical Sciences 2019;92:35-41. [DOI: 10.2478/orvtudert-2019-0009] [Reference Citation Analysis]
300 Sabzwari SR, Iqbal R, Fatmi Z, Azam I. Factors associated with geriatric morbidity and impairment in a megacity of Pakistan. PLoS One 2019;14:e0218872. [PMID: 31247025 DOI: 10.1371/journal.pone.0218872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
301 Dong S, Dongwei L, Zhang J, Liang J, Sun Z, Fang J. Individuals in the prediabetes stage exhibit reduced hippocampal tail volume and executive dysfunction. Brain Behav 2019;9:e01351. [PMID: 31240857 DOI: 10.1002/brb3.1351] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
302 Li J, Bai L, Wei F, Zhao J, Wang D, Xiao Y, Yan W, Wei J. Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review. Front Pharmacol 2019;10:661. [PMID: 31258478 DOI: 10.3389/fphar.2019.00661] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
303 Cozachenco D, Selles MC, Ribeiro FC. Interferon-γ as a Potential Link between Diabetes Mellitus and Dementia. J Neurosci 2019;39:4632-5. [PMID: 31189539 DOI: 10.1523/JNEUROSCI.3046-18.2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Kotova OV, Akarachkova ES, Belyaev AA. Neurological complications of diabetes mellitus. Med sov 2019. [DOI: 10.21518/2079-701x-2019-9-40-44] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
305 Liu W, Zhang P, Tan J, Lin Y. Differentiation of Urine-Derived Induced Pluripotent Stem Cells to Neuron, Astrocyte and Microvascular Endothelial Cells from a Diabetic Patient.. [DOI: 10.1101/667485] [Reference Citation Analysis]
306 Andrade AG, Bubu OM, Varga AW, Osorio RS. The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease. J Alzheimers Dis 2018;64:S255-70. [PMID: 29782319 DOI: 10.3233/JAD-179936] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 23.7] [Reference Citation Analysis]
307 Chen Y, Wilson L, Kornak J, Dudley RA, Merrilees J, Bonasera SJ, Byrne CM, Lee K, Chiong W, Miller BL, Possin KL. The costs of dementia subtypes to California Medicare fee-for-service, 2015. Alzheimers Dement 2019;15:899-906. [PMID: 31175026 DOI: 10.1016/j.jalz.2019.03.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
308 Han R, Liu Z, Sun N, Liu S, Li L, Shen Y, Xiu J, Xu Q. BDNF Alleviates Neuroinflammation in the Hippocampus of Type 1 Diabetic Mice via Blocking the Aberrant HMGB1/RAGE/NF-κB Pathway. Aging Dis 2019;10:611-25. [PMID: 31165005 DOI: 10.14336/AD.2018.0707] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
309 Uranga RM, Keller JN. The Complex Interactions Between Obesity, Metabolism and the Brain. Front Neurosci 2019;13:513. [PMID: 31178685 DOI: 10.3389/fnins.2019.00513] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 16.3] [Reference Citation Analysis]
310 Infante-Garcia C, Garcia-Alloza M. Review of the Effect of Natural Compounds and Extracts on Neurodegeneration in Animal Models of Diabetes Mellitus. Int J Mol Sci 2019;20:E2533. [PMID: 31126031 DOI: 10.3390/ijms20102533] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
311 Clarke J, Sanatkar S, Baldwin PA, Fletcher S, Gunn J, Wilhelm K, Campbell L, Zwar N, Harris M, Lapsley H, Hadzi-Pavlovic D, Christensen H, Proudfoot J. A Web-Based Cognitive Behavior Therapy Intervention to Improve Social and Occupational Functioning in Adults With Type 2 Diabetes (The SpringboarD Trial): Randomized Controlled Trial. J Med Internet Res 2019;21:e12246. [PMID: 31115345 DOI: 10.2196/12246] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
312 Park S, Jeon SM, Jung SY, Hwang J, Kwon JW. Effect of late-life weight change on dementia incidence: a 10-year cohort study using claim data in Korea. BMJ Open 2019;9:e021739. [PMID: 31110079 DOI: 10.1136/bmjopen-2018-021739] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
313 Moreira PI. Sweet Mitochondria: A Shortcut to Alzheimer's Disease. J Alzheimers Dis 2018;62:1391-401. [PMID: 29562542 DOI: 10.3233/JAD-170931] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
314 Legdeur N, van der Lee SJ, de Wilde M, van der Lei J, Muller M, Maier AB, Visser PJ. The association of vascular disorders with incident dementia in different age groups. Alzheimers Res Ther 2019;11:47. [PMID: 31097030 DOI: 10.1186/s13195-019-0496-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
315 Zhang L, Chopp M, Jiang Q, Zhang Z. Role of the glymphatic system in ageing and diabetes mellitus impaired cognitive function. Stroke Vasc Neurol 2019;4:90-2. [PMID: 31338217 DOI: 10.1136/svn-2018-000203] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
316 Ke B, Lu R, Zhang X. Phosphorylated Glycogen Synthase Kinase-3β (GSK-3β) Improves Cognition in Rats with Diabetes-Associated Cognitive Decline. Med Sci Monit 2019;25:3336-43. [PMID: 31057171 DOI: 10.12659/MSM.914653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
317 Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M. Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives. Int J Mol Sci 2019;20:E2139. [PMID: 31052203 DOI: 10.3390/ijms20092139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
318 Otsuka R, Nishita Y, Tange C, Tomida M, Ando F, Shimokata H. Hemoglobin A1c and 10-year information processing speed in Japanese community dwellers. Environ Health Prev Med 2019;24:24. [PMID: 31014232 DOI: 10.1186/s12199-019-0778-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
319 Srujana M, Ramesh R, Nanjaiah LD. Antidiabetic potential of active fraction obtained from methanolic extract of Ichnocarpus frutescens: A possible herbal remedy. Indian J Pharmacol 2018;50:251-9. [PMID: 30636828 DOI: 10.4103/ijp.IJP_24_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
320 Sandström J, Kratschmar DV, Broyer A, Poirot O, Marbet P, Chantong B, Zufferey F, Dos Santos T, Boccard J, Chrast R, Odermatt A, Monnet-Tschudi F. In vitro models to study insulin and glucocorticoids modulation of trimethyltin (TMT)-induced neuroinflammation and neurodegeneration, and in vivo validation in db/db mice. Arch Toxicol 2019;93:1649-64. [PMID: 30993381 DOI: 10.1007/s00204-019-02455-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
321 Cholerton B, Omidpanah A, Verney SP, Nelson LA, Baker LD, Suchy-Dicey A, Longstreth WT Jr, Howard BV, Henderson JA, Montine TJ, Buchwald D. Type 2 diabetes and later cognitive function in older American Indians: The Strong Heart Study. Int J Geriatr Psychiatry 2019;34:1050-7. [PMID: 30924200 DOI: 10.1002/gps.5108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
322 Wakabayashi T, Yamaguchi K, Matsui K, Sano T, Kubota T, Hashimoto T, Mano A, Yamada K, Matsuo Y, Kubota N, Kadowaki T, Iwatsubo T. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease. Mol Neurodegener 2019;14:15. [PMID: 30975165 DOI: 10.1186/s13024-019-0315-7] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 16.7] [Reference Citation Analysis]
323 Zhang L, Yang J, Liao Z, Zhao X, Hu X, Zhu W, Zhang Z. Association between Diabetes and Cognitive Function among People over 45 Years Old in China: A Cross-Sectional Study. Int J Environ Res Public Health 2019;16:E1294. [PMID: 30978913 DOI: 10.3390/ijerph16071294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
324 Cheng J, Liu HP, Hwang SL, Hsu LF, Lin WY, Tsai FJ. Dystonin/BPAG1 modulates diabetes and Alzheimer's disease cross-talk: a meta-analysis. Neurol Sci 2019;40:1577-82. [PMID: 30963337 DOI: 10.1007/s10072-019-03879-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
325 Frangou S, Shirali M, Adams MJ, Howard DM, Gibson J, Hall LS, Smith BH, Padmanabhan S, Murray AD, Porteous DJ, Haley CS, Deary IJ, Clarke TK, McIntosh AM. Insulin resistance: Genetic associations with depression and cognition in population based cohorts. Exp Neurol 2019;316:20-6. [PMID: 30965038 DOI: 10.1016/j.expneurol.2019.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
326 Javadpour P, Dargahi L, Ahmadiani A, Ghasemi R. To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling. Cell Mol Life Sci 2019;76:2277-97. [PMID: 30874837 DOI: 10.1007/s00018-019-03063-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
327 Kumar N, Singh VB, Meena BL, Kumar D, Kumar H, Saini ML, Tiwari A. Mild Cognitive Impairment in Young Type 1 Diabetes Mellitus Patients and Correlation with Diabetes Control, Lipid Profile, and High-sensitivity C-reactive Protein. Indian J Endocrinol Metab 2018;22:780-4. [PMID: 30766818 DOI: 10.4103/ijem.IJEM_58_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
328 Liang Y, Zhang H, Tan X, Liu J, Qin C, Zeng H, Zheng Y, Liu Y, Chen J, Leng X, Qiu S, Shen D. Local Diffusion Homogeneity Provides Supplementary Information in T2DM-Related WM Microstructural Abnormality Detection. Front Neurosci 2019;13:63. [PMID: 30792623 DOI: 10.3389/fnins.2019.00063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
329 Bhusal A, Rahman MH, Lee IK, Suk K. Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy. Front Endocrinol (Lausanne) 2019;10:25. [PMID: 30761088 DOI: 10.3389/fendo.2019.00025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
330 Moran C, Beare R, Wang W, Callisaya M, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI). Type 2 diabetes mellitus, brain atrophy, and cognitive decline. Neurology. 2019;92:e823-e830. [PMID: 30674592 DOI: 10.1212/wnl.0000000000006955] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 21.0] [Reference Citation Analysis]
331 Redel JM, Dolan LM, DiFrancesco M, Vannest J, Shah AS. Youth-Onset Type 2 Diabetes and the Developing Brain. Curr Diab Rep 2019;19:3. [PMID: 30666503 DOI: 10.1007/s11892-019-1120-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
332 Yang J, Zhang LJ, Wang F, Hong T, Liu Z. Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting. Adv Drug Deliv Rev 2019;139:32-50. [PMID: 30529307 DOI: 10.1016/j.addr.2018.11.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
333 Simó-Servat O, Ciudin A, Ortiz-Zúñiga ÁM, Hernández C, Simó R. Usefulness of Eye Fixation Assessment for Identifying Type 2 Diabetic Subjects at Risk of Dementia. J Clin Med 2019;8:E59. [PMID: 30626106 DOI: 10.3390/jcm8010059] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
334 Albai O, Frandes M, Timar R, Roman D, Timar B. Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment. Neuropsychiatr Dis Treat. 2019;15:167-175. [PMID: 30655669 DOI: 10.2147/ndt.s189905] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
335 Lee S. Connections between Diabetes and Cognitive Dysfunction. J Korean Diabetes 2019;20:67. [DOI: 10.4093/jkd.2019.20.2.67] [Reference Citation Analysis]
336 Rigato M, Fadini GP, Avogaro A. Diabetes and the Cardiovascular System. Endocrinology 2019. [DOI: 10.1007/978-3-319-27316-7_6-2] [Reference Citation Analysis]
337 Holmes CS, Morgan KL, Powell P. Neuropsychological Sequelae of Type 1 and Type 2 Diabetes. Handbook of Medical Neuropsychology 2019. [DOI: 10.1007/978-3-030-14895-9_24] [Reference Citation Analysis]
338 Satoh H. Glycemic Control in Elderly Patients with Type 2 Diabetes Mellitus: The Importance of Preventing Hypoglycemia Especially in Patients with Chronic Kidney Disease. Juntendo Medical Journal 2019;65:517-523. [DOI: 10.14789/jmj.2019.65.jmj19-r17] [Reference Citation Analysis]
339 Caballero-corchuelo J, Guerrero-pérez F, García-sancho de la Jordana P, Pérez-maraver M. Analysis of the characteristics of patients with diabetes mellitus who attend a tertiary hospital emergency department for a hypoglycemic event. Endocrinología, Diabetes y Nutrición (English ed ) 2019;66:19-25. [DOI: 10.1016/j.endien.2018.06.007] [Reference Citation Analysis]
340 Lasierra-cirujeda J, Coronel P, Pascual-salcedo MJA, Gimeno M, Salcedo MMAP, Lasierra-ibañez A, Lasala-aza C. The Physiopathological Crossroads of Aging. JBM 2019;07:102-128. [DOI: 10.4236/jbm.2019.76007] [Reference Citation Analysis]
341 Rigato M, Fadini GP, Avogaro A. Diabetes and the Cardiovascular System. Endocrinology 2019. [DOI: 10.1007/978-3-319-27316-7_6-3] [Reference Citation Analysis]
342 Simó-servat O, Hernández C, Simó R. Diabetische Retinopathie bei Patienten mit Diabetes mellitus. Kompass Ophthalmol 2019;5:157-162. [DOI: 10.1159/000503121] [Reference Citation Analysis]
343 Kim YG, Jeon JY, Kim HJ, Kim DJ, Lee KW, Moon SY, Han SJ. Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study. J Clin Med 2018;8:E28. [PMID: 30597861 DOI: 10.3390/jcm8010028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
344 Othman MAM, Rajab E, AlMubarak A, AlNaisar M, Bahzad N, Kamal A. Erythropoietin Protects Against Cognitive Impairment and Hippocampal Neurodegeneration in Diabetic Mice. Behav Sci (Basel) 2018;9:E4. [PMID: 30597853 DOI: 10.3390/bs9010004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
345 Koyanagi A, Stubbs B, Lara E, Veronese N, Vancampfort D, Smith L, Haro JM, Oh H, DeVylder JE. Psychotic experiences and subjective cognitive complaints among 224 842 people in 48 low- and middle-income countries. Epidemiol Psychiatr Sci 2018;29:e11. [PMID: 30585571 DOI: 10.1017/S2045796018000744] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
346 Salas IH, De Strooper B. Diabetes and Alzheimer's Disease: A Link not as Simple as it Seems. Neurochem Res 2019;44:1271-8. [PMID: 30523576 DOI: 10.1007/s11064-018-2690-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 7.8] [Reference Citation Analysis]
347 Zhang X, Fu Z, Meng L, He M, Zhang Z. The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease. Front Aging Neurosci 2018;10:359. [PMID: 30542277 DOI: 10.3389/fnagi.2018.00359] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
348 Ahmadieh H, Itani H, Itani S, Sidani K, Kassem M, Farhat K, Jbeily M, Itani A. Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study. Diabetes Metab Syndr Obes 2018;11:717-28. [PMID: 30519066 DOI: 10.2147/DMSO.S179153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
349 Tamura Y, Ishikawa J, Fujiwara Y, Tanaka M, Kanazawa N, Chiba Y, Iizuka A, Kaito S, Tanaka J, Sugie M, Nishimura T, Kanemaru A, Shimoji K, Hirano H, Furuta K, Kitamura A, Seino S, Shinkai S, Harada K, Kyo S, Ito H, Araki A. Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic. BMC Geriatr 2018;18:264. [PMID: 30400831 DOI: 10.1186/s12877-018-0955-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
350 Ostroumova OD, Surkova EV, Chikh EV, Rebrova EV, Borisov MS. Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs. Diabetes mellitus 2018;21:307-18. [DOI: 10.14341/dm9660] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
351 Bancks MP, Carnethon MR, Jacobs DR Jr, Launer LJ, Reis JP, Schreiner PJ, Shah RV, Sidney S, Yaffe K, Yano Y, Allen NB. Fasting Glucose Variability in Young Adulthood and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Diabetes Care 2018;41:2579-85. [PMID: 30305344 DOI: 10.2337/dc18-1287] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
352 Soto C, Pritzkow S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat Neurosci 2018;21:1332-40. [PMID: 30250260 DOI: 10.1038/s41593-018-0235-9] [Cited by in Crossref: 460] [Cited by in F6Publishing: 479] [Article Influence: 115.0] [Reference Citation Analysis]
353 Kubota K, Nakano M, Kobayashi E, Mizue Y, Chikenji T, Otani M, Nagaishi K, Fujimiya M. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One. 2018;13:e0204252. [PMID: 30240403 DOI: 10.1371/journal.pone.0204252] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
354 Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y). 2018;4:575-590. [PMID: 30406177 DOI: 10.1016/j.trci.2018.06.014] [Cited by in Crossref: 727] [Cited by in F6Publishing: 774] [Article Influence: 181.8] [Reference Citation Analysis]
355 Pal K, Mukadam N, Petersen I, Cooper C. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol 2018;53:1149-60. [PMID: 30182156 DOI: 10.1007/s00127-018-1581-3] [Cited by in Crossref: 100] [Cited by in F6Publishing: 86] [Article Influence: 25.0] [Reference Citation Analysis]
356 Caballero-Corchuelo J, Guerrero-Pérez F, García-Sancho de la Jordana P, Pérez-Maraver M. Analysis of the characteristics of patients with diabetes mellitus who attend a tertiary hospital emergency department for a hypoglycemic event. Endocrinol Diabetes Nutr (Engl Ed) 2019;66:19-25. [PMID: 30172767 DOI: 10.1016/j.endinu.2018.06.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
357 Thoma MV, Forstmeier S, Schmid R, Kellner O, Xepapadakos F, Gasser US, Blessing A, Ropohl A, Bieri-Brüning G, Debeer D, Maercker A. Preliminary evidence for an increased likelihood of a stable trajectory in mild cognitive impairment in individuals with higher motivational abilities. BMC Geriatr 2018;18:181. [PMID: 30103681 DOI: 10.1186/s12877-018-0865-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
358 Adam S, Belleville S. Chapitre 4. Leçon n° 3. Psychogérontologie 2018. [DOI: 10.3917/dbu.amiev.2018.01.0055] [Reference Citation Analysis]
359 Feinkohl I, Lachmann G, Brockhaus WR, Borchers F, Piper SK, Ottens TH, Nathoe HM, Sauer AM, Dieleman JM, Radtke FM, van Dijk D, Pischon T, Spies C. Association of obesity, diabetes and hypertension with cognitive impairment in older age. Clin Epidemiol 2018;10:853-62. [PMID: 30100759 DOI: 10.2147/CLEP.S164793] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
360 Chauhan R, Chen KF, Kent BA, Crowther DC. Central and peripheral circadian clocks and their role in Alzheimer's disease. Dis Model Mech 2017;10:1187-99. [PMID: 28993311 DOI: 10.1242/dmm.030627] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 8.5] [Reference Citation Analysis]
361 Mehlig K, Lapidus L, Thelle DS, Waern M, Zetterberg H, Björkelund C, Skoog I, Lissner L. Low fasting serum insulin and dementia in nondiabetic women followed for 34 years. Neurology 2018;91:e427-35. [PMID: 29997193 DOI: 10.1212/WNL.0000000000005911] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
362 Tanaka H, Ihana-Sugiyama N, Sugiyama T, Ohsugi M. Contribution of Diabetes to the Incidence and Prevalence of Comorbid Conditions (Cancer, Periodontal Disease, Fracture, Impaired Cognitive Function, and Depression): A Systematic Review of Epidemiological Studies in Japanese Populations. J Epidemiol 2019;29:1-10. [PMID: 29937469 DOI: 10.2188/jea.JE20170155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
363 Bugge A, Möller S, Westfall DR, Tarp J, Gejl AK, Wedderkopp N, Hillman CH. Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis. PLoS One 2018;13:e0199281. [PMID: 29912925 DOI: 10.1371/journal.pone.0199281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
364 Cui Y, Liang X, Gu H, Hu Y, Zhao Z, Yang XY, Qian C, Yang Y, Teng GJ. Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav 2017;11:1248-57. [PMID: 27714551 DOI: 10.1007/s11682-016-9583-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 13.0] [Reference Citation Analysis]
365 Tian Z, Ren N, Wang J, Zhang D, Zhou Y. Ginsenoside Ameliorates Cognitive Dysfunction in Type 2 Diabetic Goto-Kakizaki Rats. Med Sci Monit 2018;24:3922-8. [PMID: 29886506 DOI: 10.12659/MSM.907417] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
366 Abo Hagar A, Ashour Y, Abd El-Razek R, Elsamahy M, Shehab O. Quantitative electroencephalographic changes and hippocampal atrophy in diabetic patients with mild cognitive impairment in Ismailia region. Egypt J Neurol Psychiatr Neurosurg 2018;54:15. [PMID: 29899657 DOI: 10.1186/s41983-018-0018-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
367 Sang YM, Wang LJ, Mao HX, Lou XY, Zhu YJ. The association of short-term memory and cognitive impairment with ghrelin, leptin, and cortisol levels in non-diabetic and diabetic elderly individuals. Acta Diabetol 2018;55:531-9. [PMID: 29492658 DOI: 10.1007/s00592-018-1111-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
368 Malekian N, Hosseini SR, Moudi S, Bayani MA, Kheirkhah F, Bijani A, Khalilipour A. Type 2 Diabetes Mellitus and Cognitive Function in the Elderly. Iran J Psychiatry Behav Sci 2018;12. [DOI: 10.5812/ijpbs.9494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
369 Taga M, Mouton-Liger F, Sadoune M, Gourmaud S, Norman J, Tible M, Thomasseau S, Paquet C, Nicoll JAR, Boche D, Hugon J. PKR modulates abnormal brain signaling in experimental obesity. PLoS One 2018;13:e0196983. [PMID: 29795582 DOI: 10.1371/journal.pone.0196983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
370 Geng J, Wang L, Zhang L, Qin C, Song Y, Ma Y, Chen Y, Chen S, Wang Y, Zhang Z, Yang GY. Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated With Increase of Inflammatory Cytokine. Front Aging Neurosci 2018;10:129. [PMID: 29867440 DOI: 10.3389/fnagi.2018.00129] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 12.8] [Reference Citation Analysis]
371 Liu J, Rutten-Jacobs L, Liu M, Markus HS, Traylor M. Causal Impact of Type 2 Diabetes Mellitus on Cerebral Small Vessel Disease: A Mendelian Randomization Analysis. Stroke 2018;49:1325-31. [PMID: 29686024 DOI: 10.1161/STROKEAHA.117.020536] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 15.0] [Reference Citation Analysis]
372 Hendrie HC, Zheng M, Lane KA, Ambuehl R, Purnell C, Li S, Unverzagt FW, Murray MD, Balasubramanyam A, Callahan CM, Gao S. Changes of glucose levels precede dementia in African-Americans with diabetes but not in Caucasians. Alzheimers Dement 2018;14:1572-9. [PMID: 29678640 DOI: 10.1016/j.jalz.2018.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
373 Perales J, Hinton L, Burns J, Vidoni ED. Cardiovascular health and cognitive function among Mexican older adults: cross-sectional results from the WHO Study on Global Ageing and Adult Health. Int Psychogeriatr 2018;30:1827-36. [PMID: 29667567 DOI: 10.1017/S1041610218000297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
374 Godefroy O, Barbay M, Roussel M. Les troubles neurocognitifs post-AVC légers et majeurs : du diagnostic à la prise en charge. Pratique Neurologique - FMC 2018;9:132-9. [DOI: 10.1016/j.praneu.2018.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
375 Zhang S, Chai R, Yang YY, Guo SQ, Wang S, Guo T, Xu SF, Zhang YH, Wang ZY, Guo C. Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice. Oncotarget 2017;8:43617-34. [PMID: 28467789 DOI: 10.18632/oncotarget.17116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
376 Biosa A, Outeiro TF, Bubacco L, Bisaglia M. Diabetes Mellitus as a Risk Factor for Parkinson's Disease: a Molecular Point of View. Mol Neurobiol. 2018;55:8754-8763. [PMID: 29594935 DOI: 10.1007/s12035-018-1025-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
377 Grande G, Vetrano DL, Mangialasche F. Risk Factors and Prevention in Alzheimer’s Disease and Dementia. In: Galimberti D, Scarpini E, editors. Neurodegenerative Diseases. Cham: Springer International Publishing; 2018. pp. 93-112. [DOI: 10.1007/978-3-319-72938-1_6] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
378 Pruzin JJ, Nelson PT, Abner EL, Arvanitakis Z. Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol 2018;44:347-62. [PMID: 29424027 DOI: 10.1111/nan.12476] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
379 Ekblad LL, Johansson J, Helin S, Viitanen M, Laine H, Puukka P, Jula A, Rinne JO. Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation. Neurology 2018;90:e1150-7. [PMID: 29476033 DOI: 10.1212/WNL.0000000000005214] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
380 de Souza JM, Goncalves BDC, Gomez MV, Vieira LB, Ribeiro FM. Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases. Front Pharmacol 2018;9:145. [PMID: 29527170 DOI: 10.3389/fphar.2018.00145] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
381 Calza G, Nyberg E, Mäkinen M, Soliymani R, Cascone A, Lindholm D, Barborini E, Baumann M, Lalowski M, Eriksson O. Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration - A Mass Spectrometry Imaging Study of the Perfused Rat Liver. Front Pharmacol 2018;9:141. [PMID: 29520235 DOI: 10.3389/fphar.2018.00141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
382 Minami Y, Sonoda N, Hayashida E, Makimura H, Ide M, Ikeda N, Ohgidani M, Kato TA, Seki Y, Maeda Y, Kanba S, Takayanagi R, Ogawa Y, Inoguchi T. p66Shc Signaling Mediates Diabetes-Related Cognitive Decline. Sci Rep 2018;8:3213. [PMID: 29453337 DOI: 10.1038/s41598-018-21426-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
383 Fried PJ, Schilberg L, Brem AK, Saxena S, Wong B, Cypess AM, Horton ES, Pascual-Leone A. Humans with Type-2 Diabetes Show Abnormal Long-Term Potentiation-Like Cortical Plasticity Associated with Verbal Learning Deficits. J Alzheimers Dis 2017;55:89-100. [PMID: 27636847 DOI: 10.3233/JAD-160505] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
384 Koyanagi A, Lara E, Stubbs B, Carvalho AF, Oh H, Stickley A, Veronese N, Vancampfort D. Chronic Physical Conditions, Multimorbidity, and Mild Cognitive Impairment in Low- and Middle-Income Countries. J Am Geriatr Soc 2018;66:721-7. [PMID: 29427504 DOI: 10.1111/jgs.15288] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
385 Schernthaner G, Schernthaner-Reiter MH. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies. Diabetologia 2018;61:1503-16. [PMID: 29417185 DOI: 10.1007/s00125-018-4547-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 11.8] [Reference Citation Analysis]
386 Phillips A. Diabetes and cognitive decline: Extra care required. Practice Nursing 2018;29:76-82. [DOI: 10.12968/pnur.2018.29.2.76] [Reference Citation Analysis]
387 Avgerinos KI, Kalaitzidis G, Malli A, Kalaitzoglou D, Myserlis PG, Lioutas VA. Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review. J Neurol 2018;265:1497-510. [PMID: 29392460 DOI: 10.1007/s00415-018-8768-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 16.3] [Reference Citation Analysis]
388 Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, Craft S, Gandy S, Buettner C, Stoeckel LE, Holtzman DM, Nathan DM. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14:168-181. [PMID: 29377010 DOI: 10.1038/nrneurol.2017.185] [Cited by in Crossref: 581] [Cited by in F6Publishing: 600] [Article Influence: 145.3] [Reference Citation Analysis]
389 Zheng F, Yan L, Yang Z, Zhong B, Xie W. HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing. Diabetologia 2018;61:839-48. [PMID: 29368156 DOI: 10.1007/s00125-017-4541-7] [Cited by in Crossref: 100] [Cited by in F6Publishing: 106] [Article Influence: 25.0] [Reference Citation Analysis]
390 Mazza E, Fava A, Ferro Y, Rotundo S, Romeo S, Bosco D, Pujia A, Montalcini T. Effect of the replacement of dietary vegetable oils with a low dose of extravirgin olive oil in the Mediterranean Diet on cognitive functions in the elderly. J Transl Med 2018;16:10. [PMID: 29351799 DOI: 10.1186/s12967-018-1386-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
391 Biessels GJ, Janssen J, van den Berg E, Zinman B, Espeland MA, Mattheus M, Johansen OE; CAROLINA® investigators. Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus. BMC Neurol 2018;18:7. [PMID: 29334906 DOI: 10.1186/s12883-018-1014-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
392 Ishimaru K, Nakajima T, Namiki Y, Ryotokuji K. Influences of Pinpoint Plantar Long-Wavelength Infrared Light Irradiation (Stress-Free Therapy) on Chorioretinal Hemodynamics, Atherosclerosis Factors, and Vascular Endothelial Growth Factor. Integr Med Res 2018;7:103-7. [PMID: 29629297 DOI: 10.1016/j.imr.2017.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
393 Rigato M, Fadini GP, Avogaro A. Diabetes and the Cardiovascular System. Endocrinology 2018. [DOI: 10.1007/978-3-319-44433-8_6] [Reference Citation Analysis]
394 Kumar A, Singh S. The Association of Diabetes in the Onset of Dementia in the Elderly Population. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome 2018. [DOI: 10.1016/b978-0-12-812019-4.00008-8] [Reference Citation Analysis]
395 Koenig AM, Arvanitakis Z, Arnold SE. The Role of Insulin Resistance and Signaling in Dementia. Type 2 Diabetes and Dementia 2018. [DOI: 10.1016/b978-0-12-809454-9.00008-1] [Reference Citation Analysis]
396 Shin EC. Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients. J Korean Diabetes 2018;19:101. [DOI: 10.4093/jkd.2018.19.2.101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
397 Gray SM, Barrett EJ. The Blood–Brain Barrier in Diabetes Mellitus. Type 2 Diabetes and Dementia 2018. [DOI: 10.1016/b978-0-12-809454-9.00011-1] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
398 Macpherson KP, de Sousa Rodrigues ME, Cintron AF, Tansey MG. Neuroinflammation in Age-Related Neurodegenerative Diseases. The Molecular and Cellular Basis of Neurodegenerative Diseases 2018. [DOI: 10.1016/b978-0-12-811304-2.00016-x] [Reference Citation Analysis]
399 Ganmore I, Schnaider Beeri M. Magnitude and Trajectories of Cognitive Dysfunction in Type 2 Diabetes Mellitus. Type 2 Diabetes and Dementia 2018. [DOI: 10.1016/b978-0-12-809454-9.00003-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
400 Farooqui AA, Farooqui T. Contribution of Diabetes and Metabolic Syndrome in the Pathogenesis of Alzheimer’s Disease. Role of the Mediterranean Diet in the Brain and Neurodegenerative Diseases 2018. [DOI: 10.1016/b978-0-12-811959-4.00019-5] [Reference Citation Analysis]
401 Miloushev VZ, Blasberg RG. Brain Disorders. Imaging and Metabolism 2018. [DOI: 10.1007/978-3-319-61401-4_9] [Reference Citation Analysis]
402 Wong CH, Wanrooy BJ, Bruce DG. Neuroinflammation, Type 2 Diabetes, and Dementia. Type 2 Diabetes and Dementia 2018. [DOI: 10.1016/b978-0-12-809454-9.00010-x] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
403 Verdelho A. Role of Cerebrovascular Disease in Cognition. Neurodegenerative Diseases 2018. [DOI: 10.1007/978-3-319-72938-1_5] [Reference Citation Analysis]
404 Pruzin JJ, Nelson PT, Abner EL, Arvanitakis Z. Neuropathological Insights Into the Link Between Type 2 Diabetes and Dementia. Type 2 Diabetes and Dementia 2018. [DOI: 10.1016/b978-0-12-809454-9.00006-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
405 Oikonomou D. Fall 67: Therapie – 78 Jahre, ♀, DM Typ 2, Risiko von Demenz und Apoplex. Diabetes-Therapie – informiert entscheiden 2018. [DOI: 10.1007/978-3-662-55972-7_67] [Reference Citation Analysis]
406 Rigato M, Fadini GP, Avogaro A. Diabetes and the Cardiovascular System. Endocrinology 2018. [DOI: 10.1007/978-3-319-27316-7_6-1] [Reference Citation Analysis]
407 Milne NT, Bucks RS, Davis WA, Davis TME, Pierson R, Starkstein SE, Bruce DG. Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus. Brain Behav 2018;8:e00741. [PMID: 29568674 DOI: 10.1002/brb3.741] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
408 Tsugawa A, Ogawa Y, Takenoshita N, Kaneko Y, Hatanaka H, Jaime E, Fukasawa R, Hanyu H. Decreased Muscle Strength and Quality in Diabetes-Related Dementia. Dement Geriatr Cogn Dis Extra 2017;7:454-62. [PMID: 29430248 DOI: 10.1159/000485177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
409 Chang SS, Tu S, Baek KI, Pietersen A, Liu YH, Savage VM, Hwang SL, Hsiai TK, Roper M. Optimal occlusion uniformly partitions red blood cells fluxes within a microvascular network. PLoS Comput Biol 2017;13:e1005892. [PMID: 29244812 DOI: 10.1371/journal.pcbi.1005892] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
410 Zhao X, Han Q, Lv Y, Sun L, Gang X, Wang G. Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies. Oncotarget 2018;9:7710-26. [PMID: 29484146 DOI: 10.18632/oncotarget.23284] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
411 Stomby A, Otten J, Ryberg M, Nyberg L, Olsson T, Boraxbekk CJ. A Paleolithic Diet with and without Combined Aerobic and Resistance Exercise Increases Functional Brain Responses and Hippocampal Volume in Subjects with Type 2 Diabetes. Front Aging Neurosci 2017;9:391. [PMID: 29255413 DOI: 10.3389/fnagi.2017.00391] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
412 Sudo FK, Amado P, Alves GS, Laks J, Engelhardt E. A continuum of executive function deficits in early subcortical vascular cognitive impairment: A systematic review and meta-analysis. Dement Neuropsychol 2017;11:371-80. [PMID: 29354217 DOI: 10.1590/1980-57642016dn11-040006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
413 Li D, Liu L, Li L, Li X, Huang B, Zhou C, Zhang Z, Wang C, Dong P, Zhang X, Yang B, Zhang L. Sevoflurane Induces Exaggerated and Persistent Cognitive Decline in a Type II Diabetic Rat Model by Aggregating Hippocampal Inflammation. Front Pharmacol 2017;8:886. [PMID: 29238302 DOI: 10.3389/fphar.2017.00886] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
414 Maestre GE. Reduction of Cognitive Decline in Patients with or at High Risk for Diabetes. Curr Geriatr Rep 2017;6:188-95. [PMID: 29170725 DOI: 10.1007/s13670-017-0216-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
415 Djelti F, Dhenain M, Terrien J, Picq JL, Hardy I, Champeval D, Perret M, Schenker E, Epelbaum J, Aujard F. Impaired fasting blood glucose is associated to cognitive impairment and cerebral atrophy in middle-aged non-human primates. Aging (Albany NY) 2016;9:173-86. [PMID: 28039490 DOI: 10.18632/aging.101148] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
416 Lu CH, Yang CY, Li CY, Hsieh CY, Ou HT. Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study. Diabetologia 2018;61:562-73. [PMID: 29138876 DOI: 10.1007/s00125-017-4499-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 6.6] [Reference Citation Analysis]
417 Fink A, Buchmann N, Tegeler C, Steinhagen-Thiessen E, Demuth I, Doblhammer G. Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany. PLoS One 2017;12:e0187119. [PMID: 29073237 DOI: 10.1371/journal.pone.0187119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
418 Stephan Y, Sutin AR, Luchetti M, Terracciano A. Feeling Older and the Development of Cognitive Impairment and Dementia. J Gerontol B Psychol Sci Soc Sci 2017;72:966-73. [PMID: 27436103 DOI: 10.1093/geronb/gbw085] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
419 Shi X, Miyakawa T, Nakamura A, Hou F, Hibi M, Ogawa J, Kwon Y, Tanokura M. Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers. Sci Rep 2017;7:13703. [PMID: 29057974 DOI: 10.1038/s41598-017-13978-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
420 Zhao N, Liu CC, Van Ingelgom AJ, Martens YA, Linares C, Knight JA, Painter MM, Sullivan PM, Bu G. Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes. Neuron 2017;96:115-129.e5. [PMID: 28957663 DOI: 10.1016/j.neuron.2017.09.003] [Cited by in Crossref: 143] [Cited by in F6Publishing: 153] [Article Influence: 28.6] [Reference Citation Analysis]
421 Selvi Y, Gergerlioglu HS, Akbaba N, Oz M, Kandeger A, Demir EA, Yerlikaya FH, Nurullahoglu-Atalik KE. Impact of enriched environment on production of tau, amyloid precursor protein and, amyloid-β peptide in high-fat and high-sucrose-fed rats. Acta Neuropsychiatr 2017;29:291-8. [PMID: 27923413 DOI: 10.1017/neu.2016.63] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
422 Masoud A, Al-ghazali M, Al-futini F, Al-mansori A, Al-subahi A, Farhan A, Al-sharafi M, Al-absi R, Al-matari S. Antioxidant effect of frankincense extract in the brain cortex of diabetic rats. Journal of the Association of Arab Universities for Basic and Applied Sciences 2017;24:95-100. [DOI: 10.1016/j.jaubas.2016.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
423 Chen GQ, Zhang X, Xing Y, Wen D, Cui GB, Han Y. Resting-state functional magnetic resonance imaging shows altered brain network topology in Type 2 diabetic patients without cognitive impairment. Oncotarget 2017;8:104560-70. [PMID: 29262661 DOI: 10.18632/oncotarget.21282] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
424 Mehta HB, Mehta V, Goodwin JS. Association of Hypoglycemia With Subsequent Dementia in Older Patients With Type 2 Diabetes Mellitus. J Gerontol A Biol Sci Med Sci 2017;72:1110-6. [PMID: 27784724 DOI: 10.1093/gerona/glw217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
425 Shah AS, Urbina EM. Vascular and endothelial function in youth with type 2 diabetes mellitus. Curr Diab Rep. 2017;17:36. [PMID: 28432570 DOI: 10.1007/s11892-017-0869-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
426 Stephan BCM, Harrison SL, Keage HAD, Babateen A, Robinson L, Siervo M. Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia. Curr Cardiol Rep 2017;19:87. [PMID: 28801790 DOI: 10.1007/s11886-017-0898-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
427 Matveeva MV, Samoiiova YG, Zhukova NG, Oleynik OA, Rotkank MA. Tauopathy and cognitive impairment in experimental diabetes mellitus. Diabetes mellitus 2017;20:181-184. [DOI: 10.14341/2072-0351-5842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
428 Zilliox LA, Chadrasekaran K, Kwan JY, Russell JW. Diabetes and Cognitive Impairment. Curr Diab Rep. 2016;16:87. [PMID: 27491830 DOI: 10.1007/s11892-016-0775-x] [Cited by in Crossref: 199] [Cited by in F6Publishing: 161] [Article Influence: 39.8] [Reference Citation Analysis]
429 Phillips A, Phillips S. Diabetes mellitus and its impact on older people. Nursing and Residential Care 2017;19:446-448. [DOI: 10.12968/nrec.2017.19.8.446] [Reference Citation Analysis]
430 Song J, Whitcomb DJ, Kim BC. The role of melatonin in the onset and progression of type 3 diabetes. Mol Brain 2017;10:35. [PMID: 28764741 DOI: 10.1186/s13041-017-0315-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
431 Ly H, Verma N, Wu F, Liu M, Saatman KE, Nelson PT, Slevin JT, Goldstein LB, Biessels GJ, Despa F. Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. Ann Neurol 2017;82:208-22. [PMID: 28696548 DOI: 10.1002/ana.24992] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
432 Gu PY, Yu F, Jin S, Yang Q, Su J, Chen Y, Zhao L, Hu SL. Analysis of serum undercarboxylated osteocalcin level in rats with type 2 diabetes mellitus and the correlation with cognitive impairment. Exp Ther Med 2017;14:2603-7. [PMID: 28962201 DOI: 10.3892/etm.2017.4838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
433 Kulas JA, Puig KL, Combs CK. Amyloid precursor protein in pancreatic islets. J Endocrinol 2017;235:49-67. [PMID: 28710249 DOI: 10.1530/JOE-17-0122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
434 Markowicz-Piasecka M, Sikora J, Mateusiak Ł, Mikiciuk-Olasik E, Huttunen KM. Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity. Oxid Med Cell Longev 2017;2017:7303096. [PMID: 28770024 DOI: 10.1155/2017/7303096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
435 Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, Butts AM, Graff-Radford J, Lahr BD, Bailey KR, Miller VM. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol 2017;217:74.e1-74.e11. [PMID: 28322777 DOI: 10.1016/j.ajog.2017.03.008] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
436 Rakesh G, Szabo ST, Alexopoulos GS, Zannas AS. Strategies for dementia prevention: latest evidence and implications. Ther Adv Chronic Dis 2017;8:121-36. [PMID: 28815009 DOI: 10.1177/2040622317712442] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
437 Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ, Egan K. Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst) 2017;8:165-78. [PMID: 28761927 DOI: 10.1016/j.dadm.2017.05.007] [Cited by in Crossref: 100] [Cited by in F6Publishing: 113] [Article Influence: 20.0] [Reference Citation Analysis]
438 Roy S, Jiang JX, Li AF, Kim D. Connexin channel and its role in diabetic retinopathy. Prog Retin Eye Res 2017;61:35-59. [PMID: 28602949 DOI: 10.1016/j.preteyeres.2017.06.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
439 Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. Pharm Res 2017;34:2614-27. [PMID: 28589443 DOI: 10.1007/s11095-017-2199-y] [Cited by in Crossref: 137] [Cited by in F6Publishing: 129] [Article Influence: 27.4] [Reference Citation Analysis]
440 Femminella GD, Bencivenga L, Petraglia L, Visaggi L, Gioia L, Grieco FV, de Lucia C, Komici K, Corbi G, Edison P, Rengo G, Ferrara N. Antidiabetic Drugs in Alzheimer's Disease: Mechanisms of Action and Future Perspectives. J Diabetes Res. 2017;2017:7420796. [PMID: 28656154 DOI: 10.1155/2017/7420796] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
441 Bordet R, Ihl R, Korczyn AD, Lanza G, Jansa J, Hoerr R, Guekht A. Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report. BMC Med. 2017;15:107. [PMID: 28539119 DOI: 10.1186/s12916-017-0869-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 82] [Article Influence: 12.6] [Reference Citation Analysis]
442 Bordet R, Ihl R, Korczyn AD, Lanza G, Jansa J, Hoerr R, Guekht A. Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report. BMC Med 2017;15:107. [PMID: 28539119 DOI: 10.1186/s12916-017-0869-6] [Reference Citation Analysis]
443 Mazza E, Fava A, Ferro Y, Moraca M, Rotundo S, Colica C, Provenzano F, Terracciano R, Greco M, Foti D, Gulletta E, Russo D, Bosco D, Pujia A, Montalcini T. Impact of legumes and plant proteins consumption on cognitive performances in the elderly. J Transl Med 2017;15:109. [PMID: 28532453 DOI: 10.1186/s12967-017-1209-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
444 Power MC, Tingle JV, Reid RI, Huang J, Sharrett AR, Coresh J, Griswold M, Kantarci K, Jack CR Jr, Knopman D, Gottesman RF, Mosley TH. Midlife and Late-Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study. J Am Heart Assoc 2017;6:e005608. [PMID: 28522676 DOI: 10.1161/JAHA.117.005608] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
445 Wennberg AMV, Hagen CE, Gottesman RF, Zipunnikov V, Kaufmann CN, Albert MS, Rebok GW, Kasper JD, Spira AP. Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study. Arch Gerontol Geriatr 2017;72:39-44. [PMID: 28544945 DOI: 10.1016/j.archger.2017.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
446 Au DT, Strickland DK, Muratoglu SC. The LDL Receptor-Related Protein 1: At the Crossroads of Lipoprotein Metabolism and Insulin Signaling. J Diabetes Res 2017;2017:8356537. [PMID: 28584820 DOI: 10.1155/2017/8356537] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
447 Machida T, Takata F, Matsumoto J, Miyamura T, Hirata R, Kimura I, Kataoka Y, Dohgu S, Yamauchi A. Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model. PLoS One 2017;12:e0177447. [PMID: 28489922 DOI: 10.1371/journal.pone.0177447] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
448 Cross N, Lampit A, Pye J, Grunstein RR, Marshall N, Naismith SL. Is Obstructive Sleep Apnoea Related to Neuropsychological Function in Healthy Older Adults? A Systematic Review and Meta-Analysis. Neuropsychol Rev 2017;27:389-402. [PMID: 28484904 DOI: 10.1007/s11065-017-9344-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
449 Mukherjee A, Soto C. Prion-Like Protein Aggregates and Type 2 Diabetes. Cold Spring Harb Perspect Med 2017;7:a024315. [PMID: 28159831 DOI: 10.1101/cshperspect.a024315] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
450 Simó R, Ciudin A, Simó-Servat O, Hernández C. Cognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective. Acta Diabetol 2017;54:417-24. [PMID: 28210868 DOI: 10.1007/s00592-017-0970-5] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 18.6] [Reference Citation Analysis]
451 Westwood S, Liu B, Baird AL, Anand S, Nevado-Holgado AJ, Newby D, Pikkarainen M, Hallikainen M, Kuusisto J, Streffer JR, Novak G, Blennow K, Andreasson U, Zetterberg H, Smith U, Laakso M, Soininen H, Lovestone S. The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology. Alzheimers Res Ther 2017;9:31. [PMID: 28441961 DOI: 10.1186/s13195-017-0258-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
452 Patel SK, Restrepo C, Werden E, Churilov L, Ekinci EI, Srivastava PM, Ramchand J, Wai B, Chambers B, O'Callaghan CJ, Darby D, Hachinski V, Cumming T, Donnan G, Burrell LM, Brodtmann A. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study. BMC Endocr Disord 2017;17:24. [PMID: 28388897 DOI: 10.1186/s12902-017-0173-7] [Reference Citation Analysis]
453 van Bussel FCG, Backes WH, Hofman PAM, van Oostenbrugge RJ, van Boxtel MPJ, Verhey FRJ, Steinbusch HWM, Schram MT, Stehouwer CDA, Wildberger JE, Jansen JFA. Cerebral Pathology and Cognition in Diabetes: The Merits of Multiparametric Neuroimaging. Front Neurosci 2017;11:188. [PMID: 28424581 DOI: 10.3389/fnins.2017.00188] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
454 Chen J, Zhang J, Liu X, Wang X, Xu X, Li H, Cao B, Yang Y, Lu J, Chen Z. Abnormal subcortical nuclei shapes in patients with type 2 diabetes mellitus. Eur Radiol 2017;27:4247-56. [PMID: 28374074 DOI: 10.1007/s00330-017-4790-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
455 Liu Z, Cui X, Tang Z, Dong D, Zang Y, Tian J. Identifying cognitive impairment in type 2 diabetes with functional connectivity: a multivariate pattern analysis of resting state fMRI data. Medical Imaging 2017: Biomedical Applications in Molecular, Structural, and Functional Imaging 2017. [DOI: 10.1117/12.2254062] [Reference Citation Analysis]
456 Dunning T, Sinclair AJ. Palliative and end-of-life care. Diabetes in Old Age 2017. [DOI: 10.1002/9781118954621.ch33] [Reference Citation Analysis]
457 Xie Y, Zhang Y, Qin W, Lu S, Ni C, Zhang Q. White Matter Microstructural Abnormalities in Type 2 Diabetes Mellitus: A Diffusional Kurtosis Imaging Analysis. AJNR Am J Neuroradiol 2017;38:617-25. [PMID: 27979796 DOI: 10.3174/ajnr.A5042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
458 Neuner SM, Wilmott LA, Burger C, Kaczorowski CC. Advances at the intersection of normal brain aging and Alzheimer’s disease. Behavioural Brain Research 2017;322:187-90. [DOI: 10.1016/j.bbr.2017.01.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
459 Wernecke J. Diabetes mellitus bei multimorbiden Patienten. Diabetologe 2017;13:79-84. [DOI: 10.1007/s11428-016-0180-8] [Reference Citation Analysis]
460 Lauridsen JK, Olesen RH, Vendelbo J, Hyde TM, Kleinman JE, Bibby BM, Brock B, Rungby J, Larsen A. High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex. Transl Psychiatry 2017;7:e1044. [PMID: 28244985 DOI: 10.1038/tp.2016.259] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
461 Phan DT, Bender RHF, Andrejecsk JW, Sobrino A, Hachey SJ, George SC, Hughes CC. Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface. Exp Biol Med (Maywood) 2017;242:1669-78. [PMID: 28195514 DOI: 10.1177/1535370217694100] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 14.4] [Reference Citation Analysis]
462 Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimers Dement (Amst) 2017;7:69-87. [PMID: 28275702 DOI: 10.1016/j.dadm.2017.01.005] [Cited by in Crossref: 199] [Cited by in F6Publishing: 220] [Article Influence: 39.8] [Reference Citation Analysis]
463 Fan YC, Hsu JL, Tung HY, Chou CC, Bai CH. Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study. Alzheimers Res Ther 2017;9:7. [PMID: 28162091 DOI: 10.1186/s13195-017-0236-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
464 Bunn F, Burn AM, Robinson L, Poole M, Rait G, Brayne C, Schoeman J, Norton S, Goodman C. Healthcare organisation and delivery for people with dementia and comorbidity: a qualitative study exploring the views of patients, carers and professionals. BMJ Open 2017;7:e013067. [PMID: 28100562 DOI: 10.1136/bmjopen-2016-013067] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
465 Moreno-Gonzalez I, Edwards Iii G, Salvadores N, Shahnawaz M, Diaz-Espinoza R, Soto C. Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding. Mol Psychiatry 2017;22:1327-34. [PMID: 28044060 DOI: 10.1038/mp.2016.230] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 23.0] [Reference Citation Analysis]
466 Hu D, Hu C, Corum E. Nonpharmacological Treatment Approaches. Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders 2017. [DOI: 10.1016/b978-0-12-802810-0.00014-3] [Reference Citation Analysis]
467 Porter K, Hughes C, Hoey L, Ward M, Molloy A, Cunningham C, Casey M, Strain J, O'kane M, Tracey F, Mccarroll K, Mccann A, Mcnulty H. Impact of diabetes and metformin use on B-vitamin status and cognitive function in older Irish adults: results of the TUDA cohort study. Proc Nutr Soc 2017;76:E120. [DOI: 10.1017/s0029665117001938] [Reference Citation Analysis]
468 Biessels G, Ryan C. Cognitive Dysfunction in Diabetes Mellitus. Hormones, Brain and Behavior. Elsevier; 2017. pp. 421-43. [DOI: 10.1016/b978-0-12-803592-4.00088-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
469 Sindi S, Rosenberg A, Juster R, Lupien SJ. Aging and Alzheimer's Disease. Hormones, Brain and Behavior 2017. [DOI: 10.1016/b978-0-12-803592-4.00082-1] [Reference Citation Analysis]
470 Bensamoun D, Mouton A, Ettore E, Robert P, David R. (Neurobiology of) Dementia: Causes, Presentation, and Management. Mental Health and Illness Worldwide 2017. [DOI: 10.1007/978-981-10-2414-6_7] [Reference Citation Analysis]
471 [DOI: 10.1145/3041021.3054930] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
472 Schimming C, Luo X, Zhang C, Sano M. Cognitive performance of older adults in a specialized diabetes clinic. J Diabetes 2017;9:929-35. [PMID: 27807922 DOI: 10.1111/1753-0407.12503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
473 McAdams-DeMarco MA, Bae S, Chu N, Gross AL, Brown CH 4th, Oh E, Rosenberg P, Neufeld KJ, Varadhan R, Albert M, Walston J, Segev DL. Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients. J Am Soc Nephrol 2017;28:1575-83. [PMID: 27979990 DOI: 10.1681/ASN.2016080816] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
474 Lietzau G, Nyström T, Östenson CG, Darsalia V, Patrone C. Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4. Oncotarget 2016;7:5865-76. [PMID: 26744321 DOI: 10.18632/oncotarget.6823] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
475 Pouwer F, Speight J. Psychological Factors and Diabetes Mellitus. Textbook of Diabetes 2016. [DOI: 10.1002/9781118924853.ch56] [Reference Citation Analysis]
476 Abdelhafiz AH, Sinclair AJ. Diabetes in Old Age. Textbook of Diabetes 2016. [DOI: 10.1002/9781118924853.ch62] [Reference Citation Analysis]
477 Watanabe Y, Kitamura K, Nakamura K, Sanpei K, Wakasugi M, Yokoseki A, Kabasawa K, Onodera O, Ikeuchi T, Kuwano R, Momotsu T, Narita I, Endo N. Association between dialysis treatment and cognitive decline: A study from the Project in Sado for Total Health (PROST), Japan. Geriatr Gerontol Int 2017;17:1584-7. [PMID: 27869346 DOI: 10.1111/ggi.12937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
478 Murata Y, Kadoya Y, Yamada S, Sanke T. Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors. Diabetol Int 2017;8:193-8. [PMID: 30603321 DOI: 10.1007/s13340-016-0292-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
479 Nevado-Holgado AJ, Lovestone S. Determining the Molecular Pathways Underlying the Protective Effect of Non-Steroidal Anti-Inflammatory Drugs for Alzheimer's Disease: A Bioinformatics Approach. Comput Struct Biotechnol J 2017;15:1-7. [PMID: 27872687 DOI: 10.1016/j.csbj.2016.10.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
480 Tan X, Fang P, An J, Lin H, Liang Y, Shen W, Leng X, Zhang C, Zheng Y, Qiu S. Micro-structural white matter abnormalities in type 2 diabetic patients: a DTI study using TBSS analysis. Neuroradiology 2016;58:1209-16. [PMID: 27783100 DOI: 10.1007/s00234-016-1752-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
481 Han N, Kim YJ, Park SM, Kim SM, Lee JS, Jung HS, Lee EJ, Kim TK, Kim TN, Kwon MJ, Lee SH, Kim MK, Rhee BD, Park JH. Repeated Glucose Deprivation/Reperfusion Induced PC-12 Cell Death through the Involvement of FOXO Transcription Factor. Diabetes Metab J 2016;40:396-405. [PMID: 27766247 DOI: 10.4093/dmj.2016.40.5.396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
482 Murray AM, Hsu FC, Williamson JD, Bryan RN, Gerstein HC, Sullivan MD, Miller ME, Leng I, Lovato LL, Launer LJ; Action to Control Cardiovascular Risk in Diabetes Follow-On Memory in Diabetes (ACCORDION MIND) Investigators. ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial. Diabetologia 2017;60:69-80. [PMID: 27766347 DOI: 10.1007/s00125-016-4118-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
483 Alfaro FJ, Lioutas VA, Pimentel DA, Chung CC, Bedoya F, Yoo WK, Novak V. Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities. J Neurol 2016;263:2505-14. [PMID: 27730376 DOI: 10.1007/s00415-016-8292-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
484 Li W, Wang T, Xiao S. Type 2 diabetes mellitus might be a risk factor for mild cognitive impairment progressing to Alzheimer's disease. Neuropsychiatr Dis Treat 2016;12:2489-95. [PMID: 27729793 DOI: 10.2147/NDT.S111298] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
485 Tsai LT, Liao KM, Jang Y, Hu FC, Wu WC. Detecting Visual Function Abnormality with a Contrast-Dependent Visual Test in Patients with Type 2 Diabetes. PLoS One 2016;11:e0162383. [PMID: 27611680 DOI: 10.1371/journal.pone.0162383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
486 Morales-Corraliza J, Wong H, Mazzella MJ, Che S, Lee SH, Petkova E, Wagner JD, Hemby SE, Ginsberg SD, Mathews PM. Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes. J Neurosci 2016;36:4248-58. [PMID: 27076423 DOI: 10.1523/JNEUROSCI.4640-14.2016] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
487 Suwanjang W, Prachayasittikul S, Prachayasittikul V. Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose. PeerJ 2016;4:e2389. [PMID: 27635352 DOI: 10.7717/peerj.2389] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
488 Khattar D, Khaliq F, Vaney N, Madhu SV. Is Metformin-Induced Vitamin B12 Deficiency Responsible for Cognitive Decline in Type 2 Diabetes? Indian J Psychol Med 2016;38:285-90. [PMID: 27570337 DOI: 10.4103/0253-7176.185952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
489 Yang S, Wu M, Ajilore O, Lamar M, Kumar A. Metabolic Aberrations Impact Biophysical Integrity of Macromolecular Protein Pools in the Default Mode Network. Diabetes 2016;65:3464-72. [PMID: 27543086 DOI: 10.2337/db15-1714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
490 Li XH, Deng YY, Li F, Shi JS, Gong QH. Neuroprotective effects of sodium hydrosulfide against β-amyloid-induced neurotoxicity. Int J Mol Med 2016;38:1152-60. [PMID: 27511125 DOI: 10.3892/ijmm.2016.2701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
491 Umemura T, Kawamura T, Hotta N. Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities. J Diabetes Investig 2017;8:134-48. [PMID: 27239779 DOI: 10.1111/jdi.12545] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
492 Sun J, Cai R, Huang R, Wang P, Tian S, Sun H, Xia W, Wang S. Cholesteryl Ester Transfer Protein Intimately Involved in Dyslipidemia-Related Susceptibility to Cognitive Deficits in Type 2 Diabetic Patients. J Alzheimers Dis 2016;54:175-84. [PMID: 27497473 DOI: 10.3233/JAD-160053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
493 Hessler JB, Ander KH, Brönner M, Etgen T, Förstl H, Poppert H, Sander D, Bickel H. Predicting dementia in primary care patients with a cardiovascular health metric: a prospective population-based study. BMC Neurol 2016;16:116. [PMID: 27459854 DOI: 10.1186/s12883-016-0646-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
494 Charles EF, Lambert CG, Kerner B. Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications. Int J Bipolar Disord 2016;4:13. [PMID: 27389787 DOI: 10.1186/s40345-016-0054-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
495 Lee SH, Zabolotny JM, Huang H, Lee H, Kim YB. Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood. Mol Metab. 2016;5:589-601. [PMID: 27656397 DOI: 10.1016/j.molmet.2016.06.011] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 16.2] [Reference Citation Analysis]
496 Huang ES. Management of diabetes mellitus in older people with comorbidities. BMJ 2016;353:i2200. [PMID: 27307175 DOI: 10.1136/bmj.i2200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
497 Sultan A. Modification de la structure cérébrale au cours du diabète de type 2 et impact du contrôle glycémique. Médecine des Maladies Métaboliques 2016;10:11-12. [DOI: 10.1016/s1957-2557(16)30073-6] [Reference Citation Analysis]
498 Wood AG, Chen J, Moran C, Phan T, Beare R, Cooper K, Litras S, Srikanth V. Brain Activation during Memory Encoding in Type 2 Diabetes Mellitus: A Discordant Twin Pair Study. J Diabetes Res 2016;2016:3978428. [PMID: 27314047 DOI: 10.1155/2016/3978428] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
499 Moran C, Tapp RJ, Hughes AD, Magnussen CG, Blizzard L, Phan TG, Beare R, Witt N, Venn A, Münch G, Amaratunge BC, Srikanth V. The Association of Type 2 Diabetes Mellitus with Cerebral Gray Matter Volume Is Independent of Retinal Vascular Architecture and Retinopathy. J Diabetes Res 2016;2016:6328953. [PMID: 27314049 DOI: 10.1155/2016/6328953] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
500 Wakabayashi T, Hidaka R, Fujimaki S, Asashima M, Kuwabara T. Diabetes Impairs Wnt3 Protein-induced Neurogenesis in Olfactory Bulbs via Glutamate Transporter 1 Inhibition. J Biol Chem 2016;291:15196-211. [PMID: 27226528 DOI: 10.1074/jbc.M115.672857] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
501 Midorikawa K, Soukaloun D, Akkhavong K, Southivong B, Rattanavong O, Sengkhygnavong V, Pyaluanglath A, Sayasithsena S, Nakamura S, Midorikawa Y, Murata M. APOE Genotype in the Ethnic Majority and Minority Groups of Laos and the Implications for Non-Communicable Diseases. PLoS One 2016;11:e0155072. [PMID: 27168072 DOI: 10.1371/journal.pone.0155072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
502 Ciudin A. Diabetes mellitus and Alzheimer's disease: An unforgettable relation. Endocrinología y Nutrición (English Edition) 2016;63:191-193. [DOI: 10.1016/j.endoen.2016.05.001] [Reference Citation Analysis]
503 Moon JH. Endocrine Risk Factors for Cognitive Impairment. Endocrinol Metab (Seoul) 2016;31:185-92. [PMID: 27118278 DOI: 10.3803/EnM.2016.31.2.185] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
504 Luchsinger JA, Cabral R, Eimicke JP, Manly JJ, Teresi J. Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 Years. Psychosom Med 2015;77:653-63. [PMID: 26163818 DOI: 10.1097/PSY.0000000000000208] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
505 Everson-Rose SA, Ryan JP. Diabetes, Obesity, and the Brain: New Developments in Biobehavioral Medicine. Psychosom Med 2015;77:612-5. [PMID: 26163814 DOI: 10.1097/PSY.0000000000000223] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
506 Nardin P, Zanotto C, Hansen F, Batassini C, Gasparin MS, Sesterheim P, Gonçalves CA. Peripheral Levels of AGEs and Astrocyte Alterations in the Hippocampus of STZ-Diabetic Rats. Neurochem Res 2016;41:2006-16. [PMID: 27084774 DOI: 10.1007/s11064-016-1912-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
507 Zhang Y, Lu S, Liu C, Zhang H, Zhou X, Ni C, Qin W, Zhang Q. Altered brain activation and functional connectivity in working memory related networks in patients with type 2 diabetes: An ICA-based analysis. Sci Rep 2016;6:23767. [PMID: 27021340 DOI: 10.1038/srep23767] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
508 McGuire MJ, Ishii M. Leptin Dysfunction and Alzheimer's Disease: Evidence from Cellular, Animal, and Human Studies. Cell Mol Neurobiol. 2016;36:203-217. [PMID: 26993509 DOI: 10.1007/s10571-015-0282-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 10.0] [Reference Citation Analysis]
509 Sałat K, Gdula-Argasińska J, Malikowska N, Podkowa A, Lipkowska A, Librowski T. Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice. Naunyn Schmiedebergs Arch Pharmacol 2016;389:613-23. [PMID: 26984821 DOI: 10.1007/s00210-016-1230-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
510 Xiong Y, Sui Y, Xu Z, Zhang Q, Karaman MM, Cai K, Anderson TM, Zhu W, Wang J, Zhou XJ. A Diffusion Tensor Imaging Study on White Matter Abnormalities in Patients with Type 2 Diabetes Using Tract-Based Spatial Statistics. AJNR Am J Neuroradiol 2016;37:1462-9. [PMID: 26988810 DOI: 10.3174/ajnr.A4740] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
511 Kelly A, Calamia M, Koval A, Terrera GM, Piccinin AM, Clouston S, Hassing LB, Bennett DA, Johansson B, Hofer SM. Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States. Psychol Aging 2016;31:262-73. [PMID: 26913926 DOI: 10.1037/pag0000078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
512 Kawamura T, Umemura T, Umegaki H, Imamine R, Kawano N, Mase H, Mizoguchi A, Minatoguchi M, Kusama M, Kouchi Y, Watarai A, Kanai A, Nakashima E, Hotta N. Factors Associated with Changes in Brain Atrophy during a Three-Year Observation in Elderly Diabetic Patients: Effect of Renal Impairment on Hippocampal Atrophy. Dement Geriatr Cogn Dis Extra 2016;6:55-67. [PMID: 27293417 DOI: 10.1159/000443497] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
513 Ott S, Vishnivetskaya A, Malmendal A, Crowther DC. Metabolic changes may precede proteostatic dysfunction in a Drosophila model of amyloid beta peptide toxicity. Neurobiol Aging 2016;41:39-52. [PMID: 27103517 DOI: 10.1016/j.neurobiolaging.2016.01.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
514 Sherzai D, Sherzai A, Lui K, Pan D, Chiou D, Bazargan M, Shaheen M. The Association Between Diabetes and Dementia Among Elderly Individuals: A Nationwide Inpatient Sample Analysis. J Geriatr Psychiatry Neurol 2016;29:120-5. [PMID: 26862150 DOI: 10.1177/0891988715627016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
515 Chao AC, Lee TC, Juo SH, Yang DI. Hyperglycemia Increases the Production of Amyloid Beta-Peptide Leading to Decreased Endothelial Tight Junction. CNS Neurosci Ther 2016;22:291-7. [PMID: 26842741 DOI: 10.1111/cns.12503] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
516 Bitra VR, Rapaka D, Akula A. Prediabetes and Alzheimer's Disease. Indian J Pharm Sci 2015;77:511-4. [PMID: 26798163 DOI: 10.4103/0250-474x.169026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
517 Naidu VV, Ismail K, Amiel S, Kohli R, Crosby-Nwaobi R, Sivaprasad S, Stewart R. Associations between Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes Mellitus: A Case Control Study. PLoS One 2016;11:e0147160. [PMID: 26771382 DOI: 10.1371/journal.pone.0147160] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
518 Akhtar MW, Sanz-Blasco S, Dolatabadi N, Parker J, Chon K, Lee MS, Soussou W, McKercher SR, Ambasudhan R, Nakamura T, Lipton SA. Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation. Nat Commun 2016;7:10242. [PMID: 26743041 DOI: 10.1038/ncomms10242] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 12.5] [Reference Citation Analysis]
519 Bunn F, Goodman C, Malone JR, Jones PR, Burton C, Rait G, Trivedi D, Bayer A, Sinclair A. Managing diabetes in people with dementia: protocol for a realist review. Syst Rev 2016;5:5. [PMID: 26744074 DOI: 10.1186/s13643-015-0182-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
520 Kanekiyo T, Bu G. Apolipoprotein E and Amyloid-β-Independent Mechanisms in Alzheimer’s Disease. Genes, Environment and Alzheimer's Disease 2016. [DOI: 10.1016/b978-0-12-802851-3.00006-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
521 Lasierra-cirujeda J, Pascual-salcedo MJA, Lasierra-ibañez A, Aza CL, Pascual-salcedo MMA. Aging: Thromboembolic Disease, Metabolic Syndrome, Type 2 Diabetes Mellitus, and Alzheimer’s Disease. JBM 2016;04:1-20. [DOI: 10.4236/jbm.2016.45001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
522 Sacuiu SF. Dementias. Handb Clin Neurol 2016;138:123-51. [PMID: 27637956 DOI: 10.1016/B978-0-12-802973-2.00008-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
523 Matsumoto K, Fujiwara H. Memory/Learning, Dementia, and Kampo. Herbal Medicines 2016. [DOI: 10.1007/978-1-4939-4002-8_12] [Reference Citation Analysis]
524 Werner P, Savva GM, Maidment I, Thyrian JR, Fox C. Dementia: Introduction, Epidemiology and Economic Impact. Mental Health and Older People 2016. [DOI: 10.1007/978-3-319-29492-6_16] [Reference Citation Analysis]
525 Boltz M, Galvin JE. Introduction: Principles of Dementia Care. Dementia Care 2016. [DOI: 10.1007/978-3-319-18377-0_1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
526 White MF, Copps KD. The Mechanisms of Insulin Action. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00033-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
527 Solov'eva EY, Dzhutova ED, Knyazeva VS. [Pathogenetic approaches to treatment of cognitive disorders in patients with diabetes mellitus]. Zh Nevrol Psikhiatr Im S S Korsakova 2016;116:85-93. [PMID: 28635936 DOI: 10.17116/jnevro20161167185-93] [Reference Citation Analysis]
528 Bensamoun D, Mouton A, Ettore E, Robert P, David R. (Neurobiology of) Dementia: Causes, Presentation and Management. Mental Health and Illness Worldwide 2016. [DOI: 10.1007/978-981-10-0370-7_7-1] [Reference Citation Analysis]
529 Seetharaman S. The Influences of Dietary Sugar and Related Metabolic Disorders on Cognitive Aging and Dementia. Molecular Basis of Nutrition and Aging 2016. [DOI: 10.1016/b978-0-12-801816-3.00024-8] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
530 Moser VA, Pike CJ. Obesity and sex interact in the regulation of Alzheimer's disease. Neurosci Biobehav Rev 2016;67:102-18. [PMID: 26708713 DOI: 10.1016/j.neubiorev.2015.08.021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
531 Konrad-Martin D, Billings CJ, McMillan GP, McDermott D, Gordon J, Austin D, Dille MF. Diabetes-Associated Changes in Cortical Auditory-Evoked Potentials in Relation to Normal Aging. Ear Hear 2016;37:e173-87. [PMID: 26656318 DOI: 10.1097/AUD.0000000000000255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
532 Zhu C, Schwarz P, Abakumova I, Aguzzi A. Unaltered Prion Pathogenesis in a Mouse Model of High-Fat Diet-Induced Insulin Resistance. PLoS One 2015;10:e0144983. [PMID: 26658276 DOI: 10.1371/journal.pone.0144983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
533 Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Mol Brain 2015;8:82. [PMID: 26637371 DOI: 10.1186/s13041-015-0174-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
534 Mehl-madrona L, Mainguy B, Shah A. Integrative Approaches for Geriatric Depression. Integrative Therapies for Depression 2015. [DOI: 10.1201/b19089-31] [Reference Citation Analysis]
535 Barzilay JI, Morgan TM, Murray AM, Bryan RN, Williamson JD, Schnall A, Launer LJ. Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study. J Gerontol A Biol Sci Med Sci 2016;71:803-10. [PMID: 26589241 DOI: 10.1093/gerona/glv187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
536 Mellendijk L, Wiesmann M, Kiliaan AJ. Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome. Nutrients 2015;7:9416-39. [PMID: 26580647 DOI: 10.3390/nu7115477] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
537 Zuloaga KL, Johnson LA, Roese NE, Marzulla T, Zhang W, Nie X, Alkayed FN, Hong C, Grafe MR, Pike MM, Raber J, Alkayed NJ. High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion. J Cereb Blood Flow Metab 2016;36:1257-70. [PMID: 26661233 DOI: 10.1177/0271678X15616400] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 7.7] [Reference Citation Analysis]
538 van der Harg JM, Eggels L, Ruigrok SR, Hoozemans JJ, la Fleur SE, Scheper W. Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation. Front Neurosci 2015;9:432. [PMID: 26617484 DOI: 10.3389/fnins.2015.00432] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
539 Kim H, Kang H, Heo RW, Jeon BT, Yi CO, Shin HJ, Kim J, Jeong SY, Kwak W, Kim WH, Kang SS, Roh GS. Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice. J Cereb Blood Flow Metab 2016;36:1098-110. [PMID: 26661177 DOI: 10.1177/0271678X15606724] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
540 Mathur S, Zammitt NN, Frier BM. Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say? Drug Saf. 2015;38:17-32. [PMID: 25481812 DOI: 10.1007/s40264-014-0247-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
541 Ishii M, Iadecola C. Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology. Cell Metab 2015;22:761-76. [PMID: 26365177 DOI: 10.1016/j.cmet.2015.08.016] [Cited by in Crossref: 120] [Cited by in F6Publishing: 99] [Article Influence: 17.1] [Reference Citation Analysis]
542 Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI). Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 2015;85:1123-30. [PMID: 26333802 DOI: 10.1212/WNL.0000000000001982] [Cited by in Crossref: 172] [Cited by in F6Publishing: 179] [Article Influence: 24.6] [Reference Citation Analysis]
543 Liao KM, Lin TC, Li CY, Yang YK. Dementia Increases Severe Sepsis and Mortality in Hospitalized Patients With Chronic Obstructive Pulmonary Disease. Medicine (Baltimore) 2015;94:e967. [PMID: 26061334 DOI: 10.1097/MD.0000000000000967] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
544 Garwood CJ, Ratcliffe LE, Morgan SV, Simpson JE, Owens H, Vazquez-Villaseñor I, Heath PR, Romero IA, Ince PG, Wharton SB. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol Brain 2015;8:51. [PMID: 26297026 DOI: 10.1186/s13041-015-0138-6] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 7.9] [Reference Citation Analysis]
545 Ekblad LL, Rinne JO, Puukka PJ, Laine HK, Ahtiluoto SE, Sulkava RO, Viitanen MH, Jula AM. Insulin resistance is associated with poorer verbal fluency performance in women. Diabetologia 2015;58:2545-53. [PMID: 26276262 DOI: 10.1007/s00125-015-3715-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
546 Kamei S, Kaneto H, Irie S, Kinoshita T, Tanabe A, Hirukawa H, Tatsumi F, Shimoda M, Kohara K, Mune T, Kaku K. Pseudoaldosteronism induced by Yokukansan in an elderly Japanese type 2 diabetic patient with Alzheimer's disease. J Diabetes Investig 2015;6:487-8. [PMID: 26221529 DOI: 10.1111/jdi.12297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
547 Whitlow CT, Sink KM, Divers J, Smith SC, Xu J, Palmer ND, Hugenschmidt CE, Williamson JD, Bowden DW, Freedman BI, Maldjian JA. Effects of Type 2 Diabetes on Brain Structure and Cognitive Function: African American-Diabetes Heart Study MIND. AJNR Am J Neuroradiol 2015;36:1648-53. [PMID: 26206811 DOI: 10.3174/ajnr.A4321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
548 Tierney MC, Naglie G, Upshur R, Jaakkimainen L, Moineddin R, Charles J, Ganguli M. Factors associated with primary care physicians' recognition of cognitive impairment in their older patients. Alzheimer Dis Assoc Disord 2014;28:320-5. [PMID: 24632991 DOI: 10.1097/WAD.0000000000000039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
549 Akintola AA, van den Berg A, Altmann-Schneider I, Jansen SW, van Buchem MA, Slagboom PE, Westendorp RG, van Heemst D, van der Grond J. Parameters of glucose metabolism and the aging brain: a magnetization transfer imaging study of brain macro- and micro-structure in older adults without diabetes. Age (Dordr) 2015;37:9802. [PMID: 26178969 DOI: 10.1007/s11357-015-9802-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
550 Ojo O, Brooke J. Evaluating the Association between Diabetes, Cognitive Decline and Dementia. Int J Environ Res Public Health 2015;12:8281-94. [PMID: 26193295 DOI: 10.3390/ijerph120708281] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 6.7] [Reference Citation Analysis]
551 Xu WL, Pedersen NL, Keller L, Kalpouzos G, Wang HX, Graff C, Winblad B, Bäckman L, Fratiglioni L. HHEX_23 AA Genotype Exacerbates Effect of Diabetes on Dementia and Alzheimer Disease: A Population-Based Longitudinal Study. PLoS Med 2015;12:e1001853. [PMID: 26173052 DOI: 10.1371/journal.pmed.1001853] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
552 Kumar A, Yang S, Ajilore O, Wu M, Cohen J, Lamar M, Bhaumik D. Biophysical changes in subcortical nuclei: the impact of diabetes and major depression. Mol Psychiatry 2016;21:531-6. [PMID: 26169972 DOI: 10.1038/mp.2015.89] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
553 Pandey SP, Singh HK, Prasad S. Alterations in Hippocampal Oxidative Stress, Expression of AMPA Receptor GluR2 Subunit and Associated Spatial Memory Loss by Bacopa monnieri Extract (CDRI-08) in Streptozotocin-Induced Diabetes Mellitus Type 2 Mice. PLoS One 2015;10:e0131862. [PMID: 26161865 DOI: 10.1371/journal.pone.0131862] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
554 Huhn S, Kharabian Masouleh S, Stumvoll M, Villringer A, Witte AV. Components of a Mediterranean diet and their impact on cognitive functions in aging. Front Aging Neurosci 2015;7:132. [PMID: 26217224 DOI: 10.3389/fnagi.2015.00132] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
555 Chung CC, Pimentel D, Jor'dan AJ, Hao Y, Milberg W, Novak V. Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes. Neurology 2015;85:450-8. [PMID: 26156513 DOI: 10.1212/WNL.0000000000001820] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 10.4] [Reference Citation Analysis]
556 Abdelhafiz AH, Russell JJ, Key A, Sinclair AJ. Older people with diabetes – avoiding hospitalization. Diabetes Management 2015;5:311-326. [DOI: 10.2217/dmt.15.15] [Reference Citation Analysis]
557 Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci 2015;1353:60-71. [PMID: 26132277 DOI: 10.1111/nyas.12807] [Cited by in Crossref: 201] [Cited by in F6Publishing: 215] [Article Influence: 28.7] [Reference Citation Analysis]
558 Roy S, Kim N, Desai A, Komaragiri M, Baxi N, Jassil N, Blessinger M, Khan M, Cole R, Desai N, Terrigno R, Hunter K. Cognitive Function and Control of Type 2 Diabetes Mellitus in Young Adults. N Am J Med Sci 2015;7:220-6. [PMID: 26110134 DOI: 10.4103/1947-2714.157627] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
559 Barsanti C, Lenzarini F, Kusmic C. Diagnostic and prognostic utility of non-invasive imaging in diabetes management. World J Diabetes 2015; 6(6): 792-806 [PMID: 26131322 DOI: 10.4239/wjd.v6.i6.792] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
560 Dye L, Best T. Evidence, Innovations and Implications. Nutrition for Brain Health and Cognitive Performance 2015. [DOI: 10.1201/b18563-18] [Reference Citation Analysis]
561 Uchida K, Shan L, Suzuki H, Tabuse Y, Nishimura Y, Hirokawa Y, Mizukami K, Akatsu H, Meno K, Asada T. Amyloid-β sequester proteins as blood-based biomarkers of cognitive decline. Alzheimers Dement (Amst) 2015;1:270-80. [PMID: 27239510 DOI: 10.1016/j.dadm.2015.04.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
562 Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, Bu G. Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neurosci 2015;35:5851-9. [PMID: 25855193 DOI: 10.1523/JNEUROSCI.5180-14.2015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 89] [Article Influence: 12.3] [Reference Citation Analysis]
563 Bangen KJ, Gu Y, Gross AL, Schneider BC, Skinner JC, Benitez A, Sachs BC, Shih R, Sisco S, Schupf N. Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort. J Am Geriatr Soc. 2015;63:1075-1083. [PMID: 26096383 DOI: 10.1111/jgs.13441] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
564 Wong RH, Scholey A, Howe PR. Assessing premorbid cognitive ability in adults with type 2 diabetes mellitus--a review with implications for future intervention studies. Curr Diab Rep 2014;14:547. [PMID: 25273482 DOI: 10.1007/s11892-014-0547-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
565 Koekkoek PS, Janssen J, Kooistra M, van den Berg E, Kappelle LJ, Biessels GJ, Rutten GE. Cognitive Impairment in Diabetes: Rationale and Design Protocol of the Cog-ID Study. JMIR Res Protoc 2015;4:e69. [PMID: 26058427 DOI: 10.2196/resprot.4224] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
566 Vance DE, Fazeli PL, Dodson JE, Ackerman M, Talley M, Appel SJ. The synergistic effects of HIV, diabetes, and aging on cognition: implications for practice and research. J Neurosci Nurs 2014;46:292-305. [PMID: 25099061 DOI: 10.1097/JNN.0000000000000074] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
567 Matioli MNPS, Nitrini R. Mechanisms linking brain insulin resistance to Alzheimer's disease. Dement Neuropsychol 2015;9:96-102. [PMID: 29213950 DOI: 10.1590/1980-57642015DN92000003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
568 Liu Z, Patil IY, Jiang T, Sancheti H, Walsh JP, Stiles BL, Yin F, Cadenas E. High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PLoS One 2015;10:e0128274. [PMID: 26023930 DOI: 10.1371/journal.pone.0128274] [Cited by in Crossref: 112] [Cited by in F6Publishing: 126] [Article Influence: 16.0] [Reference Citation Analysis]
569 Mukherjee A, Morales-Scheihing D, Butler PC, Soto C. Type 2 diabetes as a protein misfolding disease. Trends Mol Med. 2015;21:439-449. [PMID: 25998900 DOI: 10.1016/j.molmed.2015.04.005] [Cited by in Crossref: 205] [Cited by in F6Publishing: 186] [Article Influence: 29.3] [Reference Citation Analysis]
570 van Dijk G, van Heijningen S, Reijne AC, Nyakas C, van der Zee EA, Eisel UL. Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. Front Neurosci. 2015;9:173. [PMID: 26041981 DOI: 10.3389/fnins.2015.00173] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
571 Zhang L, Li M, Zhan L, Lu X, Liang L, Su B, Sui H, Gao Z, Li Y, Liu Y, Wu B, Liu Q. Plasma metabolomic profiling of patients with diabetes-associated cognitive decline. PLoS One 2015;10:e0126952. [PMID: 25974350 DOI: 10.1371/journal.pone.0126952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
572 Zilkens RR, Bruce DG, Duke J, Spilsbury K, Semmens JB. Severe psychiatric disorders in mid-life and risk of dementia in late- life (age 65-84 years): a population based case-control study. Curr Alzheimer Res 2014;11:681-93. [PMID: 25115541 DOI: 10.2174/1567205011666140812115004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 82] [Article Influence: 10.7] [Reference Citation Analysis]
573 Emoto N, Okajima F, Sugihara H, Goto R. Behavioral economics survey of patients with type 1 and type 2 diabetes. Patient Prefer Adherence 2015;9:649-58. [PMID: 25999700 DOI: 10.2147/PPA.S82022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
574 Morrone CD, Liu M, Black SE, McLaurin J. Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms. Front Aging Neurosci 2015;7:64. [PMID: 25999850 DOI: 10.3389/fnagi.2015.00064] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
575 Kim DY, Jung SY, Kim TW, Lee KS, Kim K. Treadmill exercise decreases incidence of Alzheimer's disease by suppressing glycogen synthase kinase-3β expression in streptozotocin-induced diabetic rats. J Exerc Rehabil 2015;11:87-94. [PMID: 25960981 DOI: 10.12965/jer.150198] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
576 Seto SW, Yang GY, Kiat H, Bensoussan A, Kwan YW, Chang D. Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine. Int J Endocrinol 2015;2015:810439. [PMID: 26060494 DOI: 10.1155/2015/810439] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
577 Kern W. Hypoglykämien: Risikofaktor für Demenz. Deutsches Ärzteblatt Online 2015. [DOI: 10.3238/persdia.2015.04.24.02] [Reference Citation Analysis]
578 Comai S, Gobbi G. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci. 2014;39:6-21. [PMID: 23971978 DOI: 10.1503/jpn.130009] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 15.9] [Reference Citation Analysis]
579 Trubnikova ОА, Mamontova AS, Tarasova IV, Maleva OV, Kuzmina AA, Barbarash OL. [Association of cognitive impairments with carbohydrate and lipid metabolic parameters in type 2 diabetes mellitus patients undergoing coronary bypass surgery]. Ter Arkh 2015;87:69-75. [PMID: 25823272 DOI: 10.17116/terarkh201587169-75] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
580 Cunningham C, Hennessy E. Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research. Alzheimers Res Ther 2015;7:33. [PMID: 25802557 DOI: 10.1186/s13195-015-0117-2] [Cited by in Crossref: 118] [Cited by in F6Publishing: 124] [Article Influence: 16.9] [Reference Citation Analysis]
581 Backeström A, Eriksson S, Nilsson LG, Olsson T, Rolandsson O. Glucose but not insulin or insulin resistance is associated with memory performance in middle-aged non-diabetic women: a cross sectional study. Diabetol Metab Syndr 2015;7:20. [PMID: 25798199 DOI: 10.1186/s13098-015-0014-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
582 Kim B, Feldman EL. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med. 2015;47:e149. [PMID: 25766618 DOI: 10.1038/emm.2015.3] [Cited by in Crossref: 164] [Cited by in F6Publishing: 175] [Article Influence: 23.4] [Reference Citation Analysis]
583 Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, Griswold M, Gottesman RF, Wagenknecht LE, Windham BG, Selvin E. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med 2014;161:785-93. [PMID: 25437406 DOI: 10.7326/M14-0737] [Cited by in Crossref: 241] [Cited by in F6Publishing: 254] [Article Influence: 34.4] [Reference Citation Analysis]
584 Li X, Song D, Leng SX. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment. Clin Interv Aging 2015;10:549-60. [PMID: 25792818 DOI: 10.2147/CIA.S74042] [Cited by in Crossref: 137] [Cited by in F6Publishing: 152] [Article Influence: 19.6] [Reference Citation Analysis]
585 Kern W. Wie schlechte Zuckerwerte dem Gehirn schaden. MMW - Fortschritte der Medizin 2015;157:63-67. [DOI: 10.1007/s15006-015-2776-0] [Reference Citation Analysis]
586 Smolina K, Wotton CJ, Goldacre MJ. Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: a retrospective national record linkage cohort study. Diabetologia 2015;58:942-50. [PMID: 25673256 DOI: 10.1007/s00125-015-3515-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 9.7] [Reference Citation Analysis]
587 Merino EN, Sendin MC, Osorio JV. Enfermedad de Alzheimer. Medicine - Programa de Formación Médica Continuada Acreditado 2015;11:4306-15. [DOI: 10.1016/j.med.2015.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
588 Buysschaert M, Bordier L, Bauduceau B, Buysschaert M, Le Floch J, Verny C, Doucet J. La dysfonction cognitive chez le diabétique âgé et ses causes : que nous apprend en plus la littérature récente ? Médecine des Maladies Métaboliques 2015;9:47-52. [DOI: 10.1016/s1957-2557(15)30010-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
589 He XS, Wang ZX, Zhu YZ, Wang N, Hu X, Zhang DR, Zhu DF, Zhou JN. Hyperactivation of working memory-related brain circuits in newly diagnosed middle-aged type 2 diabetics. Acta Diabetol 2015;52:133-42. [PMID: 24993663 DOI: 10.1007/s00592-014-0618-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
590 Nettiksimmons J, Ayonayon H, Harris T, Phillips C, Rosano C, Satterfield S, Yaffe K; Health ABC Study. Development and validation of risk index for cognitive decline using blood-derived markers. Neurology 2015;84:696-702. [PMID: 25609760 DOI: 10.1212/WNL.0000000000001263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
591 Thorpe CT, Gellad WF, Good CB, Zhang S, Zhao X, Mor M, Fine MJ. Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care 2015;38:588-95. [PMID: 25592195 DOI: 10.2337/dc14-0599] [Cited by in Crossref: 61] [Cited by in F6Publishing: 80] [Article Influence: 8.7] [Reference Citation Analysis]
592 Jagielski AC, Jiang CQ, Xu L, Taheri S, Zhang WS, Cheng KK, Lam TH, Thomas GN. Glycaemia is associated with cognitive impairment in older adults: the Guangzhou Biobank Cohort Study. Age Ageing 2015;44:65-71. [PMID: 25005262 DOI: 10.1093/ageing/afu088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
593 Yu R, Chau PH, Woo J. Implications of Temporal Trends in Chronic Illness Burden. Successful Aging 2015. [DOI: 10.1007/978-94-017-9331-5_13] [Reference Citation Analysis]
594 Hanyu H. 3) Dementia: Concept and Clinical Features in Diabetes-related Dementia. J Jpn Soc Intern Med 2015;104:1901-1906. [DOI: 10.2169/naika.104.1901] [Reference Citation Analysis]
595 Lee J. New Guidelines for Elderly Diabetic Patients. J Korean Diabetes 2015;16:89. [DOI: 10.4093/jkd.2015.16.2.89] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
596 Yoshinari N, Ishihara Y. The Role of Periodontal Treatment in Hyper-aged society. Journal of the Japanese Society of Periodontology 2015;57:18-25. [DOI: 10.2329/perio.57.18] [Reference Citation Analysis]
597 Ninomiya T, Ozawa M. Japanese Perspectives on Dietary Patterns and Risk of Dementia. Diet and Nutrition in Dementia and Cognitive Decline 2015. [DOI: 10.1016/b978-0-12-407824-6.00026-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
598 Sims-robinson C, Kim B, Feldman EL. Diabetes and Cognitive Dysfunction. Neurobiology of Brain Disorders 2015. [DOI: 10.1016/b978-0-12-398270-4.00013-6] [Reference Citation Analysis]
599 Zeytinoglu M, Huang ES. Diabetes: A Primary Health Care Approach. Prevention of Cardiovascular Diseases 2015. [DOI: 10.1007/978-3-319-22357-5_10] [Reference Citation Analysis]
600 Chang TT, Lung FW, Yen YC. Depressive symptoms, cognitive impairment, and metabolic syndrome in community-dwelling elderly in Southern Taiwan. Psychogeriatrics 2015;15:109-15. [PMID: 25521171 DOI: 10.1111/psyg.12080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
601 Guenette MD, Chintoh A, Remington G, Hahn M. Atypical antipsychotic-induced metabolic disturbances in the elderly. Drugs Aging 2014;31:159-84. [PMID: 24477569 DOI: 10.1007/s40266-014-0152-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
602 Barbagallo M, Dominguez LJ. Type 2 diabetes mellitus and Alzheimer’s disease. World J Diabetes 2014; 5(6): 889-893 [PMID: 25512792 DOI: 10.4239/wjd.v5.i6.889] [Cited by in CrossRef: 143] [Cited by in F6Publishing: 147] [Article Influence: 17.9] [Reference Citation Analysis]
603 Biessels GJ. Brain MRI correlates of cognitive dysfunction in type 2 diabetes: the needle recovered from the haystack? Diabetes Care 2013;36:3855-6. [PMID: 24265363 DOI: 10.2337/dc13-1501] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
604 Ninomiya T. Diabetes mellitus and dementia. Curr Diab Rep. 2014;14:487. [PMID: 24623199 DOI: 10.1007/s11892-014-0487-z] [Cited by in Crossref: 134] [Cited by in F6Publishing: 118] [Article Influence: 16.8] [Reference Citation Analysis]
605 de Bruijn RF, Ikram MA. Cardiovascular risk factors and future risk of Alzheimer's disease. BMC Med 2014;12:130. [PMID: 25385322 DOI: 10.1186/s12916-014-0130-5] [Cited by in Crossref: 181] [Cited by in F6Publishing: 192] [Article Influence: 22.6] [Reference Citation Analysis]
606 Maimaiti S, DeMoll C, Anderson KL, Griggs RB, Taylor BK, Porter NM, Thibault O. Short-lived diabetes in the young-adult ZDF rat does not exacerbate neuronal Ca(2+) biomarkers of aging. Brain Res 2015;1621:214-21. [PMID: 25451110 DOI: 10.1016/j.brainres.2014.10.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
607 Bunn F, Burn AM, Goodman C, Rait G, Norton S, Robinson L, Schoeman J, Brayne C. Comorbidity and dementia: a scoping review of the literature. BMC Med 2014;12:192. [PMID: 25358236 DOI: 10.1186/s12916-014-0192-4] [Cited by in Crossref: 198] [Cited by in F6Publishing: 215] [Article Influence: 24.8] [Reference Citation Analysis]
608 Erus G, Battapady H, Zhang T, Lovato J, Miller ME, Williamson JD, Launer LJ, Bryan RN, Davatzikos C. Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care 2015;38:97-104. [PMID: 25336747 DOI: 10.2337/dc14-1196] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
609 Blázquez E, Velázquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol (Lausanne) 2014;5:161. [PMID: 25346723 DOI: 10.3389/fendo.2014.00161] [Cited by in Crossref: 283] [Cited by in F6Publishing: 300] [Article Influence: 35.4] [Reference Citation Analysis]
610 Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine 2015;48:371-93. [PMID: 25294012 DOI: 10.1007/s12020-014-0436-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 11.1] [Reference Citation Analysis]
611 Song X, Mitnitski A, Rockwood K. Age-related deficit accumulation and the risk of late-life dementia. Alzheimers Res Ther 2014;6:54. [PMID: 25356088 DOI: 10.1186/s13195-014-0054-5] [Cited by in Crossref: 70] [Cited by in F6Publishing: 78] [Article Influence: 8.8] [Reference Citation Analysis]
612 Yokono K. Total management of diabetes mellitus in the elderly. Diabetol Int 2014;5:155-157. [DOI: 10.1007/s13340-014-0180-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
613 Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev 2014;2014:102158. [PMID: 25215171 DOI: 10.1155/2014/102158] [Cited by in Crossref: 226] [Cited by in F6Publishing: 242] [Article Influence: 28.3] [Reference Citation Analysis]
614 Seetharaman S, Andel R, McEvoy C, Dahl Aslan AK, Finkel D, Pedersen NL. Blood glucose, diet-based glycemic load and cognitive aging among dementia-free older adults. J Gerontol A Biol Sci Med Sci 2015;70:471-9. [PMID: 25149688 DOI: 10.1093/gerona/glu135] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
615 Gąsecki D, Kwarciany M, Nyka W, Narkiewicz K. Hypertension, brain damage and cognitive decline. Curr Hypertens Rep 2013;15:547-58. [PMID: 24146223 DOI: 10.1007/s11906-013-0398-4] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 14.1] [Reference Citation Analysis]
616 Dearborn JL, Knopman D, Sharrett AR, Schneider AL, Jack CR Jr, Coker LH, Alonso A, Selvin E, Mosley TH, Wagenknecht LE, Windham BG, Gottesman RF. The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC). Dement Geriatr Cogn Disord 2014;38:337-46. [PMID: 25171458 DOI: 10.1159/000362265] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
617 Yang S, Ajilore O, Wu M, Lamar M, Kumar A. Impaired macromolecular protein pools in fronto-striato-thalamic circuits in type 2 diabetes revealed by magnetization transfer imaging. Diabetes 2015;64:183-92. [PMID: 25092675 DOI: 10.2337/db14-0316] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
618 Saadatnia M, Keyhanian K. Cognitive Impairment in Type 2 Diabetic Patients Treated with Metformin in Comparison with those Taking Glibenclamide. JNSK 2014;1. [DOI: 10.15406/jnsk.2014.01.00019] [Reference Citation Analysis]
619 Ouwens DM, van Duinkerken E, Schoonenboom SN, Herzfeld de Wiza D, Klein M, van Golen L, Pouwels PJ, Barkhof F, Moll AC, Snoek FJ, Teunissen CE, Scheltens P, Diamant M. Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes. Diabetologia 2014;57:2208-14. [PMID: 25034377 DOI: 10.1007/s00125-014-3333-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
620 Lee JH, Choi Y, Jun C, Hong YS, Cho HB, Kim JE, Lyoo IK. Neurocognitive changes and their neural correlates in patients with type 2 diabetes mellitus. Endocrinol Metab (Seoul) 2014;29:112-21. [PMID: 25031883 DOI: 10.3803/EnM.2014.29.2.112] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
621 Han JY, Han SH. Primary prevention of Alzheimer's disease: is it an attainable goal? J Korean Med Sci 2014;29:886-92. [PMID: 25045219 DOI: 10.3346/jkms.2014.29.7.886] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
622 Guerchet M, Mbelesso P, Ndamba-Bandzouzi B, Pilleron S, Desormais I, Lacroix P, Aboyans V, Jésus P, Desport JC, Tchalla AE, Marin B, Lambert JC, Clément JP, Dartigues JF, Preux PM; EPIDEMCA group. Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. Springerplus 2014;3:338. [PMID: 25045613 DOI: 10.1186/2193-1801-3-338] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
623 Biessels G. Vasculaire oorzaken van dementie; de waarde van het levensloopperspectief. Tijdsvoor Neuropsy en Gedragsneuro 2014;2:48-56. [DOI: 10.1007/s40533-014-0009-y] [Reference Citation Analysis]
624 Yogi-Morren D, Galioto R, Strandjord SE, Kennedy L, Manroa P, Kirwan JP, Kashyap S, Gunstad J. Duration of type 2 diabetes and very low density lipoprotein levels are associated with cognitive dysfunction in metabolic syndrome. Cardiovasc Psychiatry Neurol 2014;2014:656341. [PMID: 25057411 DOI: 10.1155/2014/656341] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
625 Greenbaum L, Springer RR, Lutz MW, Heymann A, Lubitz I, Cooper I, Kravitz E, Sano M, Roses AD, Silverman JM, Saunders AM, Beeri MS. The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. Eur Neuropsychopharmacol 2014;24:1492-9. [PMID: 25044051 DOI: 10.1016/j.euroneuro.2014.06.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
626 Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med 2014;160:517-25. [PMID: 24733192 DOI: 10.7326/M13-2411] [Cited by in Crossref: 367] [Cited by in F6Publishing: 400] [Article Influence: 45.9] [Reference Citation Analysis]
627 Riby LM, Riby DM. Raised blood glucose as a predictor of dementia risk in adults with and without diabetes. Evid Based Med 2014;19:112. [PMID: 24336609 DOI: 10.1136/eb-2013-101557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
628 Kawamura T, Umemura T. Is cognitive impairment the fourth diabetic microvascular complication? J Diabetes Investig 2011;2:351-3. [PMID: 24843511 DOI: 10.1111/j.2040-1124.2011.00140.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
629 Smith GC, McEwen H, Steinberg JD, Shepherd PR. The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect. Psychopharmacology (Berl) 2014;231:4553-60. [PMID: 24800899 DOI: 10.1007/s00213-014-3608-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
630 Yajima K, Matsushita T, Sumitomo H, Sakurai H, Katayama T, Kanno K, Sakai M, Shigeta M, Shirabe S, Nakano T, Nishimura K, Ueki A, Kitaoka M. One-minute mental status examination for category fluency is more useful than mini-mental state examination to evaluate the reliability of insulin self-injection in elderly diabetic patients. J Diabetes Investig 2014;5:340-4. [PMID: 24843784 DOI: 10.1111/jdi.12159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
631 Ferro JM, Verdelho A, Madureira S. Cognitive consequences of cerebral small vessel disease. Cerebral Small Vessel Disease 2014. [DOI: 10.1017/cbo9781139382694.020] [Reference Citation Analysis]
632 Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, Murray AM, Sullivan MD, Horowitz KR, Ding J, Marcovina S, Lovato L, Lovato J, Margolis KL, Davatzikos C, Barzilay J, Ginsberg HN, Linz PE, Miller ME; Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Investigators. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med 2014;174:324-33. [PMID: 24493100 DOI: 10.1001/jamainternmed.2013.13656] [Cited by in Crossref: 103] [Cited by in F6Publishing: 114] [Article Influence: 12.9] [Reference Citation Analysis]
633 Clinical aspects of cerebral small vessel disease. Cerebral Small Vessel Disease 2014. [DOI: 10.1017/cbo9781139382694.019] [Reference Citation Analysis]
634 Bornstein NM, Brainin M, Guekht A, Skoog I, Korczyn AD. Diabetes and the brain: issues and unmet needs. Neurol Sci 2014;35:995-1001. [PMID: 24777546 DOI: 10.1007/s10072-014-1797-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
635 Chen C, Wang Y, Zhang J, Ma L, Gu J, Ho G. Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice. Dis Model Mech 2014;7:723-30. [PMID: 24764190 DOI: 10.1242/dmm.016162] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
636 Malek-Ahmadi M, Beach T, Obradov A, Sue L, Belden C, Davis K, Walker DG, Lue L, Adem A, Sabbagh MN. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE ε.4 carrier status. Curr Alzheimer Res 2013;10:654-9. [PMID: 23627755 DOI: 10.2174/15672050113109990006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 5.4] [Reference Citation Analysis]
637 Rosland AM, Heisler M, Janevic MR, Connell CM, Langa KM, Kerr EA, Piette JD. Current and potential support for chronic disease management in the United States: the perspective of family and friends of chronically ill adults. Fam Syst Health 2013;31:119-31. [PMID: 23795624 DOI: 10.1037/a0031535] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
638 Fox C, Kilvert A. Diabetes and dementia. Practical Diabetes 2014;31:94-95. [DOI: 10.1002/pdi.1839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
639 Arnold SE, Lucki I, Brookshire BR, Carlson GC, Browne CA, Kazi H, Bang S, Choi BR, Chen Y, McMullen MF, Kim SF. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol Dis 2014;67:79-87. [PMID: 24686304 DOI: 10.1016/j.nbd.2014.03.011] [Cited by in Crossref: 192] [Cited by in F6Publishing: 199] [Article Influence: 24.0] [Reference Citation Analysis]
640 Belfort-Deaguiar R, Constable RT, Sherwin RS. Functional MRI signal fluctuations: a preclinical biomarker for cognitive impairment in type 2 diabetes? Diabetes 2014;63:396-8. [PMID: 24464717 DOI: 10.2337/db13-1685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
641 Huang YC, Hsu CC, Lin WC, Yin TK, Huang CW, Wang PW, Chang HH, Chiu NT. Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients. ScientificWorldJournal 2014;2014:694326. [PMID: 24782665 DOI: 10.1155/2014/694326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
642 Nenov MN, Laezza F, Haidacher SJ, Zhao Y, Sadygov RG, Starkey JM, Spratt H, Luxon BA, Dineley KT, Denner L. Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. J Neurosci 2014;34:1028-36. [PMID: 24431460 DOI: 10.1523/JNEUROSCI.3413-13.2014] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
643 Han C, Lu Y, Wei Y, Wu B, Liu Y, He R. D-ribosylation induces cognitive impairment through RAGE-dependent astrocytic inflammation. Cell Death Dis 2014;5:e1117. [PMID: 24625976 DOI: 10.1038/cddis.2014.89] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
644 Wang W, Yang L, Tan L, Wu X, Jiang B, Shen X. Arg972 insulin receptor substrate-1 polymorphism and risk and severity of Alzheimer's disease. J Clin Neurosci 2014;21:1233-7. [PMID: 24589556 DOI: 10.1016/j.jocn.2013.09.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
645 Palta P, Schneider AL, Biessels GJ, Touradji P, Hill-Briggs F. Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc. 2014;20:278-291. [PMID: 24555960 DOI: 10.1017/s1355617713001483] [Cited by in Crossref: 188] [Cited by in F6Publishing: 196] [Article Influence: 23.5] [Reference Citation Analysis]
646 Chen JM, Chang CW, Chang TH, Hsu CC, Horng JT, Sheu WH. Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan. PLoS One 2014;9:e88434. [PMID: 24520388 DOI: 10.1371/journal.pone.0088434] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
647 Bauer K, Schwarzkopf L, Graessel E, Holle R. A claims data-based comparison of comorbidity in individuals with and without dementia. BMC Geriatr 2014;14:10. [PMID: 24472217 DOI: 10.1186/1471-2318-14-10] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 12.0] [Reference Citation Analysis]
648 Anstey KJ, Cherbuin N, Herath PM. Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention. Prev Sci 2013;14:411-21. [PMID: 23319292 DOI: 10.1007/s11121-012-0313-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 10.5] [Reference Citation Analysis]
649 Weinstein G, Seshadri S. Circulating biomarkers that predict incident dementia. Alzheimers Res Ther 2014;6:6. [PMID: 25031629 DOI: 10.1186/alzrt235] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
650 Samaras K, Lutgers HL, Kochan NA, Crawford JD, Campbell LV, Wen W, Slavin MJ, Baune BT, Lipnicki DM, Brodaty H, Trollor JN, Sachdev PS. The impact of glucose disorders on cognition and brain volumes in the elderly: the Sydney Memory and Ageing Study. Age (Dordr) 2014;36:977-93. [PMID: 24402401 DOI: 10.1007/s11357-013-9613-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
651 Abbondante S, Baglietto-Vargas D, Rodriguez-Ortiz CJ, Estrada-Hernandez T, Medeiros R, Laferla FM. Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes. Am J Pathol 2014;184:819-26. [PMID: 24412516 DOI: 10.1016/j.ajpath.2013.11.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
652 Moreno G, Mangione CM, Kimbro L, Vaisberg E; American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus. Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update. J Am Geriatr Soc 2013;61:2020-6. [PMID: 24219204 DOI: 10.1111/jgs.12514] [Cited by in Crossref: 191] [Cited by in F6Publishing: 222] [Article Influence: 23.9] [Reference Citation Analysis]
653 Verdelho A. The Role of Cerebrovascular Disease in Cognitive Decline. Neurodegenerative Diseases 2014. [DOI: 10.1007/978-1-4471-6380-0_5] [Reference Citation Analysis]
654 Li M, Tang Z. Should Renal Function Become an Important Factor in Cognitive Impairment and Cognitive Decline? Med Princ Pract 2014;23:486-486. [DOI: 10.1159/000362795] [Reference Citation Analysis]
655 Herghelegiu AM, Prada GI. Impact of Metabolic Control on Cognitive Function and Health-Related Quality of Life in Older Diabetics. International Perspectives on Aging 2014. [DOI: 10.1007/978-3-319-06650-9_3] [Reference Citation Analysis]
656 Hanyu H, Fukasawa R. 3. Diabetes-related Dementia. J Jpn Soc Intern Med 2014;103:1831-1838. [DOI: 10.2169/naika.103.1831] [Reference Citation Analysis]
657 Zochodne DW, Toth C. Diabetes and the Nervous System. Aminoff's Neurology and General Medicine 2014. [DOI: 10.1016/b978-0-12-407710-2.00019-9] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
658 Fong IW. Can Microbes Play a Role in the Pathogenesis of Alzheimer Disease? The Role of Microbes in Common Non-Infectious Diseases 2014. [DOI: 10.1007/978-1-4939-1670-2_7] [Reference Citation Analysis]
659 Ngandu T, Mangialasche F, Kivipelto M. The Epidemiology and Prevention of Alzheimer’s Disease and Projected Burden of Disease. Global Clinical Trials for Alzheimer's Disease 2014. [DOI: 10.1016/b978-0-12-411464-7.00001-8] [Reference Citation Analysis]
660 Clerici F. Nongenetic Risk Factors for Alzheimer’s Disease. Neurodegenerative Diseases 2014. [DOI: 10.1007/978-1-4471-6380-0_6] [Reference Citation Analysis]
661 Jang IM, Lee K, Roh H, Ahn M. Prevalence and Risk Factors of Dementia and MCI in Community-dwelling Elderly Koreans. Dement Neurocognitive Disord 2014;13:121. [DOI: 10.12779/dnd.2014.13.4.121] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
662 Morgan VA, McGrath JJ, Jablensky A, Badcock JC, Waterreus A, Bush R, Carr V, Castle D, Cohen M, Galletly C, Harvey C, Hocking B, McGorry P, Neil AL, Saw S, Shah S, Stain HJ, Mackinnon A. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med 2014;44:2163-76. [PMID: 24365456 DOI: 10.1017/S0033291713002973] [Cited by in Crossref: 126] [Cited by in F6Publishing: 134] [Article Influence: 14.0] [Reference Citation Analysis]
663 Tuligenga RH, Dugravot A, Tabák AG, Elbaz A, Brunner EJ, Kivimäki M, Singh-Manoux A. Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study. Lancet Diabetes Endocrinol 2014;2:228-35. [PMID: 24622753 DOI: 10.1016/S2213-8587(13)70192-X] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 13.6] [Reference Citation Analysis]
664 van Eersel ME, Joosten H, Gansevoort RT, Dullaart RP, Slaets JP, Izaks GJ. The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older. PLoS One 2013;8:e82991. [PMID: 24367577 DOI: 10.1371/journal.pone.0082991] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
665 Franke K, Gaser C, Manor B, Novak V. Advanced BrainAGE in older adults with type 2 diabetes mellitus. Front Aging Neurosci 2013;5:90. [PMID: 24381557 DOI: 10.3389/fnagi.2013.00090] [Cited by in Crossref: 105] [Cited by in F6Publishing: 115] [Article Influence: 11.7] [Reference Citation Analysis]
666 Popa-Wagner A, Buga AM, Popescu B, Muresanu D. Vascular cognitive impairment, dementia, aging and energy demand. A vicious cycle. J Neural Transm (Vienna) 2015;122 Suppl 1:S47-54. [PMID: 24337666 DOI: 10.1007/s00702-013-1129-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
667 Orr ME, Salinas A, Buffenstein R, Oddo S. Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology. Neurobiol Aging 2014;35:1233-42. [PMID: 24411482 DOI: 10.1016/j.neurobiolaging.2013.12.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
668 Shu Y, Zhang H, Kang T, Zhang JJ, Yang Y, Liu H, Zhang L. PI3K/Akt signal pathway involved in the cognitive impairment caused by chronic cerebral hypoperfusion in rats. PLoS One 2013;8:e81901. [PMID: 24339978 DOI: 10.1371/journal.pone.0081901] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
669 Yanev S, Aloe L, Fiore M, Chaldakov GN. Neurotrophic and metabotrophic potential of nerve growth factor and brain-derived neurotrophic factor: Linking cardiometabolic and neuropsychiatric diseases. World J Pharmacol 2013; 2(4): 92-99 [DOI: 10.5497/wjp.v2.i4.92] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
670 Xu X, Guo L, Tian G. Diabetes cognitive impairments and the effect of traditional chinese herbs. Evid Based Complement Alternat Med 2013;2013:649396. [PMID: 24386004 DOI: 10.1155/2013/649396] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
671 Davydow DS, Zivin K, Langa KM. Hospitalization, depression and dementia in community-dwelling older Americans: findings from the national health and aging trends study. Gen Hosp Psychiatry 2014;36:135-41. [PMID: 24388630 DOI: 10.1016/j.genhosppsych.2013.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
672 Hayden MR, Banks WA, Shah GN, Gu Z, Sowers JR. Cardiorenal metabolic syndrome and diabetic cognopathy. Cardiorenal Med 2013;3:265-82. [PMID: 24474955 DOI: 10.1159/000357113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
673 Hanson AJ, Bayer-Carter JL, Green PS, Montine TJ, Wilkinson CW, Baker LD, Watson GS, Bonner LM, Callaghan M, Leverenz JB, Tsai E, Postupna N, Zhang J, Lampe J, Craft S. Effect of apolipoprotein E genotype and diet on apolipoprotein E lipidation and amyloid peptides: randomized clinical trial. JAMA Neurol 2013;70:972-80. [PMID: 23779114 DOI: 10.1001/jamaneurol.2013.396] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
674 Hackel JM. 'Patient-centered care' for complex patients with type 2 diabetes mellitus-analysis of two cases. Clin Med Insights Endocrinol Diabetes 2013;6:47-61. [PMID: 24250240 DOI: 10.4137/CMED.S12231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
675 Solas M, Ramírez MJ. Modulation of Cognition by Insulin and Aging: Implications for Alzheimer Disease. Metabolic Syndrome and Neurological Disorders 2013. [DOI: 10.1002/9781118395318.ch6] [Reference Citation Analysis]
676 Kodiha M, Mahboubi H, Stochaj U. Contributions of AMP kinase to the Pathogenesis of Type 2 Diabetes and Neurodegenerative Diseases. Metabolic Syndrome and Neurological Disorders 2013. [DOI: 10.1002/9781118395318.ch22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
677 Erickson JR, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland RJ, Despa F, Hart GW, Ripplinger CM, Bers DM. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013;502:372-6. [PMID: 24077098 DOI: 10.1038/nature12537] [Cited by in Crossref: 391] [Cited by in F6Publishing: 415] [Article Influence: 43.4] [Reference Citation Analysis]
678 Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV; Health ABC Study. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173:1300-1306. [PMID: 23753199 DOI: 10.1001/jamainternmed.2013.6176] [Cited by in Crossref: 247] [Cited by in F6Publishing: 268] [Article Influence: 27.4] [Reference Citation Analysis]
679 Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med. 2013;173:1300-1306. [PMID: 23753199 DOI: 10.1001/jamain-ternmed.2013.6176] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
680 Morales R, Moreno-Gonzalez I, Soto C. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases. PLoS Pathog 2013;9:e1003537. [PMID: 24068917 DOI: 10.1371/journal.ppat.1003537] [Cited by in Crossref: 133] [Cited by in F6Publishing: 136] [Article Influence: 14.8] [Reference Citation Analysis]
681 Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab 2013;33:1696-706. [PMID: 24022624 DOI: 10.1038/jcbfm.2013.159] [Cited by in Crossref: 101] [Cited by in F6Publishing: 108] [Article Influence: 11.2] [Reference Citation Analysis]
682 Reis JP, Launer LJ, Terry JG, Loria CM, Zeki Al Hazzouri A, Sidney S, Yaffe K, Jacobs DR Jr, Whitlow CT, Zhu N, Carr JJ. Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study. Atherosclerosis 2013;231:72-7. [PMID: 24125414 DOI: 10.1016/j.atherosclerosis.2013.08.038] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
683 Tarumi T, Gonzales MM, Fallow B, Nualnim N, Lee J, Tanaka H, Haley AP. Aerobic fitness and cognitive function in midlife: an association mediated by plasma insulin. Metab Brain Dis 2013;28:727-30. [PMID: 24000071 DOI: 10.1007/s11011-013-9431-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
684 Exalto LG, Biessels GJ, Karter AJ, Huang ES, Katon WJ, Minkoff JR, Whitmer RA. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol 2013;1:183-90. [PMID: 24622366 DOI: 10.1016/S2213-8587(13)70048-2] [Cited by in Crossref: 138] [Cited by in F6Publishing: 116] [Article Influence: 15.3] [Reference Citation Analysis]
685 Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, Münch G, Wood AG, Forbes J, Greenaway TM. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care. 2013;36:4036-4042. [PMID: 23939539 DOI: 10.2337/dc13-0143] [Cited by in Crossref: 330] [Cited by in F6Publishing: 348] [Article Influence: 36.7] [Reference Citation Analysis]
686 Yang Y, Wu Y, Zhang S, Song W. High glucose promotes Aβ production by inhibiting APP degradation. PLoS One 2013;8:e69824. [PMID: 23894546 DOI: 10.1371/journal.pone.0069824] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
687 Thibault O, Anderson KL, DeMoll C, Brewer LD, Landfield PW, Porter NM. Hippocampal calcium dysregulation at the nexus of diabetes and brain aging. Eur J Pharmacol 2013;719:34-43. [PMID: 23872402 DOI: 10.1016/j.ejphar.2013.07.024] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
688 Temizel M, Mert M, Yanar H, Arman Y, Arslan K, Alakus F, Velioglu EA. Evaluation of cognitive functions and the related factors in 50–80 year type 2 diabetic subjects. Int J Diabetes Dev Ctries 2013;33:71-4. [DOI: 10.1007/s13410-013-0126-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
689 Nguyen HT, Kirk JK, Arcury TA, Ip EH, Grzywacz JG, Saldana SJ, Bell RA, Quandt SA. Cognitive function is a risk for health literacy in older adults with diabetes. Diabetes Res Clin Pract 2013;101:141-7. [PMID: 23806477 DOI: 10.1016/j.diabres.2013.05.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
690 Han M, Huang XF, Chen DC, Xiu M, Kosten TR, Zhang XY. Diabetes and cognitive deficits in chronic schizophrenia: a case-control study. PLoS One 2013;8:e66299. [PMID: 23840437 DOI: 10.1371/journal.pone.0066299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
691 Zilkens RR, Davis WA, Spilsbury K, Semmens JB, Bruce DG. Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. Am J Epidemiol 2013;177:1246-54. [PMID: 23543134 DOI: 10.1093/aje/kws387] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
692 Seaquist ER, Miller ME, Fonseca V, Ismail-Beigi F, Launer LJ, Punthakee Z, Sood A. Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND. J Diabetes Complications 2013;27:485-91. [PMID: 23680059 DOI: 10.1016/j.jdiacomp.2013.03.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
693 Endocrine, metabolic, and toxin-related disorders. Neuropsychological Neurology 2013. [DOI: 10.1017/cbo9781139176095.010] [Reference Citation Analysis]
694 Fatke B, Förstl H. Diabetes mellitus und Demenz. Diabetologe 2013;9:217-225. [DOI: 10.1007/s11428-012-0951-9] [Reference Citation Analysis]
695 Fei M, Yan Ping Z, Ru Juan M, Ning Ning L, Lin G. Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age Ageing 2013;42:398-400. [PMID: 23299282 DOI: 10.1093/ageing/afs188] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
696 Gudala K, Bansal D, Schifano F, Bhansali A. Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig. 2013;4:640-650. [PMID: 24843720 DOI: 10.1111/jdi.12087] [Cited by in Crossref: 340] [Cited by in F6Publishing: 356] [Article Influence: 37.8] [Reference Citation Analysis]
697 Abdelhafiz AH, Sinclair AJ. Management of type 2 diabetes in older people. Diabetes Ther 2013;4:13-26. [PMID: 23605454 DOI: 10.1007/s13300-013-0020-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
698 Feinkohl I, Keller M, Robertson CM, Morling JR, Williamson RM, Nee LD, McLachlan S, Sattar N, Welsh P, Reynolds RM, Russ TC, Deary IJ, Strachan MW, Price JF;  Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2013;36:2779-2786. [PMID: 23579182 DOI: 10.2337/dc12-2241] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.7] [Reference Citation Analysis]
699 Lee JH, Yoon S, Renshaw PF, Kim TS, Jung JJ, Choi Y, Kim BN, Jacobson AM, Lyoo IK. Morphometric changes in lateral ventricles of patients with recent-onset type 2 diabetes mellitus. PLoS One 2013;8:e60515. [PMID: 23593231 DOI: 10.1371/journal.pone.0060515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
700 Yokono K. New therapeutic strategy for Alzheimer's disease using antidiabetes agents. J Diabetes Invest 2013;4:152-153. [DOI: 10.1111/jdi.12031] [Reference Citation Analysis]
701 Mackowiak M, Pasquier F. Treatment of patients with post-stroke dementia. The Behavioral and Cognitive Neurology of Stroke 2013. [DOI: 10.1017/cbo9781139058988.033] [Reference Citation Analysis]
702 Frank M. Insulin und Hypoglykämie. Diabetologe 2013;9:41-46. [DOI: 10.1007/s11428-012-0913-2] [Reference Citation Analysis]
703 Reijmer YD, Leemans A, Brundel M, Kappelle LJ, Biessels GJ; Utrecht Vascular Cognitive Impairment Study Group. Disruption of the cerebral white matter network is related to slowing of information processing speed in patients with type 2 diabetes. Diabetes 2013;62:2112-5. [PMID: 23349494 DOI: 10.2337/db12-1644] [Cited by in Crossref: 108] [Cited by in F6Publishing: 118] [Article Influence: 12.0] [Reference Citation Analysis]
704 Ghasemi R, Dargahi L, Haeri A, Moosavi M, Mohamed Z, Ahmadiani A. Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. Mol Neurobiol 2013;47:1045-65. [PMID: 23335160 DOI: 10.1007/s12035-013-8404-z] [Cited by in Crossref: 71] [Cited by in F6Publishing: 76] [Article Influence: 7.9] [Reference Citation Analysis]
705 Holohan KN, Lahiri DK, Schneider BP, Foroud T, Saykin AJ. Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways. Front Genet 2012;3:323. [PMID: 23335942 DOI: 10.3389/fgene.2012.00323] [Cited by in Crossref: 31] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
706 Samaras K, Sachdev PS. Diabetes and the elderly brain: sweet memories? Ther Adv Endocrinol Metab 2012;3:189-96. [PMID: 23323191 DOI: 10.1177/2042018812469645] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
707 Erbguth F. Hypoglykämien und zentrales Nervensystem. Diabetologe 2013;9:25-32. [DOI: 10.1007/s11428-012-0911-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
708 van de Ven KC, Tack CJ, Heerschap A, van der Graaf M, de Galan BE. Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia. J Clin Invest 2013;123:623-9. [PMID: 23298837 DOI: 10.1172/JCI62742] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
709 Nandipati S, Luo X, Schimming C, Grossman HT, Sano M. Cognition in non-demented diabetic older adults. Curr Aging Sci 2012;5:131-5. [PMID: 22023096 DOI: 10.2174/1874609811205020131] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
710 Ohnuma T, Nakamura T, Takebayashi Y, Hanzawa R, Kitazawa M, Higashiyama R, Takeda M, Thompson K, Komatsu M, Shimazaki H, Shibata N, Arai H. No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease. Dement Geriatr Cogn Dis Extra 2012;2:496-502. [PMID: 23277782 DOI: 10.1159/000345085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
711 Xu W. Diabetes Mellitus and Its Impact on Sporadic Alzheimer’s Disease. Studies on Alzheimer's Disease 2013. [DOI: 10.1007/978-1-62703-598-9_12] [Reference Citation Analysis]
712 Fatke B, Förstl H. Demenz und Diabetes mellitus. Psychodiabetologie 2013. [DOI: 10.1007/978-3-642-29908-7_19] [Reference Citation Analysis]
713 Murano I, Asakawa Y, Mizukami M, Takihara J. Examination of the Validity of the Japanese Version of the IPA Questionnaire for the Evaluation of the Physical Activity of Diabetes Patients. Rigakuryoho kagaku 2013;28:101-104. [DOI: 10.1589/rika.28.101] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
714 Yamamoto N. Cognitive function and diabetes mellitus in Japanese community-dwelling elderly in Tosa. Jpn J Geriat 2013;50:312-315. [DOI: 10.3143/geriatrics.50.312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
715 Spauwen PJ, Köhler S, Verhey FR, Stehouwer CD, van Boxtel MP. Effects of type 2 diabetes on 12-year cognitive change: results from the Maastricht Aging Study. Diabetes Care 2013;36:1554-61. [PMID: 23275366 DOI: 10.2337/dc12-0746] [Cited by in Crossref: 96] [Cited by in F6Publishing: 102] [Article Influence: 9.6] [Reference Citation Analysis]
716 Sanz CM, Ruidavets JB, Bongard V, Marquié JC, Hanaire H, Ferrières J, Andrieu S. Relationship between markers of insulin resistance, markers of adiposity, HbA1c, and cognitive functions in a middle-aged population-based sample: the MONA LISA study. Diabetes Care 2013;36:1512-21. [PMID: 23275371 DOI: 10.2337/dc12-1017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
717 Zhen YF, Zhang J, Liu XY, Fang H, Tian LB, Zhou DH, Kosten TR, Zhang XY. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berl). 2013;227:93-100. [PMID: 23263460 DOI: 10.1007/s00213-012-2942-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 6.5] [Reference Citation Analysis]
718 Wilson D, Peters R, Ritchie K, Ritchie CW. Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia. Ther Adv Chronic Dis 2011;2:161-73. [PMID: 23251748 DOI: 10.1177/2040622310397636] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
719 Trubnikova OA, Mamontova AS, Syrova ID, Maleva OV, Barbarash OL. Neuropsychological dynamics in patients with type 2 diabetes mellitus undergone coronary artery bypass grafting. Diabetes mellitus 2012;15:33-38. [DOI: 10.14341/2072-0351-5535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
720 Tang CY, Narula J, Friedman JI. Novel imaging strategies for assessment of cerebrovascular involvement. Mt Sinai J Med 2012;79:674-82. [PMID: 23239206 DOI: 10.1002/msj.21354] [Reference Citation Analysis]
721 Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol. 2012;69:1170-1175. [PMID: 22710333 DOI: 10.1001/archneurol.2012.1117] [Cited by in Crossref: 198] [Cited by in F6Publishing: 213] [Article Influence: 19.8] [Reference Citation Analysis]
722 Falvey CM, Rosano C, Simonsick EM, Harris T, Strotmeyer ES, Satterfield S, Yaffe K; Health ABC Study. Macro- and microstructural magnetic resonance imaging indices associated with diabetes among community-dwelling older adults. Diabetes Care 2013;36:677-82. [PMID: 23160721 DOI: 10.2337/dc12-0814] [Cited by in Crossref: 77] [Cited by in F6Publishing: 78] [Article Influence: 7.7] [Reference Citation Analysis]
723 Wang HY, Bakshi K, Frankfurt M, Stucky A, Goberdhan M, Shah SM, Burns LH. Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A. J Neurosci 2012;32:9773-84. [PMID: 22815492 DOI: 10.1523/JNEUROSCI.0354-12.2012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
724 Matsuzawa T, Takata T, Yokono K, Ueda H, Moriwaki K, Kamae I, Urakami K, Sakurai T. A warning index used in prescreening for Alzheimer's disease, based on self-reported cognitive deficits and vascular risk factors for dementia in elderly patients with type 2 diabetes. Int J Alzheimers Dis 2012;2012:124215. [PMID: 23119223 DOI: 10.1155/2012/124215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
725 Dalai VVK, Childress JE, Schulz PE. An Overview of Dementias. Perspect Swal Swal Dis (Dysph) 2012;21:75-84. [DOI: 10.1044/sasd21.3.75] [Reference Citation Analysis]
726 Cheng KC, Chen YL, Lai SW, Mou CH, Tsai PY, Sung FC. Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol 2012;13:129. [PMID: 23020192 DOI: 10.1186/1471-2369-13-129] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
727 N S, Karan. Assessment of the cognitive status in diabetes mellitus. J Clin Diagn Res 2012;6:1658-62. [PMID: 23373022 DOI: 10.7860/JCDR/2012/4837.2649] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
728 Jones DT. Neural networks, cognition, and diabetes: what is the connection? Diabetes 2012;61:1653-5. [PMID: 22723270 DOI: 10.2337/db12-0402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
729 Sun XJ, Zhao L, Zhao N, Pan XL, Fei GQ, Jin LR, Zhong CJ. Benfotiamine prevents increased β-amyloid production in HEK cells induced by high glucose. Neurosci Bull 2012;28:561-6. [PMID: 22961478 DOI: 10.1007/s12264-012-1264-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
730 Reijmer YD, Brundel M, de Bresser J, Kappelle LJ, Leemans A, Biessels GJ. Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care. 2013;36:137-144. [PMID: 22961577 DOI: 10.2337/dc12-0493] [Cited by in Crossref: 161] [Cited by in F6Publishing: 169] [Article Influence: 16.1] [Reference Citation Analysis]
731 Feinkohl I, Sattar N, Welsh P, Reynolds RM, Deary IJ, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study-ET2DS Investigators. Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes. PLoS One 2012;7:e44569. [PMID: 22973461 DOI: 10.1371/journal.pone.0044569] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
732 Kawamura T, Umemura T, Hotta N. Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig. 2012;3:413-423. [PMID: 24843599 DOI: 10.1111/j.2040-1124.2012.00234.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
733 Arab L, Sadeghi R, Walker DG, Lue LF, Sabbagh MN. Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer’s Disease. Curr Neuropharmacol. 2011;9:693-705. [PMID: 22654727 DOI: 10.2174/157015911798376334] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
734 Tokutake T, Kasuga K, Yajima R, Sekine Y, Tezuka T, Nishizawa M, Ikeuchi T. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway. J Biol Chem 2012;287:35222-33. [PMID: 22910909 DOI: 10.1074/jbc.M112.348300] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 7.4] [Reference Citation Analysis]
735 Burton C, Campbell P, Jordan K, Strauss V, Mallen C. The association of anxiety and depression with future dementia diagnosis: a case-control study in primary care. Fam Pract 2013;30:25-30. [PMID: 22915794 DOI: 10.1093/fampra/cms044] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
736 Lüders S, Stöve S, Schrader J. [Prevention of vascular dementia. Evidence and practice]. Internist (Berl) 2012;53:223-31. [PMID: 22119909 DOI: 10.1007/s00108-011-2953-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
737 Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012;122:1316-38. [PMID: 22476197 DOI: 10.1172/JCI59903] [Cited by in Crossref: 1129] [Cited by in F6Publishing: 1192] [Article Influence: 112.9] [Reference Citation Analysis]
738 Phillips S, Phillips A. Diabetes, dignity and cognitive impairment. Nursing and Residential Care 2012;14:370-373. [DOI: 10.12968/nrec.2012.14.7.370] [Reference Citation Analysis]
739 Brouwer-Brolsma EM, Feskens EJ, Steegenga WT, de Groot LC. Associations of 25-hydroxyvitamin D with fasting glucose, fasting insulin, dementia and depression in European elderly: the SENECA study. Eur J Nutr 2013;52:917-25. [PMID: 22729969 DOI: 10.1007/s00394-012-0399-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
740 Silva JLD, Ribeiro LTC, Dos Santos NRP, Beserra VCAS, Fragoso YD. The influence of diabetes mellitus II on cognitive performance. Dement Neuropsychol 2012;6:80-4. [PMID: 29213778 DOI: 10.1590/S1980-57642012DN06020003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
741 Nguyen HT, Arcury TA, Grzywacz JG, Saldana SJ, Ip EH, Kirk JK, Bell RA, Quandt SA. The association of mental conditions with blood glucose levels in older adults with diabetes. Aging Ment Health 2012;16:950-7. [PMID: 22640032 DOI: 10.1080/13607863.2012.688193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
742 Luchsinger JA. Type 2 diabetes and dementia: is there a substantial link? Diabetes Management 2012;2:177-180. [DOI: 10.2217/dmt.12.19] [Reference Citation Analysis]
743 Taipa R, Pinho J, Melo-Pires M. Clinico-pathological correlations of the most common neurodegenerative dementias. Front Neurol 2012;3:68. [PMID: 22557993 DOI: 10.3389/fneur.2012.00068] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
744 Alves L, Correia AS, Miguel R, Alegria P, Bugalho P. Alzheimer’s disease: a clinical practice-oriented review. Front Neurol. 2012;3:63. [PMID: 22529838 DOI: 10.3389/fneur.2012.00063] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
745 Williams WM, Castellani RJ, Weinberg A, Perry G, Smith MA. Do β-defensins and other antimicrobial peptides play a role in neuroimmune function and neurodegeneration? ScientificWorldJournal 2012;2012:905785. [PMID: 22606066 DOI: 10.1100/2012/905785] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
746 Cho IS, Jung M, Kwon KS, Moon E, Cho JH, Yoon KH, Kim JW, Lee YD, Kim SS, Suh-Kim H. Deregulation of CREB signaling pathway induced by chronic hyperglycemia downregulates NeuroD transcription. PLoS One 2012;7:e34860. [PMID: 22509362 DOI: 10.1371/journal.pone.0034860] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
747 Takahashi S, Izawa Y, Suzuki N. Astroglial pentose phosphate pathway rates in response to high-glucose environments. ASN Neuro 2012;4:e00078. [PMID: 22300409 DOI: 10.1042/AN20120002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
748 Thorpe CT, Thorpe JM, Kind AJ, Bartels CM, Everett CM, Smith MA. Receipt of monitoring of diabetes mellitus in older adults with comorbid dementia. J Am Geriatr Soc 2012;60:644-51. [PMID: 22428535 DOI: 10.1111/j.1532-5415.2012.03907.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
749 Lange K. lndividuelle Therapieziele bei Diabetes und Demenz. Diabetologe 2012;8:136-138. [DOI: 10.1007/s11428-012-0859-4] [Reference Citation Analysis]
750 Costello DA, Claret M, Al-Qassab H, Plattner F, Irvine EE, Choudhury AI, Giese KP, Withers DJ, Pedarzani P. Brain deletion of insulin receptor substrate 2 disrupts hippocampal synaptic plasticity and metaplasticity. PLoS One 2012;7:e31124. [PMID: 22383997 DOI: 10.1371/journal.pone.0031124] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
751 Meakin PJ, Harper AJ, Hamilton DL, Gallagher J, McNeilly AD, Burgess LA, Vaanholt LM, Bannon KA, Latcham J, Hussain I, Speakman JR, Howlett DR, Ashford ML. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice. Biochem J 2012;441:285-96. [PMID: 21880018 DOI: 10.1042/BJ20110512] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 7.8] [Reference Citation Analysis]
752 Hildreth KL, Van Pelt RE, Schwartz RS. Obesity, insulin resistance, and Alzheimer's disease. Obesity (Silver Spring) 2012;20:1549-57. [PMID: 22310232 DOI: 10.1038/oby.2012.19] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
753 Kim B, Feldman EL. Insulin resistance in the nervous system. Trends Endocrinol Metab 2012;23:133-41. [PMID: 22245457 DOI: 10.1016/j.tem.2011.12.004] [Cited by in Crossref: 180] [Cited by in F6Publishing: 167] [Article Influence: 18.0] [Reference Citation Analysis]
754 Huang J, Schmeidler J, Beeri MS, Rosendorff C, Bhatia S, West RK, Bespalova IN, Mavris R, Silverman JM. Haemoglobin A(1c) and cognitive function in very old, cognitively intact men. Age Ageing 2012;41:125-8. [PMID: 21930529 DOI: 10.1093/ageing/afr124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
755 Barber SE, Clegg AP, Young JB. Is there a role for physical activity in preventing cognitive decline in people with mild cognitive impairment? Age Ageing 2012;41:5-8. [PMID: 22083840 DOI: 10.1093/ageing/afr138] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
756 Lee C, Park K. Risk Factors of Dementia. J Korean Diabetes 2012;13:129. [DOI: 10.4093/jkd.2012.13.3.129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
757 Li L, Wang Y, Yan J, Chen Y, Zhou R, Yi X, Shi Q, Zhou H; Chongqing Aging Study Group. Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study. J Neurol 2012;259:1303-11. [PMID: 22186849 DOI: 10.1007/s00415-011-6342-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
758 . Diabetes‐Associated Comorbidities. Staged Diabetes Management 2011. [DOI: 10.1002/9781119950424.ch9] [Reference Citation Analysis]
759 Luchsinger JA, Palmas W, Teresi JA, Silver S, Kong J, Eimicke JP, Weinstock RS, Shea S. Improved diabetes control in the elderly delays global cognitive decline. J Nutr Health Aging 2011;15:445-9. [PMID: 21623465 DOI: 10.1007/s12603-011-0057-x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
760 Wessels AM, Lane KA, Gao S, Hall KS, Unverzagt FW, Hendrie HC. Diabetes and cognitive decline in elderly African Americans: a 15-year follow-up study. Alzheimers Dement. 2011;7:418-424. [PMID: 21784353 DOI: 10.1016/j.jalz.2010.07.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
761 Etgen T, Sander D, Bickel H, Förstl H. Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch Arztebl Int. 2011;108:743-750. [PMID: 22163250 DOI: 10.3238/arztebl.2011.0743] [Cited by in Crossref: 26] [Cited by in F6Publishing: 68] [Article Influence: 2.4] [Reference Citation Analysis]
762 Pavlik VN, Doody RS. Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment. Alzheimers Res Ther 2011;3:30. [PMID: 21999183 DOI: 10.1186/alzrt92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
763 Pancani T, Anderson KL, Porter NM, Thibault O. Imaging of a glucose analog, calcium and NADH in neurons and astrocytes: dynamic responses to depolarization and sensitivity to pioglitazone. Cell Calcium 2011;50:548-58. [PMID: 21978418 DOI: 10.1016/j.ceca.2011.09.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
764 Price JF, Strachan MW. Cognitive impairment in elderly people with Type 2 diabetes: is there an association and why? Aging Health 2011;7:653-656. [DOI: 10.2217/ahe.11.38] [Reference Citation Analysis]
765 Nazarko L. Health risks in undiagnosed or poorly-controlled diabetes. British Journal of Healthcare Assistants 2011;5:479-482. [DOI: 10.12968/bjha.2011.5.10.479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
766 Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, Sullivan M, Horowitz KR, Ding J, Marcovina S. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969-977. [PMID: 21958949 DOI: 10.1016/s1474-4422(11)70188-0] [Cited by in Crossref: 346] [Cited by in F6Publishing: 368] [Article Influence: 31.5] [Reference Citation Analysis]
767 Kooy A. Hypoglycemie bij diabetes: relevant voor het cardiovasculaire risico en de cognitie? NED TIJDSCHR DIABET 2011;9:52-61. [DOI: 10.1007/s12467-011-0016-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
768